<html lang="en" class="pb-page js" data-request-id="94d66a15f0be1927-LAX"><head data-pb-dropzone="head"><style type="text/css" nonce="94d66a15f0be1927-LAX">@font-face {font-family: "Source Sans Pro";src: url(https://consent.trustarc.com/get?name=SourceSansPro-Regular.ttf) format("truetype"),url(https://consent.trustarc.com/get?name=SourceSansPro-Regular.woff) format("woff"),url(https://consent.trustarc.com/get?name=SourceSansPro-Regular.otf) format("opentype"),url(https://consent.trustarc.com/get?name=SourceSansPro-Regular.eot) format("embedded-opentype");}.truste_cursor_pointer {cursor: pointer;}.truste_border_none {border: none;}.truste_accessible_link {font-family: "Source Sans Pro", sans-serif;color: #1D4ED8;font-size: 14px;font-weight: 600;text-decoration: underline;}.truste_accessible_link:hover {color: #1D4ED8;text-decoration: none !important;}.truste_accessible_link:focus-visible {outline: none;border-radius: 4px;box-shadow: 0 0 0 1px #FFFFFF, 0 0 0 4px #3699F1;}</style><script src="https://ssl-cdn.janraincapture.com/widget_data/flow.js:7h8bznq6j7bvyvzqcrwvyp8dfb:en-US:20240514181256512029:standard" type="text/javascript"></script><script src="https://cssjs.nejm.org/akamai/capture:login" type="text/javascript"></script><script src="https://ssl-widget-cdn.rpxnow.com/translations/login/en-US" type="text/javascript"></script><script type="text/javascript" id="janrainAuthWidget" src="https://cssjs.nejm.org/akamai/mms-prod.js"></script><script type="text/javascript" src="https://www.nejm.org/HxD9dVllVfp_fPzJ6UZeH5nvDnknyiMuj6zn345sRTHjv7g6p-zPNgr3HIhJjznwUK0L85rqcZWclQeCyoND3g=="></script>
            

<meta charset="UTF-8">






    
        
            
        
    
        
            
        
    
        
            
        
    
        
            
        
    
        
    
        
    
        
            
                
                
<title>Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women | New England Journal of Medicine</title>





                
            
        
    







    
        
            
        
    
        
            
        
    
        
            
                
                



                
            
        
    
        
            
        
    
        
    
        
    
        
            
        
    











    








    

    
    

    
    
    
    
        
            
                <link rel="stylesheet" type="text/css" href="/wro/1125813~article-metrics.css">
            
            
            
        
    

    
    
        
            <link rel="icon" href="/products/mms-nextgen/mms/releasedAssets/images/favicon/fav_nejm_1-994b0160d1eb33dc79517ef0295aab1b.ico" type="image/x-icon">
        
        
            <link rel="icon" href="/products/mms-nextgen/mms/releasedAssets/images/favicon/fav_16-4aa032aa775940f725817b7ff42f0e2c.png" type="image/png" sizes="16x16">
        
        
            <link rel="icon" href="/products/mms-nextgen/mms/releasedAssets/images/favicon/fav_32-0a94fa44823476ffa0bb15bdb320fb34.png" type="image/png" sizes="32x32">
        
        
            <link rel="apple-touch-icon" href="/products/mms-nextgen/mms/releasedAssets/images/favicon/fav_152-d6c3522864a8e483996b7e9c132c901a.png" sizes="152x152">
        
        
            <link rel="apple-touch-icon" href="/products/mms-nextgen/mms/releasedAssets/images/favicon/fav_180-f2538afc53a365d4cd3f10ab73c56aad.png" sizes="180x180">
        
        
            <link rel="apple-touch-icon" href="/products/mms-nextgen/mms/releasedAssets/images/favicon/fav_167-8e888012bbdd31a00c3e54bc5b8ca5b6.png" sizes="167x167">
        
    

    
    
            <link rel="stylesheet" href="/products/mms-nextgen/mms/releasedAssets/css/build-5b89b331018866a4a965.css" media="all">
        <link rel="stylesheet" href="/products/mms-nextgen/mms/releasedAssets/css/print-5b89b331018866a4a965.css" media="print">
           <link rel="stylesheet" href="/products/mms-nextgen/mms/releasedAssets/css/build-article-5b89b331018866a4a965.css" media="all" id="article-style-sheet">
    
        <script nonce="94d66a15f0be1927-LAX">
        try {
            document.documentElement.classList.add('js');
        } catch (e) {
        }
    </script>
     
    

















    
        
            
                
                
                
                    
                    <!-- TrustArc Scripts -->
<script async="async" src="https://consent.trustarc.com/notice?domain=nejm.com&amp;c=teconsent&amp;js=nj&amp;noticeType=bb&amp;gtm=1&amp;text=true&amp;pcookie" crossorigin="" id="truste_0.5450345206310195"></script>
<script src="https://consent.trustarc.com/autoblockasset/core.min.js?domain=nejm.com"></script>
<script src="https://consent.trustarc.com/autoblockoptout?domain=nejm.com"></script>
<!-- /TrustArc Scripts -->
<!-- BlueConic Scripts -->
<script src="https://bc.nejm.org/script.js"></script>
    <!-- /BlueConic Scripts -->
<!-- Printing Meta Tags -->
    <meta name="Specialties" content="Hematology/Oncology|Genetics">
<meta name="articleType" content="Original Article">
<meta name="articleCategory" content="Research">
<meta name="topics" content="Breast Cancer|Cancer"><script type="text/javascript">var mmsData = {"access":{"isFreeCountry":"n"},"ad":{"category":"article"},"imageChallenge":{"id":null},"article":{"doi":"10.1056/NEJMoa1913948","title":"Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women","category":"Research","type":"Original Article","topics":"Breast Cancer|Cancer","specialties":"Hematology/Oncology|Genetics","seriesTitle":"","viewType":"Full","age":"2Years-1990","issueDate":"2021-02-04T00:00Z","isFree":"y","broadTopics":"","perspectiveTopics":"","granularTopics":"","methodologicalArea":"","isOnlineFirst":"n","isCurrentIssue":"n","metaTags":"\u003cmeta name\u003d\"Specialties\" content\u003d\"Hematology/Oncology|Genetics\"/\u003e\n\u003cmeta name\u003d\"articleType\" content\u003d\"Original Article\"/\u003e\n\u003cmeta name\u003d\"articleCategory\" content\u003d\"Research\"/\u003e\n\u003cmeta name\u003d\"topics\" content\u003d\"Breast Cancer|Cancer\"/\u003e"},"page":{"activity":"showFullText","url":"www.nejm.org/doi/full/10.1056/NEJMoa1913948","viewType":"desktop","journal":"NEJM"},"user":{"ucid":null,"audienceSegment":null,"specialtyGroupCode":null,"meterCountRemaining":null,"totalMeterCount":null},"object":[]};</script>
    <script type="text/javascript">var mmsDataAdd = {"user":{"customerType":"null","accessInstitutionID":"null"}};</script>
    <!-- Prehiding snippet for Adobe Target with asynchronous Launch deployment -->
    <!-- placeholder id=null, description=Adobe-Target-Prehiding-Snippet --><!--
  Adobe Target - Prehiding Snippet
  v2.0.0
-->
<script nonce="94d66a15f0be1927-LAX">
function tgtNoFlicker(e,n,t,o,i,c,l,r){function d(){return n.getElementsByTagName("head")[0]}function a(e,t){if(e){var o=n.getElementById(t);o&&e.removeChild(o)}}function f(e,o){!function(e,t,o){if(e){var i=n.createElement("style");i.id=t,i.innerHTML=o,e.appendChild(i)}}(d(),t,e),setTimeout(function(){a(d(),t)},o)}var m;n.location.href.indexOf(c)>-1?f(l,r):f(o,i),n.location.href.indexOf("mboxDisable")>-1?(a(d(),t),console.log("[TARGET] - Disabled, removing prehiding style")):(m=function(e){e&&(a(d(),t),console.log("[TARGET] - Blocked, removing prehiding style"))},fetch("//cdn.tt.omtrdc.net/cdn/target-vec.js",{method:"HEAD",mode:"no-cors"}).then(e=>m(!1)).catch(e=>m(!0)))}

tgtNoFlicker(window, document, 'at-body-style', 'div[data-location-name="Anonymous Module"], div[data-location-name="Anonymous Banner"], main > div.page-body > div > div > div > div.col-md-2-3.o-col.o-col--primary > div[class*="u-hide"], main > div.page-body > div > div > div > div.col-md-1-3.o-col.o-col--secondary > aside, header > h1#mainContent, a.m-article__link[href*="/10.1056/NEJMoa2116747"] > span.m-article__blurb > p, li.g-nejm-group__user-tool-secondary {opacity: 0 !important}', 3000);

tgtNoFlicker(window, document, 'at-mbox-style', '.N-ad-global-top-right, #N-ad-myNEJM-contextual-top, .N-ad-recentArticles, #N-ad-article-rightRail-1, #N-ad-siteWide-rightRail-1, #N-ad-imageChallenge-rightRail-2 {opacity: 0 !important}', 3000);
</script><!-- /Prehiding snippet for Adobe Target with asynchronous Launch deployment -->
    <!-- Launch Header Embed Code -->
    <script src="//assets.adobedtm.com/launch-ENcd6450fae3ae4870becbe6a2b01ab2e1.min.js" async="" type="ta-blocked" data-ta-blocked="1"></script>
    <!-- /Launch Header Embed Code -->

                    
                
            
        
    
        
            
                
                
                
                    
                    <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="New England Journal of Medicine"><meta name="dc.Title" content="Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women"><meta name="dc.Creator" content="Breast Cancer Association Consortium"><meta name="dc.Description" content="Genetic testing for breast cancer susceptibility is widely used, but for many genes, evidence of an association with breast cancer is weak, underlying risk estimates are imprecise, and reliable sub..."><meta name="Description" content="Genetic testing for breast cancer susceptibility is widely used, but for many genes, evidence of an association with breast cancer is weak, underlying risk estimates are imprecise, and reliable sub..."><meta name="dc.Publisher" content="Massachusetts Medical Society"><meta name="dc.Date" scheme="WTN8601" content="2021-02-04"><meta name="dc.Type" content="research-article"><meta name="dc.Format" content="text/HTML"><meta name="dc.Identifier" scheme="doi" content="10.1056/NEJMoa1913948"><meta name="dc.Identifier" scheme="publisher-id" content="NJ202102043840507"><meta name="dc.Language" content="EN"><meta name="dc.Relation" content="10.1056/NEJMoa2005936"><meta name="dc.Relation" content="10.1056/NEJMe2035083"><meta name="dc.Relation" content="YXQYoa1913948"><meta name="dc.Coverage" content="world"><meta name="dc.Rights" content="Copyright © 2021 Massachusetts Medical Society. All rights reserved.">




<link rel="meta" type="application/atom+xml" href="https://doi.org/10.1056%2FNEJMoa1913948">
<link rel="meta" type="application/rdf+json" href="https://doi.org/10.1056%2FNEJMoa1913948">
<link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1056%2FNEJMoa1913948">


                    
                
            
        
    
        
            
                
                
                
                
                
            
        
    
        
            
                
                
                
                    
                    





<meta name="robots" content="noarchive">





    





    
    
        
        <meta name="twitter:title" content="Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women | NEJM">
        <meta property="og:title" content="Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women | NEJM">
    


    <meta property="og:type" content="article">


    
    
        <meta property="og:url" content="https://www.nejm.org/doi/full/10.1056/NEJMoa1913948">
    
    


    
    
        <meta property="og:image" content="https://www.nejm.org/cms/asset/d5f4eaa6-7576-49a3-889f-554c9e046254/nejmoa1913948_f1.jpg">
        <meta name="twitter:image" content="https://www.nejm.org/cms/asset/d5f4eaa6-7576-49a3-889f-554c9e046254/nejmoa1913948_f1.jpg">
    



    <meta property="og:site_name" content="The New England Journal of Medicine">


    
    
        
        <meta property="og:description" content="Genetic testing for breast cancer susceptibility is widely used, but for many genes,
evidence of an association with breast cancer is weak, underlying risk estimates are
imprecise, and reliable sub...">
        <meta name="twitter:description" content="Genetic testing for breast cancer susceptibility is widely used, but for many genes,
evidence of an association with breast cancer is weak, underlying risk estimates are
imprecise, and reliable sub...">
    


    
    
        <meta property="og:image:width" content="2640">
    


    
    
        <meta property="og:image:height" content="1376">
    


    <meta name="twitter:card" content="summary">


    <meta name="twitter:site" content="@NEJM">


<meta name="viewport" content="width=device-width,initial-scale=1"><meta name="citation_fulltext_world_readable" content="">
    <meta name="publication_doi" content="10.1056/NEJMoa1913948">


    















                    
                
            
        
    
        
    
        
    
        
            
                
                
                
                
                
            
        
    




<meta name="format-detection" content="telephone=no">

<meta http-equiv="X-UA-Compatible" content="IE=edge">
    




    
        
        
        <link rel="canonical" href="https://www.nejm.org/doi/full/10.1056/NEJMoa1913948">
    
    







<meta name="pbContext" content=";requestedJournal:journal:nejm;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:MMS NextGen Website Group;article:article:doi\:10.1056/NEJMoa1913948;pageGroup:string:Publication Pages;subPage:string:Full Text;website:website:mms-site;issue:issue:doi\:10.1056/nejm_2021.384.issue-5;journal:journal:nejms">
        <link rel="stylesheet" type="text/css" href="https://cssjs.nejm.org/custreg-933-8e181dff8b36ea01dc4c.css"><link rel="stylesheet" type="text/css" href="https://cssjs.nejm.org/custreg-34-6ea546d794fb7a1cea52.css"><link rel="stylesheet" type="text/css" href="https://cssjs.nejm.org/custreg-743-ddd329e1530654ec0846.css"><link rel="stylesheet" type="text/css" href="https://cssjs.nejm.org/custreg-305-9eee37798fdfe5196307.css"><link rel="stylesheet" type="text/css" href="https://cssjs.nejm.org/custreg-388-bb098c62445f518c0b46.css"><link rel="stylesheet" type="text/css" href="https://cssjs.nejm.org/custreg-556-8e58ca05fb5497e541ef.css"><script charset="utf-8" src="https://www.nejm.org/products/mms-nextgen/mms/releasedAssets/js/0-dfd243c732a07d3608f6.js"></script><script charset="utf-8" src="https://www.nejm.org/products/mms-nextgen/mms/releasedAssets/js/7-10d355ba95f7ec1fddf2.js"></script><script charset="utf-8" src="https://www.nejm.org/products/mms-nextgen/mms/releasedAssets/js/11-04bf2a0da30146b4a5d0.js"></script><script src="https://static.addtoany.com/menu/modules/core.pt5ow5lr.js" type="module"></script><link rel="preconnect" href="https://use.typekit.net"><link rel="stylesheet" href="https://quilt-cdn.janrain.com/HEAD/providers.css" type="text/css"><style type="text/css">.a2a_hide{display:none}.a2a_logo_color{background-color:#0166ff}.a2a_menu,.a2a_menu *{-moz-box-sizing:content-box;-webkit-box-sizing:content-box;box-sizing:content-box;float:none;margin:0;padding:0;position:static;height:auto;width:auto}.a2a_menu{border-radius:6px;display:none;direction:ltr;background:#FFF;font:16px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;color:#000;line-height:12px;border:1px solid #CCC;vertical-align:baseline;overflow:hidden}.a2a_mini{min-width:200px;position:absolute;width:300px;z-index:9999997}.a2a_overlay{display:none;background:#616c7deb;backdrop-filter:blur(4px);-webkit-backdrop-filter:blur(4px);position:fixed;top:0;right:0;left:0;bottom:0;z-index:9999998;-webkit-tap-highlight-color:transparent;transition:opacity .14s,backdrop-filter .14s}.a2a_full{background:#FFF;border:1px solid #FFF;box-shadow:#2a2a2a1a 0 0 20px 10px;height:auto;height:calc(320px);top:15%;left:50%;margin-left:-320px;position:fixed;text-align:center;width:640px;z-index:9999999;transition:transform .14s,opacity .14s}.a2a_full_footer,.a2a_full_header,.a2a_full_services{border:0;margin:0;padding:12px;box-sizing:border-box}.a2a_full_header{padding-bottom:8px}.a2a_full_services{height:280px;overflow-y:scroll;padding:0 12px;-webkit-overflow-scrolling:touch}.a2a_full_services .a2a_i{display:inline-block;float:none;width:181px;width:calc(33.334% - 18px)}div.a2a_full_footer{font-size:12px;text-align:center;padding:8px 14px}div.a2a_full_footer a,div.a2a_full_footer a:visited{display:inline;font-size:12px;line-height:14px;padding:8px 14px}div.a2a_full_footer a:focus,div.a2a_full_footer a:hover{background:0 0;border:0;color:#0166FF}div.a2a_full_footer a span.a2a_s_a2a,div.a2a_full_footer a span.a2a_w_a2a{background-size:14px;border-radius:3px;display:inline-block;height:14px;line-height:14px;margin:0 3px 0 0;vertical-align:top;width:14px}.a2a_modal{height:0;left:50%;margin-left:-320px;position:fixed;text-align:center;top:15%;width:640px;z-index:9999999;transition:transform .14s,opacity .14s;-webkit-tap-highlight-color:transparent}.a2a_modal_body{background:0 0;border:0;font:24px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;position:relative;height:auto;width:auto}.a2a_thanks{color:#fff;height:auto;margin-top:20px;width:auto}.a2a_thanks>div:first-child{margin:0 0 40px 0}.a2a_thanks div *{height:inherit}#a2a_copy_link{background:#FFF;border:1px solid #FFF;cursor:pointer;margin-top:15%}label.a2a_s_link#a2a_copy_link_icon,label.a2a_w_link#a2a_copy_link_icon{background-size:48px;border-radius:0;display:inline-block;height:48px;left:0;line-height:48px;margin:0 3px 0 0;position:absolute;vertical-align:top;width:48px}#a2a_modal input#a2a_copy_link_text{background-color:transparent;border:0;color:#2A2A2A;cursor:pointer;font:inherit;height:48px;left:62px;max-width:initial;min-height:auto;padding:0;position:relative;width:564px;width:calc(100% - 76px)}#a2a_copy_link_copied{background-color:#0166ff;color:#fff;display:none;font:inherit;font-size:16px;margin-top:1px;padding:3px 8px}@media (forced-colors:active){.a2a_color_buttons a,.a2a_svg{forced-color-adjust:none}}@media (prefers-color-scheme:dark){.a2a_menu a,.a2a_menu a.a2a_i,.a2a_menu a.a2a_i:visited,.a2a_menu a.a2a_more,i.a2a_i{border-color:#2a2a2a!important;color:#fff!important}.a2a_menu a.a2a_i:active,.a2a_menu a.a2a_i:focus,.a2a_menu a.a2a_i:hover,.a2a_menu a.a2a_more:active,.a2a_menu a.a2a_more:focus,.a2a_menu a.a2a_more:hover,.a2a_menu_find_container{border-color:#444!important;background-color:#444!important}.a2a_menu:not(.a2a_thanks){background-color:#2a2a2a;border-color:#2a2a2a}.a2a_menu_find{color:#fff!important}.a2a_menu label.a2a_s_find svg{background-color:transparent!important}.a2a_menu label.a2a_s_find svg path{fill:#fff!important}.a2a_full{box-shadow:#00000066 0 0 20px 10px}.a2a_overlay{background-color:#373737eb}}@media print{.a2a_floating_style,.a2a_menu,.a2a_overlay{visibility:hidden}}@keyframes a2aFadeIn{from{opacity:0}to{opacity:1}}.a2a_starting{opacity:0}.a2a_starting.a2a_full,.a2a_starting.a2a_modal{transform:scale(.8)}@media (max-width:639px){.a2a_full{border-radius:0;top:15%;left:0;margin-left:auto;width:100%}.a2a_modal{left:0;margin-left:10px;width:calc(100% - 20px)}}@media (min-width:318px) and (max-width:437px){.a2a_full .a2a_full_services .a2a_i{width:calc(50% - 18px)}}@media (max-width:317px){.a2a_full .a2a_full_services .a2a_i{width:calc(100% - 18px)}}@media (max-height:436px){.a2a_full{bottom:40px;height:auto;top:40px}}@media (max-height:550px){.a2a_modal{top:30px}}@media (max-height:360px){.a2a_modal{top:20px}.a2a_thanks>div:first-child{margin-bottom:20px}}.a2a_menu a{color:#0166FF;text-decoration:none;font:16px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;line-height:14px;height:auto;width:auto;outline:0}.a2a_menu a.a2a_i:visited,.a2a_menu a.a2a_more{color:#0166FF}.a2a_menu a.a2a_i:active,.a2a_menu a.a2a_i:focus,.a2a_menu a.a2a_i:hover,.a2a_menu a.a2a_more:active,.a2a_menu a.a2a_more:focus,.a2a_menu a.a2a_more:hover{color:#2A2A2A;border-color:#EEE;border-style:solid;background-color:#EEE;text-decoration:none}.a2a_menu label.a2a_s_find{background-size:24px;height:24px;left:8px;pointer-events:auto;position:absolute;top:7px;width:24px}.a2a_menu label.a2a_s_find svg{background-color:#FFF}.a2a_menu label.a2a_s_find svg path{fill:#CCC}#a2a_menu_container{display:inline-block}.a2a_menu_find_container{border:1px solid #CCC;border-radius:6px;padding:2px 24px 2px 0;position:relative;text-align:left}.a2a_cols_container .a2a_col1{overflow-x:hidden;overflow-y:auto;-webkit-overflow-scrolling:touch}#a2a_modal input,#a2a_modal input[type=text],.a2a_menu input,.a2a_menu input[type=text]{display:block;background-image:none;box-shadow:none;line-height:100%;margin:0;outline:0;overflow:hidden;padding:0;-moz-box-shadow:none;-webkit-box-shadow:none;-webkit-appearance:none}#a2afeed_find_container input,#a2afeed_find_container input[type=text],#a2apage_find_container input,#a2apage_find_container input[type=text]{background-color:transparent;border:0;box-sizing:content-box;color:#2A2A2A;float:none;font:inherit;font-size:16px;height:28px;line-height:20px;left:38px;outline:0;margin:0;max-width:initial;min-height:initial;padding:2px 0;position:relative;width:99%}.a2a_clear{clear:both}.a2a_svg{background-repeat:no-repeat;display:block;overflow:hidden;height:32px;line-height:32px;padding:0;pointer-events:none;width:32px}.a2a_svg svg{background-repeat:no-repeat;background-position:50% 50%;border:none;display:block;left:0;margin:0 auto;overflow:hidden;padding:0;position:relative;top:0;width:auto;height:auto}a.a2a_i,i.a2a_i{display:block;float:left;border:1px solid #FFF;line-height:24px;padding:6px 8px;text-align:left;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;width:132px}a.a2a_i span,a.a2a_more span{display:inline-block;overflow:hidden;vertical-align:top}a.a2a_i .a2a_svg{margin:0 6px 0 0}a.a2a_i .a2a_svg,a.a2a_more .a2a_svg{background-size:24px;height:24px;line-height:24px;width:24px}a.a2a_sss:hover{border-left:1px solid #CCC}a.a2a_more{border-bottom:1px solid #FFF;border-left:0;border-right:0;line-height:24px;margin:6px 0 0;padding:6px;-webkit-touch-callout:none}a.a2a_more span{height:24px;margin:0 6px 0 0}.a2a_kit .a2a_svg{background-repeat:repeat}.a2a_default_style a:empty,.a2a_flex_style a:empty,.a2a_floating_style a:empty,.a2a_overlay_style a:empty{display:none}.a2a_color_buttons a,.a2a_floating_style a{text-decoration:none}.a2a_default_style:not(.a2a_flex_style) a{float:left;line-height:16px;padding:0 2px}.a2a_default_style a:hover .a2a_svg,.a2a_floating_style a:hover .a2a_svg,.a2a_overlay_style a:hover .a2a_svg svg{opacity:.7}.a2a_overlay_style.a2a_default_style a:hover .a2a_svg{opacity:1}.a2a_default_style .a2a_count,.a2a_default_style .a2a_svg,.a2a_floating_style .a2a_svg,.a2a_menu .a2a_svg,.a2a_vertical_style .a2a_count,.a2a_vertical_style .a2a_svg{border-radius:4px}.a2a_default_style .a2a_counter img,.a2a_default_style .a2a_dd,.a2a_default_style .a2a_svg{float:left}.a2a_default_style .a2a_img_text{margin-right:4px}.a2a_default_style .a2a_divider{border-left:1px solid #000;display:inline;float:left;height:16px;line-height:16px;margin:0 5px}.a2a_kit a{cursor:pointer;transition:none}.a2a_floating_style{background-color:#fff;border-radius:6px;position:fixed;z-index:9999995}.a2a_overlay_style{z-index:2147483647}.a2a_floating_style,.a2a_overlay_style{animation:a2aFadeIn .2s ease-in;padding:4px}.a2a_vertical_style:not(.a2a_flex_style) a{clear:left;display:block;overflow:hidden;padding:4px}.a2a_floating_style.a2a_default_style{bottom:0}.a2a_floating_style.a2a_default_style a,.a2a_overlay_style.a2a_default_style a{padding:4px}.a2a_count{background-color:#fff;border:1px solid #ccc;box-sizing:border-box;color:#2a2a2a;display:block;float:left;font:12px Arial,Helvetica,sans-serif;height:16px;margin-left:4px;position:relative;text-align:center;width:50px}.a2a_count:after,.a2a_count:before{border:solid transparent;border-width:4px 4px 4px 0;content:"";height:0;left:0;line-height:0;margin:-4px 0 0 -4px;position:absolute;top:50%;width:0}.a2a_count:before{border-right-color:#ccc}.a2a_count:after{border-right-color:#fff;margin-left:-3px}.a2a_count span{animation:a2aFadeIn .14s ease-in}.a2a_vertical_style .a2a_counter img{display:block}.a2a_vertical_style .a2a_count{float:none;margin-left:0;margin-top:6px}.a2a_vertical_style .a2a_count:after,.a2a_vertical_style .a2a_count:before{border:solid transparent;border-width:0 4px 4px 4px;content:"";height:0;left:50%;line-height:0;margin:-4px 0 0 -4px;position:absolute;top:0;width:0}.a2a_vertical_style .a2a_count:before{border-bottom-color:#ccc}.a2a_vertical_style .a2a_count:after{border-bottom-color:#fff;margin-top:-3px}.a2a_color_buttons .a2a_count,.a2a_color_buttons .a2a_count:after,.a2a_color_buttons .a2a_count:before,.a2a_color_buttons.a2a_vertical_style .a2a_count:after,.a2a_color_buttons.a2a_vertical_style .a2a_count:before{background-color:transparent;border:none;color:#fff;float:none;width:auto}.a2a_color_buttons.a2a_vertical_style .a2a_count{margin-top:0}.a2a_flex_style{display:flex;align-items:flex-start;gap:0}.a2a_default_style.a2a_flex_style{left:0;right:0;width:100%}.a2a_vertical_style.a2a_flex_style{flex-direction:column;top:0;bottom:0}.a2a_flex_style a{display:flex;justify-content:center;flex:1;padding:4px}.a2a_flex_style.a2a_vertical_style a{flex-direction:column}.a2a_floating_style.a2a_color_buttons,.a2a_floating_style.a2a_flex_style{border-radius:0;padding:0}.a2a_floating_style.a2a_default_style.a2a_flex_style{bottom:0}.a2a_kit.a2a_flex_style .a2a_counter img,.a2a_kit.a2a_flex_style .a2a_dd,.a2a_kit.a2a_flex_style .a2a_svg{float:none}.a2a_nowrap{white-space:nowrap}.a2a_note{margin:0 auto;padding:9px;font-size:12px;text-align:center}.a2a_note .a2a_note_note{margin:0;color:#2A2A2A}.a2a_wide a{display:block;margin-top:3px;border-top:1px solid #EEE;text-align:center}.a2a_label{position:absolute!important;clip-path:polygon(0px 0px,0px 0px,0px 0px);-webkit-clip-path:polygon(0px 0px,0px 0px,0px 0px);overflow:hidden;height:1px;width:1px}.a2a_kit,.a2a_menu,.a2a_modal,.a2a_overlay{-ms-touch-action:manipulation;touch-action:manipulation;outline:0}.a2a_dd{-webkit-user-drag:none}.a2a_dd img{border:0}.a2a_button_facebook_like iframe{max-width:none}</style><script id="altmetric-embed-js" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/altmetric_badges-288192a491f0ad9cc434f05ea175659426f5ab0cfd6befb3f3592f96bb90b0d1.js"></script><meta http-equiv="P3P" content="CP=&quot;NOI DSP ADM OUR IND OTC&quot;"><link id="altmetric-embed-css" rel="stylesheet" type="text/css" href="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed-59614f5c46b49b21eeef3bb28c4fb38d1e7069e8d014752fcb66e84942556802.css"></head>
    

    



    
        
        
        
            <body class="pb-ui website-mms-site loaded">
            






    
    
        





    
    
        
        
    
    
    







<input type="hidden" id="isRoMode" name="isRoMode" value="false">

        <div id="pb-page-content" data-ng-non-bindable="">
                
            <div data-pb-dropzone="main" data-pb-dropzone-name="Main">
                
                    
                        



        
        <header data-sticky="false" class="ng-header js_stickyAd"><a href="#mainContent" class="ng-skipToMainContent">Skip to main content</a><div class="ng-header_topAd"><div class="ng-header_topAd-content d-flex justify-content-center align-items-center">



        
        <div id="DTM_Position_Topbanner" class="ad">
 <!--emptycomment-->
</div>
</div></div><div class="ng-header_journal-navbar"><div class="ng-header_journal-navbar-content"><div class="container-fluid"><div class="row"><div class="ng-header_journal-navbar_left col-lg-8 col-sm-12 pr-lg-0 d-flex align-items-center"><div data-location="nejm_group_product_nav" class="ng-header_journalNavMenu">



        
        <nav data-location="nejm_group_product_nav" role="navigation" class="ng-journalNavMenu">
<ul class="ng-journalNavMenu_list">
<li class="ng-journalNavMenu_list-item"><a href="/" class="ng-journalNavMenu_mainLink active" aria-current="page" aria-label="The New England Journal of Medicine selected item"><span class="ng-journalNavMenu_mainLink-text d-lg-block d-none">The New England Journal of Medicine</span><span class="ng-journalNavMenu_mainLink-text d-lg-none d-block">NEJM</span></a></li>
<li class="ng-journalNavMenu_list-item"><a href="https://evidence.nejm.org/" class="ng-journalNavMenu_mainLink"><span class="ng-journalNavMenu_mainLink-text"><span class="ng-journalNavMenu_mainLink-text-firstWord">NEJM</span> Evidence</span></a></li>
<li class="ng-journalNavMenu_list-item"><a href="https://ai.nejm.org/" class="ng-journalNavMenu_mainLink"><span class="ng-journalNavMenu_mainLink-text"><span class="ng-journalNavMenu_mainLink-text-firstWord">NEJM</span> AI</span></a></li>
<li class="ng-journalNavMenu_list-item"><a href="https://catalyst.nejm.org/" class="ng-journalNavMenu_mainLink"><span class="ng-journalNavMenu_mainLink-text"><span class="ng-journalNavMenu_mainLink-text-firstWord">NEJM</span> Catalyst</span></a></li>
<li class="ng-journalNavMenu_list-item"><a href="https://www.jwatch.org/" class="ng-journalNavMenu_mainLink"><span class="ng-journalNavMenu_mainLink-text"><span class="ng-journalNavMenu_mainLink-text-firstWord">NEJM</span> Journal Watch</span></a></li>
</ul>
</nav>

</div></div><div class="ng-header_journal-navbar_right col-lg-4 pl-lg-0 d-none d-xl-flex align-items-center justify-content-end"><div class="ng-header_loginBar d-xl-flex align-items-lg-center">



        
        <div data-location="authstring_nav" class="ng-header_loginBar-menu"><span class="ng-simple-menu_mainLink-icon signIn newIcon-2"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#user2"></use></svg></span></span><span class="ng-header_loginBar-signIn"><a href="/sign-in?uri=/doi/full/10.1056/NEJMoa1913948" class="ng-header_loginBar-signIn-link">Sign In</a></span><span class="ng-header_loginBar-separator">|</span><span class="ng-header_loginBar-createAcc"><a href="/action/storeProxy?action=register&amp;promo=ONFLNRC1" class="ng-header_loginBar-createAcc-link ro-mode_disabled">Create Account</a></span></div><div data-location="authstring_nav" class="ng-header_loginBar-subscribe pl-xl-16"><a href="/action/storeProxy?action=subscribe&amp;promo=ONF4NRS1" class="ng-header_loginBar-subscribe-btn ng-btn_primary ro-mode_disabled">Subscribe</a></div>
</div></div></div></div></div></div><div class="ng-header_instBanner d-none d-lg-block"></div><div class="ng-header_logoBar"><div class="container-fluid"><div class="row"><div data-location="logo" class="ng-header_logoBar_left col-lg-4 col-6 d-flex align-items-center justify-content-start"><a href="/" title="The New England Journal of Medicine homepage" class="ng-header_logo-link"><img src="/specs/products/mms-nextgen/mms/releasedAssets/images/other-images/nejm-logo-166667e91992a5212bc723b03e45d39f.svg" alt="The New England Journal of Medicine homepage" width="366" height="58" class="ng-header_logo-image"></a></div><div class="ng-header_logoBar_right ng-header_navBar col-lg-8 col-sm-12 p-lg-0 align-items-center justify-content-end"><div class="ng-header_navBar-content"><div class="container-fluid"><div class="row"><div class="ng-header_instBanner-md col-12 d-block d-lg-none"></div><div class="ng-header_loginBar-md col-12 d-block d-xl-none">



        
        <div data-location="authstring_nav" class="ng-header_loginBar-menu"><span class="ng-simple-menu_mainLink-icon signIn newIcon-2"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#user2"></use></svg></span></span><span class="ng-header_loginBar-signIn"><a href="/sign-in?uri=/doi/full/10.1056/NEJMoa1913948" class="ng-header_loginBar-signIn-link">Sign In</a></span><span class="ng-header_loginBar-separator">|</span><span class="ng-header_loginBar-createAcc"><a href="/action/storeProxy?action=register&amp;promo=ONFLNRC1" class="ng-header_loginBar-createAcc-link ro-mode_disabled">Create Account</a></span></div><div data-location="authstring_nav" class="ng-header_loginBar-subscribe pl-xl-16"><a href="/action/storeProxy?action=subscribe&amp;promo=ONF4NRS1" class="ng-header_loginBar-subscribe-btn ng-btn_primary ro-mode_disabled">Subscribe</a></div>
</div><div class="ng-header_navBar_left col-lg-8 col-sm-12 d-flex align-items-center"><div class="ng-header_stickyLogo mr-32"><a href="/" title="The New England Journal of Medicine homepage" class="ng-header_stickyLogo-link"><img src="/specs/products/mms-nextgen/mms/releasedAssets/images/other-images/nejm-small-logo-070df7a3f4d8cfa2e71c3c45bb4b172f.svg" alt="The New England Journal of Medicine homepage" class="ng-header_stickyLogo-image"></a></div><div class="ng-header_mainMenu">









    
    
        <div data-widget-def="menuWidget" data-widget-id="97fb3983-db63-4b0b-97dd-d9bb7929fce1" data-location="main_nav">
        



        
        <nav class="ng-menu"><ul class="ng-menu_list ng-simple-menu"><li class="ng-menu_list-item ng-simple-menu_item hasChildren"><a href="/toc/nejm/current" class="ng-simple-menu_mainLink"><span class="ng-simple-menu_mainLink-text">current issue</span><span class="ng-simple-menu_mainLink-arrowIcon"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-down"></use></svg></span></span></a><div class="ng-simple-menu_dropblock"><div class="ng-simple-menu_dropblock-cont"><div class="ng-simple-menu_list"><ul class="ng-simple-menu_list-items"><li class="ng-simple-menu_list-item"><a href="/toc/nejm/current" class="ng-simple-menu_list-link">VIEW CURRENT ISSUE</a></li><li class="ng-simple-menu_list-item"><a href="/toc/nejm/recently-published" class="ng-simple-menu_list-link">BROWSE RECENTLY PUBLISHED</a></li><li class="ng-simple-menu_list-item"><a href="/loi/nejm" class="ng-simple-menu_list-link">BROWSE ALL ISSUES</a></li></ul></div></div></div></li><li class="ng-menu_list-item ng-simple-menu_item hasChildren"><a href="/medical-specialties" class="ng-simple-menu_mainLink"><span class="ng-simple-menu_mainLink-text">SPECIALTIES</span><span class="ng-simple-menu_mainLink-arrowIcon"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-down"></use></svg></span></span></a><div class="ng-simple-menu_dropblock"><div class="ng-simple-menu_dropblock-cont"><div class="ng-simple-menu_list"><ul class="ng-simple-menu_list-items"><li class="ng-simple-menu_list-item"><a href="/browse/specialty/cardiology" class="ng-simple-menu_list-link">Cardiology</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/clinical-medicine" class="ng-simple-menu_list-link">Clinical Medicine</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/endocrinology" class="ng-simple-menu_list-link">Endocrinology</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/gastroenterology" class="ng-simple-menu_list-link">Gastroenterology</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/hematology-oncology" class="ng-simple-menu_list-link">Hematology/Oncology</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/infectious-disease" class="ng-simple-menu_list-link">Infectious Disease</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/nephrology" class="ng-simple-menu_list-link">Nephrology</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/neurology-neurosurgery" class="ng-simple-menu_list-link">Neurology/Neurosurgery</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/obstetrics-gynecology" class="ng-simple-menu_list-link">Obstetrics/Gynecology</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/pediatrics" class="ng-simple-menu_list-link">Pediatrics</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/pulmonary-critical-care" class="ng-simple-menu_list-link">Pulmonary/Critical Care</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/surgery" class="ng-simple-menu_list-link">Surgery</a></li><li class="ng-simple-menu_list-item"><a href="/medical-specialties" class="ng-simple-menu_list-link">View All Specialties</a></li></ul></div></div></div></li><li class="ng-menu_list-item ng-simple-menu_item hasChildren"><a href="/topics" class="ng-simple-menu_mainLink"><span class="ng-simple-menu_mainLink-text">TOPICS</span><span class="ng-simple-menu_mainLink-arrowIcon"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-down"></use></svg></span></span></a><div class="ng-simple-menu_dropblock"><div class="ng-simple-menu_dropblock-cont"><div class="ng-simple-menu_list"><ul class="ng-simple-menu_list-items"><li class="ng-simple-menu_list-item"><a href="/ai-in-medicine" class="ng-simple-menu_list-link">AI in Medicine</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/climate-change" class="ng-simple-menu_list-link">Climate Change</a></li><li class="ng-simple-menu_list-item"><a href="/coronavirus" class="ng-simple-menu_list-link">Coronavirus</a></li><li class="ng-simple-menu_list-item"><a href="/equity" class="ng-simple-menu_list-link">Efforts toward Equity</a></li><li class="ng-simple-menu_list-item"><a href="/firearm-injury-prevention" class="ng-simple-menu_list-link">Firearm Injury Prevention</a></li><li class="ng-simple-menu_list-item"><a href="/nam" class="ng-simple-menu_list-link">From the National Academy of Medicine</a></li><li class="ng-simple-menu_list-item"><a href="/fundamentals-of-medical-ethics" class="ng-simple-menu_list-link">Fundamentals of Medical Ethics</a></li><li class="ng-simple-menu_list-item"><a href="/gray-matters" class="ng-simple-menu_list-link">Gray Matters</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/health-policy" class="ng-simple-menu_list-link">Health Policy</a></li><li class="ng-simple-menu_list-item"><a href="/medicine-and-society" class="ng-simple-menu_list-link">Medicine and Society</a></li><li class="ng-simple-menu_list-item"><a href="/nutrition-in-medicine" class="ng-simple-menu_list-link">Nutrition in Medicine</a></li><li class="ng-simple-menu_list-item"><a href="/outbreaks" class="ng-simple-menu_list-link">Outbreaks Center</a></li><li class="ng-simple-menu_list-item"><a href="/race-and-medicine" class="ng-simple-menu_list-link">Race and Medicine</a></li><li class="ng-simple-menu_list-item"><a href="/recognizing-historical-injustices" class="ng-simple-menu_list-link">Recognizing Historical Injustices and the Journal</a></li><li class="ng-simple-menu_list-item"><a href="/tobacco-use-reduction" class="ng-simple-menu_list-link">Tobacco Use Reduction</a></li><li class="ng-simple-menu_list-item"><a href="/topics" class="ng-simple-menu_list-link">View All Topics</a></li></ul></div></div></div></li><li class="ng-menu_list-item ng-simple-menu_item hasChildren"><a href="/multimedia" class="ng-simple-menu_mainLink"><span class="ng-simple-menu_mainLink-text">MULTIMEDIA</span><span class="ng-simple-menu_mainLink-arrowIcon"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-down"></use></svg></span></span></a><div class="ng-simple-menu_dropblock"><div class="ng-simple-menu_dropblock-cont"><div class="ng-simple-menu_list"><ul class="ng-simple-menu_list-items"><li class="ng-simple-menu_list-item"><a href="/rss-feed" class="ng-simple-menu_list-link">Podcasts</a></li><li class="ng-simple-menu_list-item"><a href="/double-take" class="ng-simple-menu_list-link">Double Takes</a></li><li class="ng-simple-menu_list-item"><a href="https://illustrated-glossary.nejm.org/" class="ng-simple-menu_list-link">Illustrated Glossary</a></li><li class="ng-simple-menu_list-item"><a href="/image-challenge" class="ng-simple-menu_list-link">Image Challenge</a></li><li class="ng-simple-menu_list-item"><a href="/browse/nejm-media-type/images-in-clinical-medicine" class="ng-simple-menu_list-link">Images in Clinical Medicine</a></li><li class="ng-simple-menu_list-item"><a href="/browse/nejm-media-type/interactive-medical-case" class="ng-simple-menu_list-link">Interactive Medical Cases</a></li><li class="ng-simple-menu_list-item"><a href="/plain-language-research-summaries" class="ng-simple-menu_list-link">Plain Language/Research Summaries</a></li><li class="ng-simple-menu_list-item"><a href="/multimedia/quick-take-video" class="ng-simple-menu_list-link">Quick Takes</a></li><li class="ng-simple-menu_list-item"><a href="/browse/nejm-media-type/videos-in-clinical-medicine" class="ng-simple-menu_list-link">Videos in Clinical Medicine</a></li><li class="ng-simple-menu_list-item"><a href="/multimedia" class="ng-simple-menu_list-link">View All Multimedia</a></li></ul></div></div></div></li><li class="ng-menu_list-item ng-simple-menu_item hasChildren"><a href="/learning" class="ng-simple-menu_mainLink"><span class="ng-simple-menu_mainLink-text">LEARNING/CME</span><span class="ng-simple-menu_mainLink-arrowIcon"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-down"></use></svg></span></span></a><div class="ng-simple-menu_dropblock"><div class="ng-simple-menu_dropblock-cont"><div class="ng-simple-menu_list"><ul class="ng-simple-menu_list-items"><li class="ng-simple-menu_list-item"><a href="/continuing-medical-education" class="ng-simple-menu_list-link">Weekly CME</a></li><li class="ng-simple-menu_list-item"><a href="/cme-ce/obesity" class="ng-simple-menu_list-link">Obesity CME/CE</a></li><li class="ng-simple-menu_list-item"><a href="/learning" class="ng-simple-menu_list-link">VIEW ALL LEARNING/CME</a></li></ul></div></div></div></li><li class="ng-menu_list-item ng-simple-menu_item"><a href="/author-center/home" class="ng-simple-menu_mainLink"><span class="ng-simple-menu_mainLink-text">AUTHOR CENTER</span></a></li></ul></nav>

        </div>
    

</div><button aria-label="Search" class="ng-header_searchBtn searchBtnNav d-block ml-24"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#search"></use></svg></span></button></div><div class="ng-header_loginBar ng-header_loginBar-sticky col-4">



        
        <div data-location="authstring_nav" class="ng-header_loginBar-menu"><span class="ng-simple-menu_mainLink-icon signIn newIcon-2"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#user2"></use></svg></span></span><span class="ng-header_loginBar-signIn"><a href="/sign-in?uri=/doi/full/10.1056/NEJMoa1913948" class="ng-header_loginBar-signIn-link">Sign In</a></span><span class="ng-header_loginBar-separator">|</span><span class="ng-header_loginBar-createAcc"><a href="/action/storeProxy?action=register&amp;promo=ONFLNRC1" class="ng-header_loginBar-createAcc-link ro-mode_disabled">Create Account</a></span></div><div data-location="authstring_nav" class="ng-header_loginBar-subscribe pl-xl-16"><a href="/action/storeProxy?action=subscribe&amp;promo=ONF4NRS1" class="ng-header_loginBar-subscribe-btn ng-btn_primary ro-mode_disabled">Subscribe</a></div>
</div></div></div></div></div><div class="ng-header_logoBar_right-lg col-lg-8 col-6 d-flex align-items-center justify-content-end d-xl-none"><button aria-label="Search" class="ng-header_searchBtn d-flex justify-content-end"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#search"></use></svg></span></button><div class="ng-header_openCloseBtns d-flex align-items-center justify-content-end"><button aria-label="Open" class="ng-header_openBtn"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#burger"></use></svg></span></button><button aria-label="Close" class="ng-header_closeBtn"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#close"></use></svg></span></button></div></div><div class="ng-header_quickSearch col-12"><div class="ng-header_quickSearch-content">



        
        <div class="ng-quick-search js-ng-quick-search"><form action="/search" method="get" class="ng-quick-search_form js-form"><div class="ng-quick-search_inputArea js-inputArea"><input type="search" name="q" placeholder="Enter keyword, author, title or citation" autocomplete="off" value="" required="required" class="ng-quick-search_allField ng-large-text-input js-allField js-allField-def-tmpl ui-autocomplete-input"><button type="submit" aria-label="Search Button" class="ng-quick-search_iconBtn d-xl-none d-block js-submitBtn"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#search"></use></svg></span></button><ul id="ui-id-1" tabindex="0" class="ui-menu ui-widget ui-widget-content ui-autocomplete ui-front" style="display: none;"></ul></div><div class="ng-quick-search_btnsArea d-none d-xl-flex align-items-center justify-content-end"><a href="/search/advanced" class="ng-quick-search_advSearchLink ng-btn_link js-advancedSearchLink">Advanced Search</a><button type="submit" class="ng-quick-search_textBtn ng-btn_secondary ng-btn_iconRight js-submitBtn"><span class="ng-btn_text">SEARCH</span><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-right"></use></svg></span></button></div></form></div>
</div></div></div></div></div></header><div class="ng-header_overlay"></div><div class="ng-header_after">









    
    
        <div data-widget-def="literatumAd" data-widget-id="4931ddbd-d46e-4597-b4fd-92549e9847ca" id="ad-global-banner-FULLx64-1">
        



        
        



    

    

    
        
    



        </div>
    

</div>

                    
                        



        
        <div>









    
    
        <main data-widget-def="axelPublicationContent" data-widget-id="fcdb5261-d6a2-4a9c-81d5-3a3e2304e9c1" id="mainContent">
        



        
        <div class="article-tools__savePopup"><div class="ng-save"><input type="hidden" value="/action/getSavedTags" class="getKeywordsServiceUrl"><input type="hidden" value="/action/mmsSaveItemsService?itemType=article" class="saveServiceUrl"><input type="hidden" value="article" class="saveType"><input type="hidden" value="10.1056/NEJMoa1913948" class="inputDoi"><input type="hidden" value="Breast Cancer Association Consortium" class="inputAuthor"><input type="hidden" value="N Engl J Med 2021;384:428-439" class="inputCitation"><input type="hidden" value="01-20-2021" class="inputEPubDate"><input type="hidden" value="February 2021" class="inputCoverDate"><input type="hidden" value="Original Article" class="inputContentType"><input type="hidden" value="Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women" class="inputArticleTitle"><input type="hidden" value="/browse/nejm-article-type/original-article" class="inputContentTypeUrl"><button type="button" id="saveArticleShowPopupBtn" aria-hidden="true" tabindex="-1" class="ng-save-btn ng-btn_secondary isLoggedOut">Save</button></div></div><div class="article-tools__articleAlertPopup"><div id="articleAlertModal" tabindex="-1" role="dialog" aria-labelledby="exampleModalCenterTitle" aria-hidden="true" class="ng-modal modal"><div role="document" class="ng-modal_dialog modal-dialog modal-dialog-centered"><div class="ng-modal_content modal-content"><div class="ng-modal_header modal-header"><h5 id="articleAlertModalTitle" class="ng-modal_title modal-title">Create an E-mail Alert for This Article</h5><button type="button" data-dismiss="modal" aria-label="Close" class="ng-modal_close close"><span aria-hidden="true"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#close"></use></svg></span></span></button></div><div class="ng-modal_body modal-body"></div></div></div></div></div><div class="ng-do-media_popup"><div id="doPopup" tabindex="-1" role="dialog" aria-labelledby="exampleModalCenterTitle" aria-hidden="true" class="ng-modal modal"><div role="document" class="ng-modal_dialog modal-dialog modal-dialog-centered"><div class="ng-modal_content modal-content"><div class="ng-modal_header modal-header"><button type="button" data-dismiss="modal" aria-label="Close" class="ng-modal_close close"><span aria-hidden="true"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#close"></use></svg></span></span></button></div><div class="ng-modal_body modal-body"></div></div></div></div></div><link id="build-style-article" rel="stylesheet" type="text/css" href="/products/mms-nextgen/mms/releasedAssets/css/build-article-5b89b331018866a4a965.css"><article xmlns="http://www.w3.org/1999/xhtml" data-design="pill" data-has="right-rail" data-type="research-article" vocab="http://schema.org/" typeof="ScholarlyArticle" lang="en" dir="ltr"><header data-extent="frontmatter" data-location="header_article"><div class="core-container"><div data-article-access="free" data-article-access-type="free" class="meta-panel"><div class="meta-panel__left-content"><div class="meta-panel__type"><a href="/browse/nejm-article-type/original-article">Original Article</a></div></div><div class="meta-panel__right-content"><div class="meta-panel__share">









    
    
        <div data-widget-def="UX3share" data-widget-id="eee5f139-16f2-48f8-97ea-1b114367da16" data-location="share_tools_article">
        



        
        <!-- Go to https://www.addtoany.com/buttons/customize/ to customize your tools --><script type="text/javascript" defer="defer" src="https://static.addtoany.com/menu/page.js" nonce="94d66a15f0be1927-LAX"></script><div class="share"><div class="share__block share__inline-links"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="d-flex list-unstyled a2a a2a_kit a2a_default_style mb-0 a2a_kit_size_32" style="line-height: 32px;"><li class="a2a_listitem_custom"><a role="link" title="Facebook" data-interactiontype="social" class="share__link a2a_button_facebook" target="_blank" rel="nofollow noopener" href="/#facebook"><span class="icon-component " style="height: 24px; width: 24px"><svg aria-hidden="true" style="height: 24px; width: 24px"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#social-facebook"></use></svg></span></a></li><li class="a2a_listitem_custom"><a role="link" title="X (formerly Twitter)" data-interactiontype="social" class="share__link a2a_button_twitter" target="_blank" rel="nofollow noopener" href="/#twitter"><span class="icon-component " style="height: 24px; width: 24px"><svg aria-hidden="true" style="height: 24px; width: 24px"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#social-twitter"></use></svg></span></a></li><li class="a2a_listitem_custom"><a role="link" title="Linked In" data-interactiontype="social" class="share__link a2a_button_linkedin" target="_blank" rel="nofollow noopener" href="/#linkedin"><span class="icon-component " style="height: 24px; width: 24px"><svg aria-hidden="true" style="height: 24px; width: 24px"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#social-linkedin"></use></svg></span></a></li><li class="a2a_listitem_custom"><a role="link" title="Email" data-interactiontype="content_email_click" class="share__link a2a_button_email" target="_blank" rel="nofollow noopener" href="/#email"><span class="icon-component " style="height: 24px; width: 24px"><svg aria-hidden="true" style="height: 24px; width: 24px"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#social-email"></use></svg></span></a></li><li class="a2a_listitem_custom"><a role="link" title="Bluesky" data-interactiontype="social" class="share__link a2a_button_bluesky" target="_blank" rel="nofollow noopener" href="/#bluesky"><span class="icon-component " style="height: 24px; width: 24px"><svg aria-hidden="true" style="height: 24px; width: 24px"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#social-bluesky"></use></svg></span></a></li></ul></div></div>

        </div>
    

</div></div></div><h1 property="name">Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women</h1><div class="core-relations my-3"></div><div class="contributors"><span class="authors"><span class="heading">Author</span>: <span role="list"><span property="author" typeof="Person" role="listitem">Breast Cancer Association Consortium<sup class="xref"><a href="#fn1" role="doc-noteref">*</a></sup></span></span></span><a href="#tab-contributors" class="to-authors-affiliations" data-id="article-authors-viewall">Author Info &amp; Affiliations</a></div><div class="core-self-citation"><div class="core-date-published">Published <span property="datePublished">January 20, 2021</span></div><div property="isPartOf" typeof="Periodical"><span property="name">N Engl J Med</span> 2021<span property="isPartOf" typeof="PublicationVolume">;<span property="volumeNumber">384</span></span>:<span property="pageStart">428</span>-<span property="pageEnd">439</span></div><div class="doi">DOI: 10.1056/NEJMoa1913948</div><div class="core-enumeration"><a href="/toc/nejm/384/5"><span property="isPartOf" typeof="PublicationVolume">VOL. <span property="volumeNumber">384</span></span> <span property="isPartOf" typeof="PublicationIssue">NO. <span property="issueNumber">5</span></span></a></div><div><a href="#tab-information">Copyright © 2021</a></div></div><div class="info-panel"><div class="info-panel__left-content"><div class="info-panel__metrics info-panel__item"></div></div><div data-location="tools_article" class="info-panel__right-content"><div class="info-panel__article_tools info-panel__item">



        
        <div data-permission="/servlet/linkout?type=rightslink&amp;url=publisherName%3Dmassmed%26author%3D%26publication%3Dnejm%26orderBeanReset%3Dtrue%26volumeNum%3D384%26issueNum%3D5%26contentID%3D10.1056%252FNEJMoa1913948%26title%3DBreast%2BCancer%2BRisk%2BGenes%2B%25E2%2580%2594%2BAssociation%2BAnalysis%2Bin%2BMore%2Bthan%2B113%252C000%2BWomen%26publicationDate%3D02%252F04%252F2021" class="article-tools"><button id="articleToolsAlertBtn" data-url="/action/addCitationAlert?doi=10.1056%2FNEJMoa1913948" data-toggle="" data-target="#articleAlertModal" aria-label="Sign in or create account to add an article alert" data-interactiontype="article_alert" class="article-tools__citation btn btn--slim isLoggedOut"><span title="" data-toggle="tooltip" class="d-inline-block" data-original-title="Sign in or create account to add an article alert"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#alerts"></use></svg></span></span></button><button id="articleToolsSaveBtn" data-toggle="modal" data-target="#saveArticle" aria-label="Sign in or create account to save this article" data-interactiontype="article_tools_save_click" class="article-tools__favorite btn btn--slim isLoggedOut"><span title="" data-toggle="tooltip" class="d-inline-block" data-original-title="Sign in or create account to save this article"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#bookmarkFilled"></use></svg></span></span></button><a href="/servlet/linkout?type=rightslink&amp;url=publisherName%3Dmassmed%26author%3D%26publication%3Dnejm%26orderBeanReset%3Dtrue%26volumeNum%3D384%26issueNum%3D5%26contentID%3D10.1056%252FNEJMoa1913948%26title%3DBreast%2BCancer%2BRisk%2BGenes%2B%25E2%2580%2594%2BAssociation%2BAnalysis%2Bin%2BMore%2Bthan%2B113%252C000%2BWomen%26publicationDate%3D02%252F04%252F2021" target="_blank" title="" data-toggle="tooltip" aria-label="Permissions" data-interactiontype="article_tools_permissions_click" class="article-tools__permissions btn btn--slim" data-original-title="Permissions"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#permissions"></use></svg></span></a><a href="/about-nejm/reprints" title="" data-toggle="tooltip" aria-label="Reprints" data-interactiontype="article_tools_reprints_click" class="article-tools__reprints btn btn--slim" data-original-title="Reprints"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#reprints"></use></svg></span></a><a href="/cms/asset/42ac924c-629e-414e-85d4-5871ec2d884d/nejmoa1913948.pptx" target="_blank" title="" data-toggle="tooltip" aria-label="Download Slides" data-interactiontype="article_tools_slide_set_download" data-multimedia-type="Article Slideset" data-multimedia-filename="nejmoa1913948.pptx" class="article-tools__downloadSlides btn btn--slim" data-original-title="Download Slides"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#download"></use></svg></span></a><div class="article-tools__permissionsPopup"><div id="permissionsModal" tabindex="-1" role="dialog" aria-labelledby="exampleModalCenterTitle" aria-hidden="true" class="ng-modal modal"><div role="document" class="ng-modal_dialog modal-dialog modal-dialog-centered"><div class="ng-modal_content modal-content"><div class="ng-modal_header modal-header"><h5 id="permissionsModalTitle" class="ng-modal_title modal-title">Permissions</h5><button type="button" data-dismiss="modal" aria-label="Close" class="ng-modal_close close"><span aria-hidden="true"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#close"></use></svg></span></span></button></div><div class="ng-modal_body modal-body">For permission requests, please contact NEJM Reprints at <a href="mailto:reprints@nejm.org">reprints@nejm.org</a></div></div></div></div></div></div>
</div><div class="info-panel__citations info-panel__item"><a href="#tab-citations" class="btn btn--slim" aria-label="View Citations" data-toggle="tooltip" data-original-title="View Citations" data-interactiontype="article_tools_citation_download" data-multimedia-type="Citation"><i aria-hidden="true" class="icon-format_quote"></i></a></div><div class="info-panel__formats info-panel__item"><a href="https://www.nejm.org/doi/pdf/10.1056/NEJMoa1913948" class="btn btn--pdf btn--slim" aria-label="View PDF" data-toggle="tooltip" data-original-title="View PDF" data-behavior="trackDownloadEvent" data-doi="10.1056/NEJMoa1913948" data-interactiontype="article_tools_download_pdf" data-multimedia-type="Article PDF" data-multimedia-filename="nejmoa1913948.pdf"><i aria-hidden="true" class="icon-PDF"></i></a></div></div></div></div></header><div data-core-nav="header" data-extent="frontmatter"><div class="core-nav-wrapper core-container" aria-label="Article navigation"><div class="core-sections-menu"><button data-id="article-toolbar-showhide" aria-controls="article_sections_menu" aria-expanded="false" aria-label="Toggle section navigation menu" style="margin-top: 0px;"><i class="icon-list" aria-hidden="true"></i><span>Contents</span></button><nav id="article_sections_menu" aria-label="Contents" data-core-nav="article" style="margin-top: 0px;"><ul><li><a href="#summary-abstract" aria-current="true">Abstract</a></li><li><a href="#sec-1" aria-current="false">Methods</a></li><li><a href="#sec-2" aria-current="false">Results</a></li><li><a href="#sec-3" aria-current="false">Discussion</a></li><li class="bordered"><a href="#backnotes" aria-current="false">Notes</a></li><li><a href="#supplementary-materials" aria-current="false">Supplementary Material</a></li><li><a href="#appendix-1" aria-current="false">Appendix</a></li><li><a href="#bibliography" aria-current="false">References</a></li></ul></nav></div><nav id="article_collateral_menu"><ul data-core-nav="collateral" class="collateral-pill" style="margin-top: 0px;"><li><a href="#core-collateral-info" data-id="article-nav-menubar-info" title="" tabindex="0" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="Information &amp; Authors"><i aria-hidden="true" class="icon-info"></i><span class="sr-only">Information &amp; Authors</span></a></li><li><a href="#core-collateral-metrics" data-id="article-nav-menubar-metrics" title="" tabindex="0" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="Metrics &amp; Citations"><i aria-hidden="true" class="icon-timeline"></i><span class="sr-only">Metrics &amp; Citations</span></a></li><li><a href="#core-collateral-fulltext-options" data-id="article-nav-menubar-metrics" title="" tabindex="0" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="View Options"><i aria-hidden="true" class="icon-eye"></i><span class="sr-only">View Options</span></a></li><li><a href="#core-collateral-references" data-id="article-nav-menubar-references" title="" tabindex="0" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="References"><i aria-hidden="true" class="icon-references"></i><span class="sr-only">References</span></a></li><li><a href="#core-collateral-media" data-id="article-nav-menubar-media" title="" tabindex="0" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="Media"><i aria-hidden="true" class="icon-photo"></i><span class="sr-only">Media</span></a></li><li><a href="#core-collateral-tables" data-id="article-nav-menubar-tables" title="" tabindex="0" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="Tables"><i aria-hidden="true" class="icon-tables"></i><span class="sr-only">Tables</span></a></li><li><a href="#core-collateral-share" data-id="article-nav-menubar-share" title="" tabindex="0" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="Share"><i aria-hidden="true" class="icon-share"></i><span class="sr-only">Share</span></a></li></ul></nav></div></div><div data-core-wrapper="content"><div id="abstracts" data-extent="frontmatter" data-location="articleTab_article"><div class="core-container"><section id="summary-abstract" property="abstract" typeof="Text" role="doc-abstract"><h2 property="name">Abstract</h2><section id="abs-sec-1"><h3>Background</h3><div role="paragraph">Genetic testing for breast cancer susceptibility is widely used, but for many genes, evidence of an association with breast cancer is weak, underlying risk estimates are imprecise, and reliable subtype-specific risk estimates are lacking.</div></section><section id="abs-sec-2"><h3>Methods</h3><div role="paragraph">We used a panel of 34 putative susceptibility genes to perform sequencing on samples from 60,466 women with breast cancer and 53,461 controls. In separate analyses for protein-truncating variants and rare missense variants in these genes, we estimated odds ratios for breast cancer overall and tumor subtypes. We evaluated missense-variant associations according to domain and classification of pathogenicity.</div></section><section id="abs-sec-3"><h3>Results</h3><div role="paragraph">Protein-truncating variants in 5 genes (<i>ATM</i>, <i>BRCA1</i>, <i>BRCA2</i>, <i>CHEK2</i>, and <i>PALB2</i>) were associated with a risk of breast cancer overall with a P value of less than 0.0001. Protein-truncating variants in 4 other genes (<i>BARD1</i>, <i>RAD51C</i>, <i>RAD51D</i>, and <i>TP53</i>) were associated with a risk of breast cancer overall with a P value of less than 0.05 and a Bayesian false-discovery probability of less than 0.05. For protein-truncating variants in 19 of the remaining 25 genes, the upper limit of the 95% confidence interval of the odds ratio for breast cancer overall was less than 2.0. For protein-truncating variants in <i>ATM</i> and <i>CHEK2</i>, odds ratios were higher for estrogen receptor (ER)–positive disease than for ER-negative disease; for protein-truncating variants in <i>BARD1</i>, <i>BRCA1</i>, <i>BRCA2</i>, <i>PALB2</i>, <i>RAD51C</i>, and <i>RAD51D</i>, odds ratios were higher for ER-negative disease than for ER-positive disease. Rare missense variants (in aggregate) in <i>ATM</i>, <i>CHEK2</i>, and <i>TP53</i> were associated with a risk of breast cancer overall with a P value of less than 0.001. For <i>BRCA1</i>, <i>BRCA2</i>, and <i>TP53</i>, missense variants (in aggregate) that would be classified as pathogenic according to standard criteria were associated with a risk of breast cancer overall, with the risk being similar to that of protein-truncating variants.</div></section><section id="abs-sec-4"><h3>Conclusions</h3><div role="paragraph">The results of this study define the genes that are most clinically useful for inclusion on panels for the prediction of breast cancer risk, as well as provide estimates of the risks associated with protein-truncating variants, to guide genetic counseling. (Funded by European Union Horizon 2020 programs and others.)</div></section></section></div></div><section id="bodymatter" data-extent="bodymatter" property="articleBody" typeof="Text" data-location="articleTab_article"><div class="core-container"><div role="paragraph">Genetic testing for cancer susceptibility is an established part of medical practice. Until recently, testing was performed mainly in patients with a strong family history of cancer and involved a limited number of genes known to be associated with a high risk of cancer or with specific cancer syndromes. With the advent of affordable sequencing, testing with larger panels of genes has become possible. However, for many genes on such panels, evidence of an association with cancer is often weak and accurate estimates of the cancer risks associated with variants are often not available.<sup><a href="#core-r1" role="doc-biblioref" data-xml-rid="r1" id="body-ref-r1" href-manipulated="true" aria-label="Reference 1">1</a></sup></div><div role="paragraph">To better define the set of genes associated with breast cancer risk, we designed a panel consisting of 34 known or suspected breast cancer susceptibility genes, including genes provided on commercial panels. Using this panel, we sequenced germline DNA from more than 60,000 women with breast cancer and more than 53,000 controls participating in studies of the Breast Cancer Association Consortium (BCAC).<sup><a href="#core-r2" role="doc-biblioref" data-xml-rid="r2" id="body-ref-r2" href-manipulated="true" aria-label="Reference 2">2</a></sup> We used these data to estimate the risks of breast cancer overall and tumor subtypes associated with germline protein-truncating variants and rare missense variants in these genes.</div><section id="sec-1" data-type="methods"><h2>Methods</h2><section id="sec-1-1"><h3>Studies</h3><div role="paragraph">We included samples from women with breast cancer and unaffected controls participating in 44 BCAC studies (Tables S1 and S2 in the <a href="#ap1">Supplementary Appendix</a>, available with the full text of this article at NEJM.org). All the studies were approved by the relevant ethics review boards and used appropriate consent procedures. Overall, 30 studies did not select patients or controls on the basis of family history (population-based studies); the remaining 14 studies oversampled patients with a family history of breast cancer (family-based studies). After all quality-control steps were taken, 53,461 controls and 60,466 women with an invasive tumor (54,624 [90.3%]), in situ tumor (4187 [6.9%]), or tumor of unknown invasiveness (1655 [2.7%]) were included in the analyses. Of these, 48,826 patients and 50,703 controls were from population-based studies.</div></section><section id="sec-1-2"><h3>Sequence Analysis</h3><div role="paragraph">We analyzed a panel of 34 known or suspected breast cancer susceptibility genes (Tables S3 and S4), including genes provided on commercial panels. Details regarding library preparation, sequencing, variant calling, quality-control procedures, and variant classification are provided in the Supplementary Methods section in the <a href="#ap1">Supplementary Appendix</a>.</div></section><section id="sec-1-3"><h3>Statistical Analysis</h3><div role="paragraph">The primary analyses were burden analyses in which odds ratios and 95% confidence intervals for breast cancer associated with the presence of any variant in a given category were estimated by means of logistic regression. The two main categories were protein-truncating variants and rare missense variants (i.e., variants with a population frequency of &lt;0.001). Missense-variant associations were evaluated according to domain and classification of pathogenicity. Analyses were also conducted according to tumor subtype, age, and ancestry (European vs. Asian).</div><div role="paragraph">We conducted separate analyses for the population-based studies and the family-based studies. The inclusion of studies that oversampled patients with a family history of breast cancer improves the power to detect association<sup><a href="#core-r3" role="doc-biblioref" data-xml-rid="r3" id="body-ref-r3" href-manipulated="true" aria-label="Reference 3">3</a></sup> but leads to biased risk estimates. Therefore, we report risk estimates, 95% confidence intervals, and P values from the population-based studies but also report the results of association tests from all studies when appropriate. For protein-truncating variants in each gene, evidence of an association is also expressed in terms of Bayesian false-discovery probabilities, reflecting both evidence from the data in this study and evidence from previous research.<sup><a href="#core-r4" role="doc-biblioref" data-xml-rid="r4" id="body-ref-r4" href-manipulated="true" aria-label="Reference 4">4</a></sup> Absolute risks were calculated by combining age-specific estimated odds ratios with population incidences in the United Kingdom in 2016 as a baseline.<sup><a href="#core-r5" role="doc-biblioref" data-xml-rid="r5 r6" id="body-ref-r6-1" href-manipulated="true">5,6</a></sup> Details regarding the statistical analysis are provided in Supplementary Methods.</div></section></section><section id="sec-2" data-type="results"><h2>Results</h2><section id="sec-2-1"><h3>Protein-Truncating Variants</h3><section id="sec-2-1-1"><h4>Risk of Breast Cancer Overall</h4><div role="paragraph">Protein-truncating variants in 5 genes (<i>ATM</i>, <i>BRCA1</i>, <i>BRCA2</i>, <i>CHEK2</i>, and <i>PALB2</i>) were associated with a significant risk of breast cancer overall (P&lt;0.0001) (<a href="#t1">Table 1</a> and <a href="#f1">Figure 1</a> and <a href="#f2">Figure 2</a>). For these genes, odds ratios ranged from 2.10 to 10.57. In <i>CHEK2</i>, the c.1100delC variant accounted for approximately 80% of the protein-truncating variants. The effect size for this variant (odds ratio, 2.66; 95% confidence interval [CI], 2.27 to 3.11; P=1.1×10<sup>−33</sup> [P=5.3×10<sup>−53</sup> in all studies]) did not differ significantly from the effect size for all other protein-truncating variants in <i>CHEK2</i> (odds ratio, 2.13; 95% CI, 1.60 to 2.84; P=3.0×10<sup>−7</sup> [P=7.4×10<sup>−10</sup> in all studies]), with a P value of 0.19 for the difference in the odds ratios.</div><div class="figure-wrap" data-presentation="diminished-in-flow"><header><div class="label">Figure 1</div><nav><a href="#f1" title="Open in viewer" class="open-in-viewer" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa1913948_f1.jpg"><i aria-hidden="true" class="icon-expand"></i></a></nav></header><figure id="f1" class="graphic"><a aria-label="Open figure in viewer" class="open-in-viewer" data-index="0" href="#f1" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa1913948_f1.jpg"><img src="/cms/10.1056/NEJMoa1913948/asset/d5f4eaa6-7576-49a3-889f-554c9e046254/assets/images/large/nejmoa1913948_f1.jpg" height="1376" width="2640" aria-labelledby="f1" loading="lazy"></a><figcaption><div class="caption">Frequency of Protein-Truncating Variants in 34 Genes in Population-Based Studies.</div><div class="notes"><div role="doc-footnote">Shown are percentages of women with breast cancer and controls who were carriers of protein-truncating variants in 34 genes. The genes are listed in order of increasing estimated odds ratios for breast cancer overall.</div></div></figcaption></figure></div><div class="figure-wrap" data-presentation="diminished-in-flow"><header><div class="label">Figure 2</div><nav><a href="#f2" title="Open in viewer" class="open-in-viewer" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa1913948_f2.jpg"><i aria-hidden="true" class="icon-expand"></i></a></nav></header><figure id="f2" class="graphic"><a aria-label="Open figure in viewer" class="open-in-viewer" data-index="0" href="#f2" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa1913948_f2.jpg"><img src="/cms/10.1056/NEJMoa1913948/asset/3fc0bdd2-fe62-4d6f-ad60-b59ea2386dfd/assets/images/large/nejmoa1913948_f2.jpg" height="2155" width="2640" aria-labelledby="f2" loading="lazy"></a><figcaption><div class="caption">Risk of Breast Cancer Overall and Tumor Subtypes Associated with Protein-Truncating Variants in 34 Genes in Population-Based Studies.</div><div class="notes"><div role="doc-footnote">Shown are odds ratios and 95% confidence intervals (CIs) for breast cancer overall (Panel A), estrogen receptor (ER)–positive breast cancer (Panel B), and ER-negative breast cancer (Panel C) associated with protein-truncating variants in 34 genes. The genes are listed in order of decreasing estimated odds ratios for breast cancer overall.</div></div></figcaption></figure></div><div class="figure-wrap" data-presentation="diminished-in-flow"><header><div class="label">Table 1</div><nav><a href="#t1" title="Open in viewer" class="open-in-viewer" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa1913948_t1.jpg"><i aria-hidden="true" class="icon-expand"></i></a></nav></header><figure id="t1" class="table"><div class="graphic-wrap" data-presentation="suppressed-in-viewer"><a aria-label="Open figure in viewer" class="open-in-viewer" data-index="0" href="#t1" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa1913948_t1.jpg"><img src="/cms/10.1056/NEJMoa1913948/asset/258fd6a8-9ef9-490a-ac10-fbd526187536/assets/images/large/nejmoa1913948_t1.jpg" height="2788" width="1999" loading="lazy"></a></div><div class="table-wrap catalyst-standard" data-presentation="suppressed-in-flow"><table data-shading="custom"><thead><tr class="head1" data-type="row head1"><th class="txlx-borders" data-xml-align="left">Gene</th><th class="txxx-borders" colspan="4"><span>Population-Based Studies<br>(48,826 patients and 50,703 controls)<a href="#t1fn2" role="doc-noteref">†</a></span></th><th class="txxx-borders">All Studies<br>(60,466 patients and 53,461 controls)<a href="#t1fn2" role="doc-noteref">†</a></th><th class="txxx-borders">Prior Probability<a href="#t1fn3" role="doc-noteref">‡</a></th><th class="txxr-borders">BFDP</th></tr><tr class="head2" data-type="row head2"><td class="xxlx-borders">&nbsp;</td><th class="xxxx-borders" colspan="2"><span>No. of Carriers of Protein-Truncating Variants</span></th><th class="xxxx-borders">Odds Ratio (95% CI)</th><th class="xxxx-borders">P Value</th><th class="xxxx-borders">P Value</th><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr class="head2" data-type="row head2"><td class="xxlx-borders">&nbsp;</td><th class="xxxx-borders">Women with Breast Cancer</th><th class="xxxx-borders">Controls</th><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr></thead><tbody><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left"><i>ABRAXAS1</i></td><td class="xxxx-borders shading">17</td><td class="xxxx-borders shading">19</td><td class="xxxx-borders shading">0.98 (0.50–1.94)</td><td class="xxxx-borders shading">0.96</td><td class="xxxx-borders shading">0.93</td><td class="xxxx-borders shading">0.1</td><td class="xxxr-borders shading">0.98</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left"><i>AKT1</i></td><td class="xxxx-borders">3</td><td class="xxxx-borders">6</td><td class="xxxx-borders">0.47 (0.12–1.93)</td><td class="xxxx-borders">0.29</td><td class="xxxx-borders">0.14</td><td class="xxxx-borders">0.1</td><td class="xxxr-borders">0.94</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left"><i>ATM</i></td><td class="xxxx-borders shading">294</td><td class="xxxx-borders shading">150</td><td class="xxxx-borders shading">2.10 (1.71–2.57)</td><td class="xxxx-borders shading">9.2×10<sup>−13</sup></td><td class="xxxx-borders shading">5.5×10<sup>−20</sup></td><td class="xxxx-borders shading">0.8</td><td class="xxxr-borders shading">1.3×10<sup>−18</sup></td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left"><i>BABAM2</i></td><td class="xxxx-borders">7</td><td class="xxxx-borders">9</td><td class="xxxx-borders">0.62 (0.23–1.71)</td><td class="xxxx-borders">0.36</td><td class="xxxx-borders">0.34</td><td class="xxxx-borders">0.1</td><td class="xxxr-borders">0.95</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left"><i>BARD1</i></td><td class="xxxx-borders shading">62</td><td class="xxxx-borders shading">32</td><td class="xxxx-borders shading">2.09 (1.35–3.23)</td><td class="xxxx-borders shading">0.00098</td><td class="xxxx-borders shading">0.00011</td><td class="xxxx-borders shading">0.2</td><td class="xxxr-borders shading">0.0076</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left"><i>BRCA1</i></td><td class="xxxx-borders">515</td><td class="xxxx-borders">58</td><td class="xxxx-borders">10.57 (8.02–13.93)</td><td class="xxxx-borders">1.1×10<sup>−62</sup></td><td class="xxxx-borders">3.7×10<sup>−65</sup></td><td class="xxxx-borders">0.99</td><td class="xxxr-borders">1.5×10<sup>−64</sup></td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left"><i>BRCA2</i></td><td class="xxxx-borders shading">754</td><td class="xxxx-borders shading">135</td><td class="xxxx-borders shading">5.85 (4.85–7.06)</td><td class="xxxx-borders shading">2.2×10<sup>−75</sup></td><td class="xxxx-borders shading">8.4×10<sup>−77</sup></td><td class="xxxx-borders shading">0.99</td><td class="xxxr-borders shading">3.1×10<sup>−76</sup></td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left"><i>BRIP1</i></td><td class="xxxx-borders">86</td><td class="xxxx-borders">75</td><td class="xxxx-borders">1.11 (0.80–1.53)</td><td class="xxxx-borders">0.54</td><td class="xxxx-borders">0.54</td><td class="xxxx-borders">0.2</td><td class="xxxr-borders">0.85</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left"><i>CDH1</i></td><td class="xxxx-borders shading">11</td><td class="xxxx-borders shading">12</td><td class="xxxx-borders shading">0.86 (0.37–1.98)</td><td class="xxxx-borders shading">0.72</td><td class="xxxx-borders shading">0.58</td><td class="xxxx-borders shading">0.2</td><td class="xxxr-borders shading">0.94</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left"><i>CHEK2</i></td><td class="xxxx-borders">704</td><td class="xxxx-borders">315</td><td class="xxxx-borders">2.54 (2.21–2.91)</td><td class="xxxx-borders">3.1×10<sup>−39</sup></td><td class="xxxx-borders">3.2×10<sup>−61</sup></td><td class="xxxx-borders">0.99</td><td class="xxxr-borders">1.3×10<sup>−60</sup></td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">c.1100delC variant</td><td class="xxxx-borders shading">548</td><td class="xxxx-borders shading">245</td><td class="xxxx-borders shading">2.66 (2.27–3.11)</td><td class="xxxx-borders shading">1.1×10<sup>−33</sup></td><td class="xxxx-borders shading">5.3×10<sup>−53</sup></td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Other variants</td><td class="xxxx-borders">156</td><td class="xxxx-borders">70</td><td class="xxxx-borders">2.13 (1.60–2.84)</td><td class="xxxx-borders">3.0×10<sup>−7</sup></td><td class="xxxx-borders">7.4×10<sup>−10</sup></td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left"><i>EPCAM</i></td><td class="xxxx-borders shading">14</td><td class="xxxx-borders shading">19</td><td class="xxxx-borders shading">0.73 (0.36–1.49)</td><td class="xxxx-borders shading">0.39</td><td class="xxxx-borders shading">0.13</td><td class="xxxx-borders shading">0.1</td><td class="xxxr-borders shading">0.95</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left"><i>FANCC</i></td><td class="xxxx-borders">71</td><td class="xxxx-borders">65</td><td class="xxxx-borders">1.26 (0.89–1.79)</td><td class="xxxx-borders">0.20</td><td class="xxxx-borders">0.20</td><td class="xxxx-borders">0.1</td><td class="xxxr-borders">0.87</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left"><i>FANCM</i></td><td class="xxxx-borders shading">302</td><td class="xxxx-borders shading">300</td><td class="xxxx-borders shading">1.06 (0.90–1.26)</td><td class="xxxx-borders shading">0.48</td><td class="xxxx-borders shading">0.28</td><td class="xxxx-borders shading">0.1</td><td class="xxxr-borders shading">0.96</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left"><i>GEN1</i></td><td class="xxxx-borders">31</td><td class="xxxx-borders">43</td><td class="xxxx-borders">0.66 (0.41–1.06)</td><td class="xxxx-borders">0.088</td><td class="xxxx-borders">0.18</td><td class="xxxx-borders">0.1</td><td class="xxxr-borders">0.95</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left"><i>MEN1</i></td><td class="xxxx-borders shading">2</td><td class="xxxx-borders shading">5</td><td class="xxxx-borders shading">0.37 (0.07–1.97)</td><td class="xxxx-borders shading">0.24</td><td class="xxxx-borders shading">0.64</td><td class="xxxx-borders shading">0.1</td><td class="xxxr-borders shading">0.95</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left"><i>MLH1</i></td><td class="xxxx-borders">5</td><td class="xxxx-borders">9</td><td class="xxxx-borders">0.58 (0.19–1.77)</td><td class="xxxx-borders">0.34</td><td class="xxxx-borders">0.55</td><td class="xxxx-borders">0.1</td><td class="xxxr-borders">0.95</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left"><i>MRE11</i></td><td class="xxxx-borders shading">48</td><td class="xxxx-borders shading">55</td><td class="xxxx-borders shading">0.88 (0.59–1.32)</td><td class="xxxx-borders shading">0.54</td><td class="xxxx-borders shading">0.34</td><td class="xxxx-borders shading">0.1</td><td class="xxxr-borders shading">0.98</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left"><i>MSH2</i></td><td class="xxxx-borders">13</td><td class="xxxx-borders">13</td><td class="xxxx-borders">1.06 (0.47–2.36)</td><td class="xxxx-borders">0.89</td><td class="xxxx-borders">0.80</td><td class="xxxx-borders">0.1</td><td class="xxxr-borders">0.92</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left"><i>MSH6</i></td><td class="xxxx-borders shading">39</td><td class="xxxx-borders shading">23</td><td class="xxxx-borders shading">1.96 (1.15–3.33)</td><td class="xxxx-borders shading">0.013</td><td class="xxxx-borders shading">0.021</td><td class="xxxx-borders shading">0.1</td><td class="xxxr-borders shading">0.55</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left"><i>MUTYH</i></td><td class="xxxx-borders">232</td><td class="xxxx-borders">231</td><td class="xxxx-borders">1.00 (0.83–1.21)</td><td class="xxxx-borders">0.99</td><td class="xxxx-borders">0.88</td><td class="xxxx-borders">0.1</td><td class="xxxr-borders">1.00</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left"><i>NBN</i></td><td class="xxxx-borders shading">90</td><td class="xxxx-borders shading">103</td><td class="xxxx-borders shading">0.90 (0.67–1.20)</td><td class="xxxx-borders shading">0.48</td><td class="xxxx-borders shading">0.65</td><td class="xxxx-borders shading">0.2</td><td class="xxxr-borders shading">0.95</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left"><i>NF1</i></td><td class="xxxx-borders">31</td><td class="xxxx-borders">17</td><td class="xxxx-borders">1.76 (0.96–3.21)</td><td class="xxxx-borders">0.068</td><td class="xxxx-borders">0.011</td><td class="xxxx-borders">0.2</td><td class="xxxr-borders">0.25</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left"><i>PALB2</i></td><td class="xxxx-borders shading">274</td><td class="xxxx-borders shading">55</td><td class="xxxx-borders shading">5.02 (3.73–6.76)</td><td class="xxxx-borders shading">1.6×10<sup>−26</sup></td><td class="xxxx-borders shading">1.1×10<sup>−32</sup></td><td class="xxxx-borders shading">0.99</td><td class="xxxr-borders shading">2.9×10<sup>−32</sup></td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left"><i>PIK3CA</i></td><td class="xxxx-borders">3</td><td class="xxxx-borders">12</td><td class="xxxx-borders">0.21 (0.06–0.75)</td><td class="xxxx-borders">0.016</td><td class="xxxx-borders">0.19</td><td class="xxxx-borders">0.1</td><td class="xxxr-borders">0.94</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left"><i>PMS2</i></td><td class="xxxx-borders shading">40</td><td class="xxxx-borders shading">36</td><td class="xxxx-borders shading">1.16 (0.73–1.85)</td><td class="xxxx-borders shading">0.53</td><td class="xxxx-borders shading">0.37</td><td class="xxxx-borders shading">0.1</td><td class="xxxr-borders shading">0.92</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left"><i>PTEN</i></td><td class="xxxx-borders">14</td><td class="xxxx-borders">6</td><td class="xxxx-borders">2.25 (0.85–6.00)</td><td class="xxxx-borders">0.10</td><td class="xxxx-borders">0.0040</td><td class="xxxx-borders">0.2</td><td class="xxxr-borders">0.14</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left"><i>RAD50</i></td><td class="xxxx-borders shading">120</td><td class="xxxx-borders shading">121</td><td class="xxxx-borders shading">1.08 (0.83–1.40)</td><td class="xxxx-borders shading">0.57</td><td class="xxxx-borders shading">0.45</td><td class="xxxx-borders shading">0.1</td><td class="xxxr-borders shading">0.95</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left"><i>RAD51C</i></td><td class="xxxx-borders">54</td><td class="xxxx-borders">26</td><td class="xxxx-borders">1.93 (1.20–3.11)</td><td class="xxxx-borders">0.0070</td><td class="xxxx-borders">0.00026</td><td class="xxxx-borders">0.3</td><td class="xxxr-borders">0.0090</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left"><i>RAD51D</i></td><td class="xxxx-borders shading">51</td><td class="xxxx-borders shading">25</td><td class="xxxx-borders shading">1.80 (1.11–2.93)</td><td class="xxxx-borders shading">0.018</td><td class="xxxx-borders shading">0.0018</td><td class="xxxx-borders shading">0.3</td><td class="xxxr-borders shading">0.044</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left"><i>RECQL</i></td><td class="xxxx-borders">103</td><td class="xxxx-borders">120</td><td class="xxxx-borders">0.84 (0.64–1.10)</td><td class="xxxx-borders">0.21</td><td class="xxxx-borders">0.89</td><td class="xxxx-borders">0.1</td><td class="xxxr-borders">0.95</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left"><i>RINT1</i></td><td class="xxxx-borders shading">32</td><td class="xxxx-borders shading">49</td><td class="xxxx-borders shading">0.72 (0.46–1.14)</td><td class="xxxx-borders shading">0.17</td><td class="xxxx-borders shading">0.31</td><td class="xxxx-borders shading">0.1</td><td class="xxxr-borders shading">0.96</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left"><i>STK11</i></td><td class="xxxx-borders">6</td><td class="xxxx-borders">5</td><td class="xxxx-borders">1.60 (0.48–5.28)</td><td class="xxxx-borders">0.44</td><td class="xxxx-borders">0.50</td><td class="xxxx-borders">0.2</td><td class="xxxr-borders">0.70</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left"><i>TP53</i></td><td class="xxxx-borders shading">7</td><td class="xxxx-borders shading">2</td><td class="xxxx-borders shading">3.06 (0.63–14.91)</td><td class="xxxx-borders shading">0.17</td><td class="xxxx-borders shading">0.015</td><td class="xxxx-borders shading">0.8</td><td class="xxxr-borders shading">0.033</td></tr><tr data-xml-align="center" data-type="row"><td class="xblx-borders hanging02" data-xml-align="left"><i>XRCC2</i></td><td class="xbxx-borders">15</td><td class="xbxx-borders">18</td><td class="xbxx-borders">0.96 (0.47–1.93)</td><td class="xbxx-borders">0.90</td><td class="xbxx-borders">0.81</td><td class="xbxx-borders">0.1</td><td class="xbxr-borders">0.98</td></tr></tbody></table></div><figcaption><div class="caption">Risk of Breast Cancer Overall Associated with Protein-Truncating Variants in 34 Genes in Population-Based Studies and All Studies.<a href="#t1fn1" role="doc-noteref">*</a></div><div class="notes"><div role="doc-footnote" data-has="label"><div class="label">*</div><div id="t1fn1" role="paragraph">BFDP denotes Bayesian false-discovery probability, and CI confidence interval.</div></div><div role="doc-footnote" data-has="label"><div class="label">†</div><div id="t1fn2" role="paragraph">The sample sizes reflect totals after quality control. Analyses for genes other than <i>BRCA1</i> and <i>BRCA2</i> excluded carriers of protein-truncating variants in <i>BRCA1</i> and <i>BRCA2</i>; therefore, sample sizes were slightly lower in those analyses (47,522 patients and 50,475 controls in population-based studies, and 58,728 patients and 52,976 controls in all studies).</div></div><div role="doc-footnote" data-has="label"><div class="label">‡</div><div id="t1fn3" role="paragraph">Details regarding the prior probabilities are provided in the Supplementary Methods section in the <a href="#ap1">Supplementary Appendix</a>.</div></div></div></figcaption></figure></div><div role="paragraph">There was more modest evidence of an association with breast cancer overall for protein-truncating variants in 7 other genes: <i>BARD1</i> (odds ratio, 2.09; 95% CI, 1.35 to 3.23; P=0.00098 [P=0.00011 in all studies]), <i>RAD51C</i> (odds ratio, 1.93; 95% CI, 1.20 to 3.11; P=0.0070 [P=0.00026 in all studies]), <i>RAD51D</i> (odds ratio, 1.80; 95% CI, 1.11 to 2.93; P=0.018 [P=0.0018 in all studies]), <i>PTEN</i> (odds ratio, 2.25; 95% CI, 0.85 to 6.00; P=0.10 [P=0.0040 in all studies]), <i>NF1</i> (odds ratio, 1.76; 95% CI, 0.96 to 3.21; P=0.068 [P=0.011 in all studies]), <i>TP53</i> (odds ratio, 3.06; 95% CI, 0.63 to 14.91; P=0.17 [P=0.015 in all studies]), and <i>MSH6</i> (odds ratio, 1.96; 95% CI, 1.15 to 3.33; P=0.013 [P=0.021 in all studies]) (<a href="#t1">Table 1</a>). For 4 of these genes (<i>BARD1</i>, <i>RAD51C</i>, <i>RAD51D</i>, and <i>TP53</i>), the Bayesian false-discovery probability was less than 0.05 (<a href="#t1">Table 1</a>).</div><div role="paragraph">For the 12 genes that had evidence of an association with breast cancer overall, the effect size for protein-truncating variants did not differ significantly between European women and Asian women (Table S7). Of the remaining 22 genes, all but 3 (<i>AKT1</i>, <i>MSH2</i>, and <i>STK11</i>) had an upper limit of the 95% confidence interval of the odds ratio of less than 2.0 in the population-based studies.</div></section><section id="sec-2-1-2"><h4>Risk of Tumor Subtypes</h4><div role="paragraph">Of the 12 genes that had evidence of an association with breast cancer overall, 2 had a stronger association with estrogen receptor (ER)–positive breast cancer than with ER-negative breast cancer: <i>ATM</i> (odds ratio, 2.33 [95% CI, 1.87 to 2.91] for ER-positive disease vs. 1.01 [95% CI, 0.64 to 1.59] for ER-negative disease; P=0.00055 for the difference) and <i>CHEK2</i> (odds ratio, 2.67 [95% CI, 2.30 to 3.11] for ER-positive disease vs. 1.64 [95% CI, 1.25 to 2.16] for ER-negative disease; P=3.6×10<sup>−5</sup> for the difference) (<a href="#f2">Figure 2</a> and Table S8). <i>CHEK2</i> also had evidence of an association with ER-negative, non–triple-negative breast cancer (odds ratio, 2.53; 95% CI, 1.75 to 3.67) but not with triple-negative breast cancer (odds ratio, 1.06; 95% CI, 0.63 to 1.76) (Table S9).</div><div role="paragraph">In contrast, for <i>BARD1</i>, <i>BRCA1</i>, <i>BRCA2</i>, <i>PALB2</i>, <i>RAD51C</i>, and <i>RAD51D</i>, odds ratios were higher for ER-negative breast cancer than for ER-positive breast cancer (P&lt;0.05 for all genes). Of these genes, 3 had a stronger association with triple-negative breast cancer than with ER-negative, non–triple-negative breast cancer: <i>BARD1</i> (P=0.044), <i>BRCA1</i> (P=9.6×10<sup>−17</sup>), and <i>BRCA2</i> (P=7.8×10<sup>−5</sup>) (Table S8).</div><div role="paragraph">Among the genes that had no evidence of an association with breast cancer overall, <i>FANCM</i> had some evidence of an association with ER-negative breast cancer (P=0.0050 in all studies) and <i>FANCC</i> had evidence of an association with triple-negative breast cancer (P=0.0021 in all studies) (Table S9).</div><div role="paragraph">For <i>BRCA1</i>, <i>BRCA2</i>, and <i>PALB2</i>, odds ratios were higher for invasive tumors than for in situ tumors. In contrast, for <i>ATM</i> and <i>CHEK2</i>, odds ratios for invasive tumors and in situ tumors were similar (Table S10).</div></section><section id="sec-2-1-3"><h4>Age Effects and Absolute Risk</h4><div role="paragraph">In the population-based studies, odds ratios decreased significantly with increasing age for 6 genes: <i>BRCA1</i>, <i>BRCA2</i>, <i>CHEK2</i>, <i>PALB2</i>, <i>PTEN</i>, and <i>TP53</i> (P&lt;0.01 for all genes) (Tables S11 and S12). Estimated absolute risks of breast cancer were derived by combining age-specific estimated odds ratios with population incidences in the United Kingdom (<a href="#f3">Figure 3</a>). For carriers of protein-truncating variants in <i>BRCA1</i>, <i>BRCA2</i>, and <i>PALB2</i>, the estimated absolute risks by 80 years of age exceeded the 30% threshold for high risk, as defined by National Institute for Health and Care Excellence guidelines.<sup><a href="#core-r7" role="doc-biblioref" data-xml-rid="r7" id="body-ref-r7" href-manipulated="true" aria-label="Reference 7">7</a></sup> For carriers of protein-truncating variants in <i>ATM</i>, <i>BARD1</i>, <i>CHEK2</i>, <i>RAD51C</i>, and <i>RAD51D</i>, the estimated absolute risks by 80 years of age were within the 17 to 30% range for moderate risk.</div><div class="figure-wrap" data-presentation="diminished-in-flow"><header><div class="label">Figure 3</div><nav><a href="#f3" title="Open in viewer" class="open-in-viewer" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa1913948_f3.jpg"><i aria-hidden="true" class="icon-expand"></i></a></nav></header><figure id="f3" class="graphic"><a aria-label="Open figure in viewer" class="open-in-viewer" data-index="0" href="#f3" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa1913948_f3.jpg"><img src="/cms/10.1056/NEJMoa1913948/asset/d4de3f12-da9d-4d12-a59c-9d6381e05ea6/assets/images/large/nejmoa1913948_f3.jpg" height="1620" width="2231" aria-labelledby="f3" loading="lazy"></a><figcaption><div class="caption">Estimated Absolute Risk of Breast Cancer Associated with Protein-Truncating Variants in 8 Genes.</div><div class="notes"><div role="doc-footnote">Shown are absolute risks of breast cancer through 80 years of age associated with protein-truncating variants in 8 genes that had significant evidence of an association with breast cancer overall, on the basis of estimated odds ratios from population-based studies. The absolute risk was not calculated for <i>TP53</i> because of the wide 95% confidence interval for the odds ratio and the known association with a substantial risk of childhood cancer. Baseline absolute risks were derived from population incidences in the United Kingdom in 2016.<sup><a href="#core-r6" role="doc-biblioref" data-xml-rid="r6" id="body-ref-r6-2" href-manipulated="true" aria-label="Reference 6">6</a></sup> The 𝙸 bars indicate 95% confidence intervals.</div></div></figcaption></figure></div></section></section><section id="sec-2-2"><h3>Rare Missense Variants</h3><div role="paragraph">There was evidence of an association with breast cancer overall for rare missense variants in 6 genes: <i>CHEK2</i> (odds ratio, 1.42; 95% CI, 1.28 to 1.58; P=2.5×10<sup>−11</sup> [P=2.9×10<sup>−18</sup> in all studies]), <i>ATM</i> (odds ratio, 1.06; 95% CI, 1.00 to 1.13; P=0.051 [P=0.0010 in all studies]), <i>TP53</i> (odds ratio, 1.10; 95% CI, 0.91 to 1.31; P=0.32 [P=0.00080 in all studies]), <i>BRCA1</i> (odds ratio, 1.11; 95% CI, 1.02 to 1.20; P=0.010 [P=0.027 in all studies]), <i>CDH1</i> (odds ratio, 1.10; 95% CI, 0.98 to 1.23; P=0.096 [P=0.042 in all studies]), and <i>RECQL</i> (odds ratio, 1.12; 95% CI, 1.00 to 1.26; P=0.047 [P=0.036 in all studies]) (<a href="#t2">Table 2</a>). Of these 6 genes, 2 had a stronger association with ER-positive breast cancer than with ER-negative breast cancer (<i>CHEK2</i> [P=9.1×10<sup>−5</sup>] and <i>CDH1</i> [P=0.012]) and 1 had a stronger association with ER-negative breast cancer than with ER-positive breast cancer (<i>BRCA1</i> [P=0.01]). Odds ratios decreased with increasing age for <i>BRCA1</i> (P=0.0026), <i>CHEK2</i> (P=0.00022), and <i>TP53</i> (P=0.00023).</div><div class="figure-wrap" data-presentation="diminished-in-flow"><header><div class="label">Table 2</div><nav><a href="#t2" title="Open in viewer" class="open-in-viewer" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa1913948_t2.jpg"><i aria-hidden="true" class="icon-expand"></i></a></nav></header><figure id="t2" class="table"><div class="graphic-wrap" data-presentation="suppressed-in-viewer"><a aria-label="Open figure in viewer" class="open-in-viewer" data-index="0" href="#t2" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa1913948_t2.jpg"><img src="/cms/10.1056/NEJMoa1913948/asset/a9b74e0e-f682-4c89-9b28-9bb002c84e18/assets/images/large/nejmoa1913948_t2.jpg" height="2602" width="1711" loading="lazy"></a></div><div class="table-wrap catalyst-standard" data-presentation="suppressed-in-flow"><table data-shading="custom"><thead><tr class="head1" data-type="row head1"><th class="txlx-borders" data-xml-align="left">Gene</th><th class="txxx-borders" colspan="4"><span>Population-Based Studies<br>(48,826 patients and 50,703 controls)<a href="#t2fn1" role="doc-noteref">*</a></span></th><th class="txxr-borders">All Studies<br>(60,466 patients and 53,461 controls)<a href="#t2fn1" role="doc-noteref">*</a></th></tr><tr class="head2" data-type="row head2"><td class="xxlx-borders">&nbsp;</td><th class="xxxx-borders" colspan="2"><span>No. of Carriers of Rare Missense Variants</span></th><th class="xxxx-borders">Odds Ratio (95% CI)</th><th class="xxxx-borders">P Value</th><th class="xxxr-borders">P Value</th></tr><tr class="head2" data-type="row head2"><td class="xxlx-borders">&nbsp;</td><th class="xxxx-borders">Women with Breast Cancer</th><th class="xxxx-borders">Controls</th><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr></thead><tbody><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01 shading" data-xml-align="left"><i>ABRAXAS1</i></td><td class="xxxx-borders shading">233</td><td class="xxxx-borders shading">242</td><td class="xxxx-borders shading" data-xml-valign="middle">1.04 (0.86–1.25)</td><td class="xxxx-borders shading">0.70</td><td class="xxxr-borders shading">0.40</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01" data-xml-align="left"><i>AKT1</i></td><td class="xxxx-borders">142</td><td class="xxxx-borders">156</td><td class="xxxx-borders" data-xml-valign="middle">0.96 (0.76–1.21)</td><td class="xxxx-borders">0.72</td><td class="xxxr-borders">0.63</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01 shading" data-xml-align="left"><i>ATM</i></td><td class="xxxx-borders shading">2411</td><td class="xxxx-borders shading">2471</td><td class="xxxx-borders shading" data-xml-valign="middle">1.06 (1.00–1.13)</td><td class="xxxx-borders shading">0.051</td><td class="xxxr-borders shading">0.0010</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01" data-xml-align="left"><i>BABAM2</i></td><td class="xxxx-borders">167</td><td class="xxxx-borders">170</td><td class="xxxx-borders" data-xml-valign="middle">1.01 (0.81–1.26)</td><td class="xxxx-borders">0.91</td><td class="xxxr-borders">0.63</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01 shading" data-xml-align="left"><i>BARD1</i></td><td class="xxxx-borders shading">591</td><td class="xxxx-borders shading">616</td><td class="xxxx-borders shading" data-xml-valign="middle">1.00 (0.89–1.12)</td><td class="xxxx-borders shading">0.94</td><td class="xxxr-borders shading">0.41</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01" data-xml-align="left"><i>BRCA1</i></td><td class="xxxx-borders">1393</td><td class="xxxx-borders">1300</td><td class="xxxx-borders" data-xml-valign="middle">1.11 (1.02–1.20)</td><td class="xxxx-borders">0.010</td><td class="xxxr-borders">0.027</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01 shading" data-xml-align="left"><i>BRCA2</i></td><td class="xxxx-borders shading">2831</td><td class="xxxx-borders shading">3038</td><td class="xxxx-borders shading" data-xml-valign="middle">0.98 (0.93–1.04)</td><td class="xxxx-borders shading">0.50</td><td class="xxxr-borders shading">0.58</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01" data-xml-align="left"><i>BRIP1</i></td><td class="xxxx-borders">868</td><td class="xxxx-borders">961</td><td class="xxxx-borders" data-xml-valign="middle">0.95 (0.86–1.04)</td><td class="xxxx-borders">0.25</td><td class="xxxr-borders">0.54</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01 shading" data-xml-align="left"><i>CDH1</i></td><td class="xxxx-borders shading">682</td><td class="xxxx-borders shading">668</td><td class="xxxx-borders shading" data-xml-valign="middle">1.10 (0.98–1.23)</td><td class="xxxx-borders shading">0.096</td><td class="xxxr-borders shading">0.042</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01" data-xml-align="left"><i>CHEK2</i></td><td class="xxxx-borders">895</td><td class="xxxx-borders">697</td><td class="xxxx-borders" data-xml-valign="middle">1.42 (1.28–1.58)</td><td class="xxxx-borders">2.5×10<sup>−11</sup></td><td class="xxxr-borders">2.9×10<sup>−18</sup></td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01 shading" data-xml-align="left"><i>EPCAM</i></td><td class="xxxx-borders shading">290</td><td class="xxxx-borders shading">328</td><td class="xxxx-borders shading" data-xml-valign="middle">0.97 (0.82–1.14)</td><td class="xxxx-borders shading">0.69</td><td class="xxxr-borders shading">0.43</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01" data-xml-align="left"><i>FANCC</i></td><td class="xxxx-borders">597</td><td class="xxxx-borders">620</td><td class="xxxx-borders" data-xml-valign="middle">0.95 (0.85–1.07)</td><td class="xxxx-borders">0.42</td><td class="xxxr-borders">0.80</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01 shading" data-xml-align="left"><i>FANCM</i></td><td class="xxxx-borders shading">1434</td><td class="xxxx-borders shading">1566</td><td class="xxxx-borders shading" data-xml-valign="middle">0.95 (0.88–1.02)</td><td class="xxxx-borders shading">0.17</td><td class="xxxr-borders shading">0.85</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01" data-xml-align="left"><i>GEN1</i></td><td class="xxxx-borders">701</td><td class="xxxx-borders">707</td><td class="xxxx-borders" data-xml-valign="middle">1.05 (0.94–1.17)</td><td class="xxxx-borders">0.38</td><td class="xxxr-borders">0.25</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01 shading" data-xml-align="left"><i>MEN1</i></td><td class="xxxx-borders shading">109</td><td class="xxxx-borders shading">130</td><td class="xxxx-borders shading" data-xml-valign="middle">0.86 (0.66–1.12)</td><td class="xxxx-borders shading">0.25</td><td class="xxxr-borders shading">0.81</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01" data-xml-align="left"><i>MLH1</i></td><td class="xxxx-borders">677</td><td class="xxxx-borders">711</td><td class="xxxx-borders" data-xml-valign="middle">1.02 (0.91–1.13)</td><td class="xxxx-borders">0.78</td><td class="xxxr-borders">0.68</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01 shading" data-xml-align="left"><i>MRE11</i></td><td class="xxxx-borders shading">552</td><td class="xxxx-borders shading">611</td><td class="xxxx-borders shading" data-xml-valign="middle">0.94 (0.84–1.06)</td><td class="xxxx-borders shading">0.33</td><td class="xxxr-borders shading">0.93</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01" data-xml-align="left"><i>MSH2</i></td><td class="xxxx-borders">908</td><td class="xxxx-borders">1024</td><td class="xxxx-borders" data-xml-valign="middle">0.92 (0.84–1.01)</td><td class="xxxx-borders">0.093</td><td class="xxxr-borders">0.12</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01 shading" data-xml-align="left"><i>MSH6</i></td><td class="xxxx-borders shading">1088</td><td class="xxxx-borders shading">1155</td><td class="xxxx-borders shading" data-xml-valign="middle">1.00 (0.92–1.09)</td><td class="xxxx-borders shading">0.98</td><td class="xxxr-borders shading">0.74</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01" data-xml-align="left"><i>MUTYH</i></td><td class="xxxx-borders">659</td><td class="xxxx-borders">702</td><td class="xxxx-borders" data-xml-valign="middle">1.00 (0.90–1.12)</td><td class="xxxx-borders">1.00</td><td class="xxxr-borders">0.58</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01 shading" data-xml-align="left"><i>NBN</i></td><td class="xxxx-borders shading">665</td><td class="xxxx-borders shading">725</td><td class="xxxx-borders shading" data-xml-valign="middle">0.95 (0.85–1.06)</td><td class="xxxx-borders shading">0.37</td><td class="xxxr-borders shading">0.71</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01" data-xml-align="left"><i>NF1</i></td><td class="xxxx-borders">816</td><td class="xxxx-borders">899</td><td class="xxxx-borders" data-xml-valign="middle">0.94 (0.85–1.03)</td><td class="xxxx-borders">0.19</td><td class="xxxr-borders">0.53</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01 shading" data-xml-align="left"><i>PALB2</i></td><td class="xxxx-borders shading">805</td><td class="xxxx-borders shading">892</td><td class="xxxx-borders shading" data-xml-valign="middle">0.96 (0.87–1.06)</td><td class="xxxx-borders shading">0.39</td><td class="xxxr-borders shading">1.00</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01" data-xml-align="left"><i>PIK3CA</i></td><td class="xxxx-borders">170</td><td class="xxxx-borders">205</td><td class="xxxx-borders" data-xml-valign="middle">0.83 (0.67–1.02)</td><td class="xxxx-borders">0.080</td><td class="xxxr-borders">0.33</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01 shading" data-xml-align="left"><i>PMS2</i></td><td class="xxxx-borders shading">934</td><td class="xxxx-borders shading">963</td><td class="xxxx-borders shading" data-xml-valign="middle">0.95 (0.87–1.05)</td><td class="xxxx-borders shading">0.31</td><td class="xxxr-borders shading">0.62</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01" data-xml-align="left"><i>PTEN</i></td><td class="xxxx-borders">68</td><td class="xxxx-borders">70</td><td class="xxxx-borders" data-xml-valign="middle">1.08 (0.76–1.53)</td><td class="xxxx-borders">0.65</td><td class="xxxr-borders">0.48</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01 shading" data-xml-align="left"><i>RAD50</i></td><td class="xxxx-borders shading">1046</td><td class="xxxx-borders shading">1089</td><td class="xxxx-borders shading" data-xml-valign="middle">0.99 (0.91–1.08)</td><td class="xxxx-borders shading">0.83</td><td class="xxxr-borders shading">0.44</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01" data-xml-align="left"><i>RAD51C</i></td><td class="xxxx-borders">196</td><td class="xxxx-borders">206</td><td class="xxxx-borders" data-xml-valign="middle">0.93 (0.76–1.14)</td><td class="xxxx-borders">0.49</td><td class="xxxr-borders">0.60</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01 shading" data-xml-align="left"><i>RAD51D</i></td><td class="xxxx-borders shading">224</td><td class="xxxx-borders shading">212</td><td class="xxxx-borders shading" data-xml-valign="middle">1.05 (0.86–1.27)</td><td class="xxxx-borders shading">0.64</td><td class="xxxr-borders shading">0.57</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01" data-xml-align="left"><i>RECQL</i></td><td class="xxxx-borders">656</td><td class="xxxx-borders">627</td><td class="xxxx-borders" data-xml-valign="middle">1.12 (1.00–1.26)</td><td class="xxxx-borders">0.047</td><td class="xxxr-borders">0.036</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01 shading" data-xml-align="left"><i>RINT1</i></td><td class="xxxx-borders shading">732</td><td class="xxxx-borders shading">762</td><td class="xxxx-borders shading" data-xml-valign="middle">1.01 (0.91–1.12)</td><td class="xxxx-borders shading">0.89</td><td class="xxxr-borders shading">0.18</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01" data-xml-align="left"><i>STK11</i></td><td class="xxxx-borders">114</td><td class="xxxx-borders">139</td><td class="xxxx-borders" data-xml-valign="middle">0.83 (0.64–1.07)</td><td class="xxxx-borders">0.15</td><td class="xxxr-borders">0.16</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01 shading" data-xml-align="left"><i>TP53</i></td><td class="xxxx-borders shading">257</td><td class="xxxx-borders shading">244</td><td class="xxxx-borders shading" data-xml-valign="middle">1.10 (0.91–1.31)</td><td class="xxxx-borders shading">0.32</td><td class="xxxr-borders shading">0.00080</td></tr><tr data-xml-align="center" data-type="row"><td class="xblx-borders hanging01" data-xml-align="left"><i>XRCC2</i></td><td class="xbxx-borders">207</td><td class="xbxx-borders">213</td><td class="xbxx-borders" data-xml-valign="middle">1.03 (0.84–1.25)</td><td class="xbxx-borders">0.80</td><td class="xbxr-borders">0.53</td></tr></tbody></table></div><figcaption><div class="caption">Risk of Breast Cancer Overall Associated with Rare Missense Variants in 34 Genes in Population-Based Studies and All Studies.</div><div class="notes"><div role="doc-footnote" data-has="label"><div class="label">*</div><div id="t2fn1" role="paragraph">The sample sizes reflect totals after quality control. The analysis for each gene excluded carriers of protein-truncating variants in that gene.</div></div></div></figcaption></figure></div><div role="paragraph">For missense variants (in aggregate) in <i>BRCA1</i>, the risk of breast cancer overall differed according to domain (P=3.0×10<sup>−6</sup>); there was an increased risk associated with variants located in the regions encoding the RING domain (P=1.0×10<sup>−6</sup>) and the BRCT1 domain (P=0.00020) (Tables S13 and S14 and Fig. S1A). For missense variants in <i>CHEK2</i>, the odds ratios did not vary according to location (P=0.52), such that the risk associated with variants within domains (P=4.2×10<sup>−9</sup>) was similar to the risk associated with variants outside domains (P=0.001) (Tables S13 and S15 and Fig. S1B). For <i>ATM</i>, there was an increased risk associated with variants in the FRAP–ATM–TRRAP (FAT) domain (P=0.00019 in all studies) and the protein kinase domains (P=0.00092 in all studies) (Tables S13 and S16 and Fig. S1C). There was no evidence of a risk associated with missense variants in specific domains in <i>BRCA2</i> (P=0.27) or <i>PALB2</i> (P=0.48) (Tables S13, S17, and S18 and Figs. S1D and S1E).</div><div role="paragraph">We specifically examined rare missense variants in <i>BRCA1</i>, <i>BRCA2</i>, and <i>TP53</i> that would be classified as pathogenic according to clinical guidelines. There was clear evidence of an association with breast cancer overall for pathogenic variants (in aggregate) in each gene (odds ratio, 16.11 [95% CI, 5.83 to 44.50] in <i>BRCA1</i>, 5.68 [95% CI, 2.62 to 12.29] in <i>BRCA2</i>, and 2.91 [95% CI, 1.71 to 4.98] in <i>TP53</i>) but not for other missense variants (in aggregate) in each gene (odds ratio, 1.06 [95% CI, 0.98 to 1.15] in <i>BRCA1</i>, 0.97 [95% CI, 0.92 to 1.02] in <i>BRCA2</i>, and 0.94 [95% CI, 0.77 to 1.14] in <i>TP53</i>) (Table S19 and Figs. S2A, S2B, and S2C).</div></section></section><section id="sec-3" data-type="discussion"><h2>Discussion</h2><div role="paragraph">This large study, in which we evaluated coding variation in putative breast cancer susceptibility genes, involved more than 60,000 patients and 53,000 controls, permitting the calculation of risk estimates that are more precise than those obtained previously. We found strong evidence of an association with breast cancer risk (Bayesian false-discovery probability, &lt;0.05) for protein-truncating variants in 9 genes, with a P value of less than 0.0001 for 5 genes (<i>ATM</i>, <i>BRCA1</i>, <i>BRCA2</i>, <i>CHEK2</i>, and <i>PALB2</i>) and a P value of less than 0.05 for the other 4 genes (<i>BARD1</i>, <i>RAD51C</i>, <i>RAD51D</i>, and <i>TP53</i>). We found that, for protein-truncating variants in most of these genes, the odds ratio differed according to breast cancer subtype. Protein-truncating variants in <i>ATM</i> and <i>CHEK2</i> were more strongly associated with ER-positive disease than with ER-negative disease, a finding consistent with earlier observations,<sup><a href="#core-r5" role="doc-biblioref" data-xml-rid="r5 r8" id="body-ref-r8" href-manipulated="true">5,8</a></sup> whereas protein-truncating variants in <i>BARD1</i>, <i>BRCA1</i>, <i>BRCA2</i>, <i>PALB2</i>, <i>RAD51C</i>, and <i>RAD51D</i> were more strongly associated with ER-negative disease than with ER-positive disease. None of the other 25 genes in the panel had a Bayesian false-discovery probability of less than 0.10. Of note, 19 genes had an upper limit of the 95% confidence interval of the odds ratio of less than 2.0, with 2.0 representing a proposed threshold for “pathogenic, moderate risk alleles”<sup><a href="#core-r9" role="doc-biblioref" data-xml-rid="r9" id="body-ref-r9-1" href-manipulated="true" aria-label="Reference 9">9</a></sup>; we therefore conclude that these genes are not informative for the prediction of breast cancer risk. We confirmed that missense variants in <i>BRCA1</i>, <i>BRCA2</i>, and <i>TP53</i> that would be classified as pathogenic according to clinical guidelines are indeed associated with clinically significant risks. We also found that rare missense variants in <i>CHEK2</i> overall, as well as variants in specific domains in <i>ATM</i>, are associated with moderate risk.</div><div role="paragraph">Our results are broadly consistent with the results of an analysis by Lee et al.,<sup><a href="#core-r10" role="doc-biblioref" data-xml-rid="r10" id="body-ref-r10-1" href-manipulated="true" aria-label="Reference 10">10</a></sup> in which the Clinical Genome Resource (ClinGen) clinical validity framework was used (Table S20). Of the 10 genes that were regarded as having definitive evidence of an association with breast cancer risk in that analysis,<sup><a href="#core-r10" role="doc-biblioref" data-xml-rid="r10" id="body-ref-r10-2" href-manipulated="true" aria-label="Reference 10">10</a></sup> 7 genes had variants associated with breast cancer risk in our analysis; deleterious variants in the remaining 3 genes (<i>CDH1</i>, <i>PTEN</i>, and <i>STK11</i>) are very rare and confer a predisposition to specific cancer syndromes. Of the 18 genes that were regarded as having moderate, limited, or disputed evidence of an association with breast cancer risk in that analysis, 2 genes (<i>RAD51C</i> and <i>RAD51D</i>) had protein-truncating variants associated with breast cancer risk in our analysis; 13 of the remaining genes had an upper limit of the 95% confidence interval of the odds ratio of less than 2.0 (and thus were classified as not conferring moderate or high risk according to our analysis), and the other 3 genes (<i>MSH2</i>, <i>MSH6</i>, and <i>NF1</i>) could not be classified. An association between breast cancer risk and variants in <i>RAD51C</i> and <i>RAD51D</i> is highly plausible, given that the functions of these genes are related to one another, that both genes had a stronger association with ER-negative breast cancer than with ER-positive breast cancer, and that both genes have evidence of an association with ovarian cancer.<sup><a href="#core-r11" role="doc-biblioref" data-xml-rid="r11" id="body-ref-r11" href-manipulated="true" aria-label="Reference 11">11</a></sup></div><div role="paragraph">Association analyses of rare variants are susceptible to bias. Inclusion of studies that oversampled patients with a family history of breast cancer improves the power to detect an association but leads to an upward bias in estimated odds ratios. The expected larger effect size in the family-based studies (as compared with the population-based studies) was seen for protein-truncating variants in all the genes with evidence of an association with breast cancer, except <i>BRCA1</i> and <i>BRCA2</i>, and was seen for missense variants in <i>ATM</i>, <i>CHEK2</i>, and <i>TP53</i> (Tables S21 and S22). Protein-truncating variants in some of these genes are also associated with other types of cancer. Moreover, testing for cancer susceptibility genes in cancer genetics clinics can lead to a downward bias, because carriers identified through previous testing may be excluded. We observed a depletion of carriers of protein-truncating variants in <i>BRCA1</i> and <i>BRCA2</i> among women with breast cancer in the family-based studies. Therefore, we regard the estimates from the population-based studies to be the most reliable.</div><div role="paragraph">With regard to rare missense variants, the clearest evidence of an association with increased breast cancer risk was for <i>CHEK2</i>. For rare missense variants (in aggregate) in <i>CHEK2</i>, the odds ratio was approximately 1.4. The association was independent of location, which suggests that a large proportion of missense variants in <i>CHEK2</i> confer risk (albeit below the threshold suggested for “pathogenic, moderate risk alleles”<sup><a href="#core-r9" role="doc-biblioref" data-xml-rid="r9" id="body-ref-r9-2" href-manipulated="true" aria-label="Reference 9">9</a></sup>). We also found some evidence of an association with risk for rare missense variants (in aggregate) in <i>ATM</i>, <i>BRCA1</i>, <i>CDH1</i>, and <i>TP53</i>, with odds ratios of approximately 1.1 (P&lt;0.05) for all genes. Furthermore, we found evidence of an association with risk for missense variants in <i>BRCA1</i>, <i>BRCA2</i>, and <i>TP53</i> that would be classified as pathogenic according to standard criteria but not for other missense variants in these genes; the odds ratios for the pathogenic variants (in aggregate) were similar to odds ratios for protein-truncating variants in these genes. For <i>ATM</i>, evidence of an association with risk appeared to be restricted to variants located in the regions encoding the phosphatidylinositol 3-kinase and 4-kinase and FAT domains, a finding consistent with previous observations.<sup><a href="#core-r12" role="doc-biblioref" data-xml-rid="r12" id="body-ref-r12" href-manipulated="true" aria-label="Reference 12">12</a></sup></div><div role="paragraph">The absolute risk estimates for protein-truncating variants in previously established risk genes were broadly consistent with previous estimates, except estimates for <i>BRCA2</i> and <i>TP53</i>, which were lower than risks reported in previous family-based studies.<sup><a href="#core-r13" role="doc-biblioref" data-xml-rid="r13 r14 r15" id="body-ref-r15" href-manipulated="true">13-15</a></sup> However, the estimate for <i>TP53</i> in this study was based on data from only seven carriers and had a wide confidence interval. The low estimate may reflect the significant early mortality among carriers of protein-truncating variants in <i>TP53</i>; alternatively, it is possible that the earlier family-based studies had overestimated the risk.<sup><a href="#core-r16" role="doc-biblioref" data-xml-rid="r16" id="body-ref-r16" href-manipulated="true" aria-label="Reference 16">16</a></sup> The analysis for <i>TP53</i> is further complicated by the possibility of unrecognized somatic mutations in the blood due to age-related clonal hematopoiesis.<sup><a href="#core-r17" role="doc-biblioref" data-xml-rid="r17 r18 r19 r20" id="body-ref-r20" href-manipulated="true">17-20</a></sup> The fact that the estimate for <i>BRCA2</i> was lower than the estimate for <i>BRCA1</i> may reflect the older age distribution in this study, as compared with previous studies, and perhaps a disproportionately large effect of genetic modifiers on risk among <i>BRCA2</i> carriers, as compared with <i>BRCA1</i> carriers.</div><div role="paragraph">Among European women, approximately 6.8% of the patients and 2.0% of the controls had protein-truncating variants in any of the 9 genes associated with breast cancer risk; in addition, 2.2% of the patients and 1.4% of the controls had missense variants in <i>CHEK2</i>. The frequency of protein-truncating variants among Asian women (4.4% of the patients and 1.3% of the controls) was lower than the frequency among European women; this finding is attributable to the much lower frequency of the c.1100delC variant in <i>CHEK2</i> among Asian women.</div><div role="paragraph">The absolute risk estimates place protein-truncating variants in <i>BRCA1</i>, <i>BRCA2</i>, and <i>PALB2</i> in the high-risk category and place protein-truncating variants in <i>ATM</i>, <i>BARD1</i>, <i>CHEK2</i>, <i>RAD51C</i>, and <i>RAD51D</i> in the moderate-risk category. These results may guide screening, as well as prevention with risk-reducing surgery or medication, in accordance with national guidelines. However, because breast cancer risk is influenced by other genetic and lifestyle factors, in addition to family history, the incorporation of this information into risk models would be required to give appropriate estimates.<sup><a href="#core-r21" role="doc-biblioref" data-xml-rid="r21" id="body-ref-r21" href-manipulated="true" aria-label="Reference 21">21</a></sup></div><div role="paragraph">Despite the size of this study, the evidence of an association with breast cancer risk for several of the genes we analyzed (e.g., <i>FANCM</i>, <i>MSH6</i>, and <i>NF1</i>) remains equivocal, and even for the genes that had a clear association with risk, the confidence intervals for the risk estimates are wide. Incorporation of pedigree data and combined analyses with other studies may improve the precision of these estimates. In the meantime, these results may help to guide the clinical reporting of results generated by multigene-panel testing and the counseling of women who are undergoing genetic testing for breast cancer susceptibility.</div></section>



        
        
</div></section><section id="backmatter" data-extent="backmatter" data-location="articleTab_article"><div class="core-container"><section id="backnotes" data-location="notes_article"><h2>Notes</h2><div data-type="published/updated" role="paragraph">This article was published on January 20, 2021, at NEJM.org.</div><div data-type="data-sharing" role="paragraph">Requests for individual-level data used in these analyses should be made through the BCAC Data Access Co-ordinating Committee (<a href="mailto:bcac@medschl.cam.ac.uk">bcac@medschl.cam.ac.uk</a>).</div><div role="paragraph">Supported by the European Union Horizon 2020 research and innovation programs BRIDGES (grant number, 634935) and B-CAST (633784), the Wellcome Trust (v203477/Z/16/Z), and Cancer Research UK (C1287/A16563). Details regarding funding of specific studies are provided in the <a href="#ap1">Supplementary Appendix</a>.</div><div role="paragraph"><a href="#ap2">Disclosure forms</a> provided by the authors are available with the full text of this article at NEJM.org.</div></section><section id="supplementary-materials" class="core-supplementary-materials"><h2>Supplementary Material</h2><div role="list"><div id="ap1" class="core-supplementary-material" role="listitem"><div class="core-description"><span class="core-label">Supplementary Appendix</span> <span class="core-filename">(nejmoa1913948_appendix.pdf)</span></div><div class="core-link"><ul><li><a href="/doi/suppl/10.1056/NEJMoa1913948/suppl_file/nejmoa1913948_appendix.pdf" download="nejmoa1913948_appendix.pdf" data-interactiontype="multimedia_download" data-multimedia-type="Supplementary Material" data-behavior="trackDownloadEvent" data-multimedia-filename="nejmoa1913948_appendix.pdf" data-doi="10.1056/NEJMoa1913948">Download</a></li><li>1.97 MB</li></ul></div></div><div id="ap2" class="core-supplementary-material" role="listitem"><div class="core-description"><span class="core-label">Disclosure Forms</span> <span class="core-filename">(nejmoa1913948_disclosures.pdf)</span></div><div class="core-link"><ul><li><a href="/doi/suppl/10.1056/NEJMoa1913948/suppl_file/nejmoa1913948_disclosures.pdf" download="nejmoa1913948_disclosures.pdf" data-interactiontype="multimedia_download" data-multimedia-type="Supplementary Material" data-behavior="trackDownloadEvent" data-multimedia-filename="nejmoa1913948_disclosures.pdf" data-doi="10.1056/NEJMoa1913948">Download</a></li><li>2.46 MB</li></ul></div></div></div></section><section id="appendix-1" role="doc-appendix"><h2>Appendix</h2><div data-type="alt-author-list" role="paragraph">The authors’ full names and academic degrees are as follows: Leila Dorling, Ph.D., Sara Carvalho, Ph.D., Jamie Allen, M.Res., Anna González-Neira, Ph.D., Craig Luccarini, Cecilia Wahlström, B.Sc., Karen A. Pooley, Ph.D., Michael T. Parsons, Cristina Fortuno, M.Sc., Qin Wang, M.Sc., Manjeet K. Bolla, M.Sc., Joe Dennis, M.Sc., Renske Keeman, M.Sc., M. Rosario Alonso, Nuria Álvarez, Belen Herraez, Victoria Fernandez, Rocio Núñez-Torres, Ph.D., Ana Osorio, Ph.D., Jeanette Valcich, B.Sc., Minerva Li, M.Sc., Therese Törngren, M.Sc., Patricia A. Harrington, Caroline Baynes, Don M. Conroy, Brennan Decker, M.D., Ph.D., Laura Fachal, Ph.D., Nasim Mavaddat, Ph.D., Thomas Ahearn, Ph.D., Kristiina Aittomäki, M.D., Ph.D., Natalia N. Antonenkova, M.D., D.Sc., Norbert Arnold, Ph.D., Patrick Arveux, Margreet G.E.M. Ausems, M.D., Ph.D., Päivi Auvinen, M.D., Heiko Becher, Matthias W. Beckmann, M.D., Sabine Behrens, Marina Bermisheva, Ph.D., Katarzyna Białkowska, Ph.D., Carl Blomqvist, M.D., Ph.D., Natalia V. Bogdanova, Ph.D., Nadja Bogdanova-Markov, M.D., Ph.D., Stig E. Bojesen, Dr.Med.Sci., Bernardo Bonanni, M.D., Anne-Lise Børresen-Dale, Ph.D., Hiltrud Brauch, Ph.D., Michael Bremer, M.D., Ignacio Briceno, M.D., Ph.D., Thomas Brüning, M.D., Barbara Burwinkel, David A. Cameron, M.D., Nicola J. Camp, Ph.D., Archie Campbell, M.A., Angel Carracedo, M.D., Jose E. Castelao, M.D., Melissa H. Cessna, M.D., Stephen J. Chanock, M.D., Hans Christiansen, M.D., J. Margriet Collée, M.D., Emilie Cordina-Duverger, Ph.D., Sten Cornelissen, B.Sc., Kamila Czene, Ph.D., Thilo Dörk, Ph.D., Arif B. Ekici, Ph.D., Christoph Engel, M.D., Mikael Eriksson, M.Sc., Peter A. Fasching, M.D., Jonine Figueroa, Ph.D., Henrik Flyger, Ph.D., Asta Försti, Ph.D., Marike Gabrielson, Ph.D., Manuela Gago-Dominguez, Vassilios Georgoulias, M.D., Fabian Gil, M.D., Graham G. Giles, Ph.D., Gord Glendon, M.Sc., Encarna B. Gómez Garcia, M.D., Ph.D., Grethe I. Grenaker Alnæs, M.Sc., Pascal Guénel, Ph.D., Andreas Hadjisavvas, Ph.D., Lothar Haeberle, Ph.D., Eric Hahnen, Ph.D., Per Hall, M.D., Ph.D., Ute Hamann, Ph.D., Elaine F. Harkness, Ph.D., Jaana M. Hartikainen, Ph.D., Mikael Hartman, M.D., Ph.D., Wei He, Ph.D., Bernadette A.M. Heemskerk-Gerritsen, Ph.D., Peter Hillemanns, M.D., Frans B.L. Hogervorst, Antoinette Hollestelle, Ph.D., Weang Kee Ho, Ph.D., Maartje J. Hooning, Ph.D., Anthony Howell, M.B., B.S., Keith Humphreys, Ph.D., Faiza Idris, Anna Jakubowska, Ph.D., Audrey Jung, Ph.D., Pooja Middha Kapoor, Ph.D., Michael J. Kerin, M.Ch., Elza Khusnutdinova, M.D., Sung-Won Kim, M.D., Ph.D., Yon-Dschun Ko, M.D., Veli-Matti Kosma, M.D., Vessela N. Kristensen, Ph.D., Kyriacos Kyriacou, Ph.D., Inge M.M. Lakeman, Jong Won Lee, Ph.D., Min Hyuk Lee, M.D., Ph.D., Jingmei Li, Ph.D., Annika Lindblom, M.D., Ph.D., Wing-Yee Lo, Ph.D., Maria A. Loizidou, Ph.D., Artitaya Lophatananon, Ph.D., Jan Lubiński, M.D., Ph.D., Robert J. MacInnis, Ph.D., Michael J. Madsen, M.Stat., Arto Mannermaa, Ph.D., Mehdi Manoochehri, Ph.D., Siranoush Manoukian, M.D., Sara Margolin, M.D., Ph.D., Maria Elena Martinez, Ph.D., Tabea Maurer, Dipl.Psych., Dimitrios Mavroudis, M.D., Catriona McLean, M.D., Alfons Meindl, Ph.D., Arjen R. Mensenkamp, Ph.D., Kyriaki Michailidou, Ph.D., Nicola Miller, Ph.D., Nur Aishah Mohd Taib, Kenneth Muir, Ph.D., Anna Marie Mulligan, M.B., B.Ch., Heli Nevanlinna, Ph.D., William G. Newman, M.D., Ph.D., Børge G. Nordestgaard, M.D., Pei-Sze Ng, Jan C. Oosterwijk, M.D., Ph.D., Sue K. Park, M.D., Ph.D., Tjoung-Won Park-Simon, M.D., Jose I.A. Perez, Ph.D., Paolo Peterlongo, Ph.D., David J. Porteous, Ph.D., Karolina Prajzendanc, Ph.D., Darya Prokofyeva, Ph.D., Paolo Radice, Ph.D., Muhammad U. Rashid, M.D., Ph.D., Valerie Rhenius, B.Sc., Matti A. Rookus, Ph.D., Thomas Rüdiger, Emmanouil Saloustros, M.D., D.Sc., Elinor J. Sawyer, Ph.D., Rita K. Schmutzler, M.D., Andreas Schneeweiss, Peter Schürmann, B.T.A., Mitul Shah, M.Sc., Christof Sohn, Melissa C. Southey, Ph.D., Harald Surowy, Ph.D., Maija Suvanto, Ph.D., Somchai Thanasitthichai, M.D., Ian Tomlinson, Ph.D., Diana Torres, Ph.D., Thérèse Truong, Ph.D., Maria Tzardi, M.D., Ph.D., Yana Valova, M.Sc., Christi J. van Asperen, Rob M. Van Dam, Ans M.W. van den Ouweland, Ph.D., Lizet E. van der Kolk, M.D., Ph.D., Elke M. van Veen, Ph.D., Camilla Wendt, M.D., Ph.D., Justin A. Williams, M.P.H., Xiaohong R. Yang, Ph.D., Sook-Yee Yoon, M. Pilar Zamora, D. Gareth Evans, M.D., Miguel de la Hoya, Ph.D., Jacques Simard, Ph.D., Antonis C. Antoniou, Ph.D., Åke Borg, Ph.D., Irene L. Andrulis, Ph.D., Jenny Chang-Claude, Ph.D., Montserrat García-Closas, M.D., Dr.P.H., Georgia Chenevix-Trench, Ph.D., Roger L. Milne, Ph.D., Paul D.P. Pharoah, Ph.D., Marjanka K. Schmidt, Ph.D., Amanda B. Spurdle, Ph.D., Maaike P.G. Vreeswijk, Javier Benitez, Ph.D., Alison M. Dunning, Ph.D., Anders Kvist, Ph.D., Soo H. Teo, Ph.D., Peter Devilee, Ph.D., and Douglas F. Easton, Ph.D.</div><div data-type="alt-author-affiliations" role="paragraph">The authors’ affiliations are as follows: the Centre for Cancer Genetic Epidemiology, Departments of Public Health and Primary Care (L.D., S. Carvalho, J.A., K.A.P., Q.W., M.K.B., J.D., B.D., N. Mavaddat, K. Michailidou, A.C.A., P.D.P.P., D.F.E.) and Oncology (C.L., P.A.H., C. Baynes, D.M.C., L.F., V.R., M. Shah, P.D.P.P., A.M.D., D.F.E.), University of Cambridge, Cambridge, the Centre for Genomic and Experimental Medicine, MRC Institute of Genetics and Molecular Medicine (A. Campbell, D.J.P.), and the Centre for Cognitive Ageing and Cognitive Epidemiology, Department of Psychology (D.J.P.), University of Edinburgh, the Cancer Research UK Edinburgh Centre (D.A.C., J.F.), and the Usher Institute of Population Health Sciences and Informatics, University of Edinburgh Medical School (A. Campbell, J.F.), Edinburgh, the Divisions of Informatics, Imaging, and Data Sciences (E.F.H.), Cancer Sciences (A. Howell), Population Health, Health Services Research, and Primary Care (A. Lophatananon, K. Muir), and Evolution and Genomic Sciences, School of Biological Sciences (W.G.N., E.M.V., D.G.E.), University of Manchester, the NIHR Manchester Biomedical Research Unit (E.F.H.) and the Nightingale Breast Screening Centre, Wythenshawe Hospital (E.F.H., H.I.), Academic Health Science Centre and North West Genomics Laboratory Hub, and the Manchester Centre for Genomic Medicine, St. Mary’s Hospital, Manchester University NHS Foundation Trust (W.G.N., E.M.V., D.G.E.), Manchester, the School of Cancer and Pharmaceutical Sciences, Comprehensive Cancer Centre, Guy’s Campus, King’s College London, London (E.J.S.), the Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham (I.T.), and the Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Oxford (I.T.) — all in the United Kingdom; the Human Genotyping-CEGEN Unit, Human Cancer Genetic Program (A.G.-N., M.R.A., N.Á., B.H., R.N.-T.), and the Human Genetics Group (V.F., A.O., J.B.), Spanish National Cancer Research Center, Centro de Investigación en Red de Enfermedades Raras (A.O., J.B.), Servicio de Oncología Médica, Hospital Universitario La Paz (M.P.Z.), and Molecular Oncology Laboratory, Hospital Clinico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (M. de la Hoya), Madrid, the Genomic Medicine Group, Galician Foundation of Genomic Medicine, Instituto de Investigación Sanitaria de Santiago de Compostela, Complejo Hospitalario Universitario de Santiago (A. Carracedo, M.G.-D.), and Centro de Investigación en Red de Enfermedades Raras y Centro Nacional de Genotipado, Universidad de Santiago de Compostela (A. Carracedo), Santiago de Compostela, the Oncology and Genetics Unit, Instituto de Investigacion Sanitaria Galicia Sur, Xerencia de Xestion Integrada de Vigo–Servizo Galeo de Saúde, Vigo (J.E.C.), and Servicio de Cirugía General y Especialidades, Hospital Monte Naranco, Oviedo (J.I.A.P.) — all in Spain; the Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund (C. Wahlström, J.V., M.L., T. Törngren, Å.B., A.K.), the Department of Oncology, Örebro University Hospital, Örebro (C. Blomqvist), and the Departments of Medical Epidemiology and Biostatistics (K.C., M.E., M.G., P. Hall, W.H., K.H.), Oncology, Södersjukhuset (P. Hall, S. Margolin), Molecular Medicine and Surgery (A. Lindblom), and Clinical Science and Education, Södersjukhuset (S. Margolin, C. Wendt), Karolinska Institutet, and the Department of Clinical Genetics, Karolinska University Hospital (A. Lindblom), Stockholm — all in Sweden; the Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD (M.T.P., C.F., G.C.-T., A.B.S.), the Cancer Epidemiology Division, Cancer Council Victoria (G.G.G., R.J.M., R.L.M.), the Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health (G.G.G., R.J.M., R.L.M.), and the Department of Clinical Pathology (M.C.S.), University of Melbourne, Anatomical Pathology, Alfred Hospital (C.M.), and the Cancer Epidemiology Division, Cancer Council Victoria (M.C.S.), Melbourne, VIC, and Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC (G.G.G., M.C.S., R.L.M.) — all in Australia; the Division of Molecular Pathology (R.K., S. Cornelissen, M.K.S.), Family Cancer Clinic (F.B.L.H., L.E.K.), Department of Epidemiology (M.A.R.), and Division of Psychosocial Research and Epidemiology (M.K.S.), the Netherlands Cancer Institute–Antoni van Leeuwenhoek Hospital, Amsterdam, Division Laboratories, Pharmacy and Biomedical Genetics, Department of Genetics, University Medical Center, Utrecht (M.G.E.M.A.), the Department of Clinical Genetics, Erasmus University Medical Center (J.M.C., A.M.W.O.), and the Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute (B.A.M.H.-G., A. Hollestelle, M.J.H.), Rotterdam, the Department of Clinical Genetics, Maastricht University Medical Center, Maastricht (E.B.G.G.), the Departments of Human Genetics (I.M.M.L., M.P.G.V., P.D.), Clinical Genetics (C.J.A.), and Pathology (P.D.), Leiden University Medical Center, Leiden, the Department of Human Genetics, Radboud University Medical Center, Nijmegen (A.R.M.), and the Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen (J.C.O.) — all in the Netherlands; the Cancer Genetics and Comparative Genomics Branch, National Human Genome Research Institute (B.D.), and the Division of Cancer Epidemiology and Genetics, National Cancer Institute (T.A., S.J.C., X.R.Y., M.G.-C.), National Institutes of Health, Bethesda, MD; the Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School (B.D.), and the Department of Nutrition, Harvard T.H. Chan School of Public Health (R.M.V.D.), Boston; the Departments of Clinical Genetics (K.A.), Oncology (C. Blomqvist), and Obstetrics and Gynecology (H.N., M. Suvanto), Helsinki University Hospital, University of Helsinki, Helsinki, and the Unit of Clinical Oncology, Kuopio University Hospital (P. Auvinen), the Institute of Clinical Medicine, Oncology (P. Auvinen), the Translational Cancer Research Area (J.M.H., V.-M.K., A. Mannermaa), and the Institute of Clinical Medicine, Pathology, and Forensic Medicine (J.M.H., V.-M.K., A. Mannermaa), University of Eastern Finland, and the Biobank of Eastern Finland, Kuopio University Hospital (V.-M.K., A. Mannermaa), Kuopio — both in Finland; the N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus (N.N.A., N.V.B.); the Department of Gynecology and Obstetrics and Institute of Clinical Molecular Biology, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Kiel (N.A.), the Institute of Medical Biometry and Epidemiology (H. Becher) and Cancer Epidemiology Group (T.M., J.C.-C.), University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, the Department of Gynecology and Obstetrics (M.W.B., P.A.F., L.H.) and Institute of Human Genetics (A.B.E.), University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen–European Metropolitan Region of Nuremberg, Erlangen, the Division of Cancer Epidemiology (S.B., A. Jung, P.M.K., J.C.-C.), Molecular Epidemiology Group, C080 (B. Burwinkel, H.S.), Division of Pediatric Neurooncology (A.F.), and Molecular Genetics of Breast Cancer (U.H., M.M., M.U.R., D.T.), German Cancer Research Center, Molecular Biology of Breast Cancer, University Women’s Clinic Heidelberg, University of Heidelberg (B. Burwinkel, A.S., H.S.), Hopp Children’s Cancer Center (A.F.), Faculty of Medicine, University of Heidelberg (P.M.K.), and National Center for Tumor Diseases, University Hospital and German Cancer Research Center (A.S., C.S.), Heidelberg, the Department of Radiation Oncology (N.V.B., M. Bremer, H.C.) and the Gynecology Research Unit (N.V.B., T.D., P. Hillemanns, T.-W.P.-S., P.S.), Hannover Medical School, Hannover, the Institute of Human Genetics, University of Münster, Münster (N.B.-M.), Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart (H. Brauch, W.-Y.L.), iFIT-Cluster of Excellence, University of Tübingen, and the German Cancer Consortium, German Cancer Research Center, Partner Site Tübingen (H. Brauch), and the University of Tübingen (W.-Y.L.), Tübingen, Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum, Bochum (T.B.), Institute for Medical Informatics, Statistics, and Epidemiology, University of Leipzig, Leipzig (C.E.), Center for Hereditary Breast and Ovarian Cancer (E.H., R.K.S.) and Center for Integrated Oncology (E.H., R.K.S.), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, the Department of Internal Medicine, Evangelische Kliniken Bonn, Johanniter Krankenhaus, Bonn (Y.-D.K.), the Department of Gynecology and Obstetrics, University of Munich, Campus Großhadern, Munich (A. Meindl), and the Institute of Pathology, Städtisches Klinikum Karlsruhe, Karlsruhe (T.R.) — all in Germany; the Gynecological Cancer Registry, Centre Georges-François Leclerc, Dijon (P. Arveux), and the Center for Research in Epidemiology and Population Health, Team Exposome and Heredity, INSERM, University Paris-Saclay, Villejuif (E.C.-D., P.G., T. Truong) — both in France; the Institute of Biochemistry and Genetics, Ufa Federal Research Center of the Russian Academy of Sciences (M. Bermisheva, E.K.), the Department of Genetics and Fundamental Medicine, Bashkir State University (E.K., D.P., Y.V.), and the Ufa Research Institute of Occupational Health and Human Ecology (Y.V.), Ufa, Russia; the Department of Genetics and Pathology (K.B., A. Jakubowska, J. Lubiński, K.P.) and the Independent Laboratory of Molecular Biology and Genetic Diagnostics (A. Jakubowska), Pomeranian Medical University, Szczecin, Poland; the Copenhagen General Population Study, the Department of Clinical Biochemistry (S.E.B., B.G.N.), and the Department of Breast Surgery (H.F.), Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, and the Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen (S.E.B., B.G.N.) — both in Denmark; the Division of Cancer Prevention and Genetics, European Institute of Oncology Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) (B. Bonanni), the Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano (S. Manoukian), the Genome Diagnostics Program, FIRC Institute of Molecular Oncology (P.P.), and the Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori (P.R.), Milan; the Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital-Radiumhospitalet (A.-L.B.-D., G.I.G.A., V.N.K.), and the Institute of Clinical Medicine, Faculty of Medicine, University of Oslo (A.-L.B.-D., V.N.K.), Oslo; Medical Faculty, Universidad de La Sabana (I.B.), and the Clinical Epidemiology and Biostatistics Department (F.G.) and Institute of Human Genetics (D.T.), Pontificia Universidad Javeriana, Bogota, Colombia; the Department of Internal Medicine and Huntsman Cancer Institute, University of Utah (N.J.C., M.J.M., J.A.W.), and the Intermountain Healthcare Biorepository and Department of Pathology, Intermountain Healthcare (M.H.C.), Salt Lake City; the David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California, Los Angeles (P.A.F.), and Moores Cancer Center (M.G.-D., M.E.M.) and the Department of Family Medicine and Public Health (M.E.M.), University of California San Diego, La Jolla; the Departments of Medical Oncology (V.G., D.M.) and Pathology (M.T.), University Hospital of Heraklion, Heraklion, and the Department of Oncology, University Hospital of Larissa, Larissa (E.S.) — both in Greece; the Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital (G.G., I.L.A.), the Departments of Laboratory Medicine and Pathobiology (A.M.M.) and Molecular Genetics (I.L.A.), University of Toronto, and the Laboratory Medicine Program, University Health Network (A.M.M.), Toronto, and the Genomics Center, Centre Hospitalier Universitaire de Québec–Université Laval Research Center, Québec City, QC (J.S.) — both in Canada; the Department of Electron Microscopy and Molecular Pathology (A. Hadjisavvas, K.K., M.A.L.), the Cyprus School of Molecular Medicine (A. Hadjisavvas, K.K., M.A.L., K. Michailidou), and the Biostatistics Unit (K. Michailidou), Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus; the Saw Swee Hock School of Public Health (M. Hartman, R.M.V.D.) and the Department of Medicine, Yong Loo Lin School of Medicine (R.M.V.D.), National University of Singapore, the Department of Surgery, National University Health System (M. Hartman, J. Li), and the Human Genetics Division, Genome Institute of Singapore (J. Li), Singapore; the Department of Mathematical Sciences, Faculty of Science and Engineering, University of Nottingham Malaysia (W.K.H.), and the Breast Cancer Research Programme, Cancer Research Malaysia (W.K.H., P.S.N., S.-Y.Y., S.H.T.), Selangor, and the Breast Cancer Research Unit, Cancer Research Institute (N.A.M.T.), and the Department of Surgery, Faculty of Medicine (N.A.M.T., P.S.N., S.H.T.), University Malaya, Kuala Lumpur — both in Malaysia; Surgery, School of Medicine, National University of Ireland, Galway (M.J.K., N. Miller); the Department of Surgery, Daerim Saint Mary’s Hospital (S.-W.K.), the Department of Surgery, Ulsan University College of Medicine and Asan Medical Center (J.W.L.), the Department of Surgery, Soonchunhyang University College of Medicine and Soonchunhyang University Hospital (M.H.L.), Integrated Major in Innovative Medical Science, Seoul National University College of Medicine (S.K.P.), and the Cancer Research Institute, Seoul National University (S.K.P.), Seoul, South Korea; the Department of Basic Sciences, Shaukat Khanum Memorial Cancer Hospital and Research Center, Lahore, Pakistan (M.U.R.); and the National Cancer Institute, Ministry of Public Health, Nonthaburi, Thailand (S.T.).</div></section><section id="bibliography" class="core-reference-list" role="doc-bibliography" data-location="references_article"><h2>References</h2><div role="list" data-method="clamp" id="collapsible-text"><div role="listitem" data-has="label"><div class="label">1.</div><div id="r1" class="citations"><div class="citation"><div class="citation-content">Easton DF, Pharoah PDP, Antoniou AC, et al. Gene-panel sequencing and the prediction of breast-cancer risk. <em>N Engl J Med</em> 2015;372:2243-2257.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r1"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_4_2_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa1913948&amp;key=10.1056%2FNEJMsr1501341&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26014596/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000355955100014" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Gene-panel+sequencing+and+the+prediction+of+breast-cancer+risk.&amp;publication_year=2015&amp;journal=N+Engl+J+Med&amp;pages=2243-2257&amp;doi=10.1056%2FNEJMsr1501341&amp;pmid=26014596" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">2.</div><div id="r2" class="citations"><div class="citation"><div class="citation-content">University of Cambridge and Cancer Research UK. Breast Cancer Association Consortium. 2020 (<a href="http://bcac.ccge.medschl.cam.ac.uk">http://bcac.ccge.medschl.cam.ac.uk</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r2"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=University+of+Cambridge+and+Cancer+Research+UK.+Breast+Cancer+Association+Consortium.+2020+%28http%3A%2F%2Fbcac.ccge.medschl.cam.ac.uk%29." target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">3.</div><div id="r3" class="citations"><div class="citation"><div class="citation-content">Antoniou AC, Easton DF. Polygenic inheritance of breast cancer: implications for design of association studies. <em>Genet Epidemiol</em> 2003;25:190-202.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r3"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1002/gepi.10261" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/14557987/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000186053600002" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Polygenic+inheritance+of+breast+cancer%3A+implications+for+design+of+association+studies.&amp;publication_year=2003&amp;journal=Genet+Epidemiol&amp;pages=190-202&amp;doi=10.1002%2Fgepi.10261&amp;pmid=14557987" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">4.</div><div id="r4" class="citations"><div class="citation"><div class="citation-content">Wakefield J. A Bayesian measure of the probability of false discovery in genetic epidemiology studies. <em>Am J Hum Genet</em> 2007;81:208-227.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r4"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1086/519024" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/17668372/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000248540400002" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=A+Bayesian+measure+of+the+probability+of+false+discovery+in+genetic+epidemiology+studies.&amp;publication_year=2007&amp;journal=Am+J+Hum+Genet&amp;pages=208-227&amp;doi=10.1086%2F519024&amp;pmid=17668372" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">5.</div><div id="r5" class="citations"><div class="citation"><div class="citation-content">Schmidt MK, Hogervorst F, van Hien R, et al. Age- and tumor subtype-specific breast cancer risk estimates for CHEK2*1100delC carriers. <em>J Clin Oncol</em> 2016;34:2750-2760.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r5" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1200/JCO.2016.66.5844" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27269948/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000382467000012" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Age-+and+tumor+subtype-specific+breast+cancer+risk+estimates+for+CHEK2%2A1100delC+carriers.&amp;publication_year=2016&amp;journal=J+Clin+Oncol&amp;pages=2750-2760&amp;doi=10.1200%2FJCO.2016.66.5844&amp;pmid=27269948" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r5" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r6-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] the United Kingdom in 2016 as a baseline. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r8" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] consistent with earlier observations, </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">6.</div><div id="r6" class="citations"><div class="citation"><div class="citation-content">Cancer Research UK. Breast cancer incidence (invasive) statistics. 2020 (<a href="https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/breast-cancer/incidence-invasive">https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/breast-cancer/incidence-invasive</a>).</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r6" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=Cancer+Research+UK.+Breast+cancer+incidence+%28invasive%29+statistics.+2020+%28https%3A%2F%2Fwww.cancerresearchuk.org%2Fhealth-professional%2Fcancer-statistics%2Fstatistics-by-cancer-type%2Fbreast-cancer%2Fincidence-invasive%29." target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r6" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r6-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] the United Kingdom in 2016 as a baseline. </span></a></li><li role="none"><a class="to-citation open-in-viewer" href="#f3" role="menuitem" data-target="#fv-body-ref-r6-2"><i aria-hidden="true" class="icon-return"></i><span>b [...] incidences in the United Kingdom in 2016. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">7.</div><div id="r7" class="citations"><div class="citation"><div class="citation-content">National Institute for Health and Care Excellence. Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer. November 20, 2019 (<a href="https://www.nice.org.uk/guidance/cg164">https://www.nice.org.uk/guidance/cg164</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r7"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=National+Institute+for+Health+and+Care+Excellence.+Familial+breast+cancer%3A+classification%2C+care+and+managing+breast+cancer+and+related+risks+in+people+with+a+family+history+of+breast+cancer.+November+20%2C+2019+%28https%3A%2F%2Fwww.nice.org.uk%2Fguidance%2Fcg164%29." target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">8.</div><div id="r8" class="citations"><div class="citation"><div class="citation-content">Renault A-L, Mebirouk N, Fuhrmann L, et al. Morphology and genomic hallmarks of breast tumours developed by ATM deleterious variant carriers. <em>Breast Cancer Res</em> 2018;20:28-28.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r8"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1186/s13058-018-0951-9" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29665859/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000430444600001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Morphology+and+genomic+hallmarks+of+breast+tumours+developed+by+ATM+deleterious+variant+carriers.&amp;publication_year=2018&amp;journal=Breast+Cancer+Res&amp;pages=28-28&amp;doi=10.1186%2Fs13058-018-0951-9&amp;pmid=29665859" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">9.</div><div id="r9" class="citations"><div class="citation"><div class="citation-content">Spurdle AB, Greville-Heygate S, Antoniou AC, et al. Towards controlled terminology for reporting germline cancer susceptibility variants: an ENIGMA report. <em>J Med Genet</em> 2019;56:347-357.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r9" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1136/jmedgenet-2018-105872" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30962250/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000471883900001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Towards+controlled+terminology+for+reporting+germline+cancer+susceptibility+variants%3A+an+ENIGMA+report.&amp;publication_year=2019&amp;journal=J+Med+Genet&amp;pages=347-357&amp;doi=10.1136%2Fjmedgenet-2018-105872&amp;pmid=30962250" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r9" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r9-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] for “pathogenic, moderate risk alleles” </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r9-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] for “pathogenic, moderate risk alleles” </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">10.</div><div id="r10" class="citations"><div class="citation"><div class="citation-content">Lee K, Seifert BA, Shimelis H, et al. Clinical validity assessment of genes frequently tested on hereditary breast and ovarian cancer susceptibility sequencing panels. <em>Genet Med</em> 2019;21:1497-1506.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r10" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41436-018-0361-5" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30504931/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000473518700007" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Clinical+validity+assessment+of+genes+frequently+tested+on+hereditary+breast+and+ovarian+cancer+susceptibility+sequencing+panels.&amp;publication_year=2019&amp;journal=Genet+Med&amp;pages=1497-1506&amp;doi=10.1038%2Fs41436-018-0361-5&amp;pmid=30504931" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r10" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r10-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] the results of an analysis by Lee et al., </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r10-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] with breast cancer risk in that analysis, </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">11.</div><div id="r11" class="citations"><div class="citation"><div class="citation-content">Song H, Dicks E, Ramus SJ, et al. Contribution of germline mutations in the RAD51B, RAD51C, and RAD51D genes to ovarian cancer in the population. <em>J Clin Oncol</em> 2015;33:2901-2907.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r11"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1200/JCO.2015.61.2408" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26261251/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000366017800013" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Contribution+of+germline+mutations+in+the+RAD51B%2C+RAD51C%2C+and+RAD51D+genes+to+ovarian+cancer+in+the+population.&amp;publication_year=2015&amp;journal=J+Clin+Oncol&amp;pages=2901-2907&amp;doi=10.1200%2FJCO.2015.61.2408&amp;pmid=26261251" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">12.</div><div id="r12" class="citations"><div class="citation"><div class="citation-content">Tavtigian SV, Oefner PJ, Babikyan D, et al. Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer. <em>Am J Hum Genet</em> 2009;85:427-446.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r12"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.ajhg.2009.08.018" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19781682/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000270836000001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Rare%2C+evolutionarily+unlikely+missense+substitutions+in+ATM+confer+increased+risk+of+breast+cancer.&amp;publication_year=2009&amp;journal=Am+J+Hum+Genet&amp;pages=427-446&amp;doi=10.1016%2Fj.ajhg.2009.08.018&amp;pmid=19781682" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">13.</div><div id="r13" class="citations"><div class="citation"><div class="citation-content">Antoniou A, Pharoah PDP, Narod S, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. <em>Am J Hum Genet</em> 2003;72:1117-1130.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r15"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1086/375033" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/12677558/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000182474400005" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Average+risks+of+breast+and+ovarian+cancer+associated+with+BRCA1+or+BRCA2+mutations+detected+in+case+series+unselected+for+family+history%3A+a+combined+analysis+of+22+studies.&amp;publication_year=2003&amp;journal=Am+J+Hum+Genet&amp;pages=1117-1130&amp;doi=10.1086%2F375033&amp;pmid=12677558" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">14.</div><div id="r14" class="citations"><div class="citation"><div class="citation-content">Kuchenbaecker KB, Hopper JL, Barnes DR, et al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. <em>JAMA</em> 2017;317:2402-2416.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r15"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1001/jama.2017.7112" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28632866/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000403654600014" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Risks+of+breast%2C+ovarian%2C+and+contralateral+breast+cancer+for+BRCA1+and+BRCA2+mutation+carriers.&amp;publication_year=2017&amp;journal=JAMA&amp;pages=2402-2416&amp;doi=10.1001%2Fjama.2017.7112&amp;pmid=28632866" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">15.</div><div id="r15" class="citations"><div class="citation"><div class="citation-content">Hwang SJ, Lozano G, Amos CI, Strong LC. Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk. <em>Am J Hum Genet</em> 2003;72:975-983.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r15"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1086/374567" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/12610779/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000181972600017" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Germline+p53+mutations+in+a+cohort+with+childhood+sarcoma%3A+sex+differences+in+cancer+risk.&amp;publication_year=2003&amp;journal=Am+J+Hum+Genet&amp;pages=975-983&amp;doi=10.1086%2F374567&amp;pmid=12610779" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">16.</div><div id="r16" class="citations"><div class="citation"><div class="citation-content">Fortuno C, James PA, Spurdle AB. Current review of TP53 pathogenic germline variants in breast cancer patients outside Li-Fraumeni syndrome. <em>Hum Mutat</em> 2018;39:1764-1773.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r16"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1002/humu.23656" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30240537/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000451194400003" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Current+review+of+TP53+pathogenic+germline+variants+in+breast+cancer+patients+outside+Li-Fraumeni+syndrome.&amp;publication_year=2018&amp;journal=Hum+Mutat&amp;pages=1764-1773&amp;doi=10.1002%2Fhumu.23656&amp;pmid=30240537" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">17.</div><div id="r17" class="citations"><div class="citation"><div class="citation-content">Watson CJ, Papula AL, Poon GYP, et al. The evolutionary dynamics and fitness landscape of clonal hematopoiesis. <em>Science</em> 2020;367:1449-1454.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r20"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aay9333" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32217721/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000523251600030" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=The+evolutionary+dynamics+and+fitness+landscape+of+clonal+hematopoiesis.&amp;publication_year=2020&amp;journal=Science&amp;pages=1449-1454&amp;doi=10.1126%2Fscience.aay9333&amp;pmid=32217721" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">18.</div><div id="r18" class="citations"><div class="citation"><div class="citation-content">Boettcher S, Miller PG, Sharma R, et al. A dominant-negative effect drives selection of <i>TP53</i> missense mutations in myeloid malignancies. <em>Science</em> 2019;365:599-604.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r20"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aax3649" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31395785/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000483195200042" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=A+dominant-negative+effect+drives+selection+of+TP53+missense+mutations+in+myeloid+malignancies.&amp;publication_year=2019&amp;journal=Science&amp;pages=599-604&amp;doi=10.1126%2Fscience.aax3649&amp;pmid=31395785" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">19.</div><div id="r19" class="citations"><div class="citation"><div class="citation-content">Coffee B, Cox HC, Kidd J, et al. Detection of somatic variants in peripheral blood lymphocytes using a next generation sequencing multigene pan cancer panel. <em>Cancer Genet</em> 2017;211:5-8.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r20"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.cancergen.2017.01.002" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28279308/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000398331600002" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Detection+of+somatic+variants+in+peripheral+blood+lymphocytes+using+a+next+generation+sequencing+multigene+pan+cancer+panel.&amp;publication_year=2017&amp;journal=Cancer+Genet&amp;pages=5-8&amp;doi=10.1016%2Fj.cancergen.2017.01.002&amp;pmid=28279308" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">20.</div><div id="r20" class="citations"><div class="citation"><div class="citation-content">Coffee B, Cox HC, Bernhisel R, et al. A substantial proportion of apparently heterozygous TP53 pathogenic variants detected with a next-generation sequencing hereditary pan-cancer panel are acquired somatically. <em>Hum Mutat</em> 2020;41:203-211.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r20"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1002/humu.23910" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31490007/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000487441800001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=A+substantial+proportion+of+apparently+heterozygous+TP53+pathogenic+variants+detected+with+a+next-generation+sequencing+hereditary+pan-cancer+panel+are+acquired+somatically.&amp;publication_year=2020&amp;journal=Hum+Mutat&amp;pages=203-211&amp;doi=10.1002%2Fhumu.23910&amp;pmid=31490007" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">21.</div><div id="r21" class="citations"><div class="citation"><div class="citation-content">Lee A, Mavaddat N, Wilcox AN, et al. BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors. <em>Genet Med</em> 2019;21:1708-1718.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r21"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41436-018-0406-9" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30643217/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000478784800009" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=BOADICEA%3A+a+comprehensive+breast+cancer+risk+prediction+model+incorporating+genetic+and+nongenetic+risk+factors.&amp;publication_year=2019&amp;journal=Genet+Med&amp;pages=1708-1718&amp;doi=10.1038%2Fs41436-018-0406-9&amp;pmid=30643217" target="_blank">Google Scholar</a></div></div></div></div></div></div><div class="citations-truncation"><button data-label-expand="Show all references" data-label-collapse="Show fewer" data-label-remaining="references remaining" class="btn btn--secondary" aria-expanded="false" aria-controls="collapsible-text"><span>Show all references</span></button></div></section></div></section></div><div class="core-collateral"><div id="core-collateral-info" role="tabpanel" data-core-tabs="core-collateral-info" tabindex="-1" aria-labelledby="pane-core-collateral-info"><header><h2 id="pane-core-collateral-info"><i class="icon-info" aria-hidden="true"></i>Information &amp; Authors</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><div role="tablist"><button aria-controls="tab-information" role="tab" id="tab-information-label" aria-selected="true" class="active">Information</button><button aria-controls="tab-contributors" role="tab" id="tab-contributors-label" tabindex="-1" aria-selected="false">Authors</button></div><section id="tab-information" aria-labelledby="tab-information-label" role="tabpanel" tabindex="0"><h3>Information</h3><section class="core-self-citation"><h4>Published In</h4><div class="core-journal-presentation"><div class="core-journal-description"><div property="isPartOf" typeof="Periodical"><span property="name">New England Journal of Medicine</span></div><div class="core-enumeration"><a href="/toc/nejm/384/5"><span property="isPartOf" typeof="PublicationVolume">Volume <span property="volumeNumber">384</span></span> • <span property="isPartOf" typeof="PublicationIssue">Number <span property="issueNumber">5</span></span> • <span property="datePublished">February 4, 2021</span></a></div><div class="core-pagination"><span class="heading">Pages</span>: <span class="content"><span property="pageStart">428</span>-<span property="pageEnd">439</span></span></div></div></div></section><section class="core-copyright"><h4>Copyright</h4><div role="paragraph">Copyright © 2021 Massachusetts Medical Society. All rights reserved.</div><div>For personal use only. Any commercial reuse of NEJM Group content requires <a href="mailto:permissions@nejm.org">permission</a>.</div></section><section data-translation="YXQYoa1913948" class="core-component-translation"><h4>Translation</h4><div role="paragraph"><a target="_blank" href="https://nejmqianyan.cn/article/YXQYoa1913948?sg=AbW1N">Chinese Translation 中文翻译</a></div></section><section class="core-history"><h4>History</h4><div><b class="core-label">Published online</b>: January 20, 2021</div><div><b class="core-label">Published in issue</b>: February 4, 2021</div></section><section data-location="recirc_topics_article" class="core-classifications"><h4>Topics</h4><div class="keywords"><ol><li><a href="/browse/topic/breast-cancer" alt="View article keyword Breast Cancer" data-interactiontype="article_recirculation_click">Breast Cancer</a></li><li role="presentation" aria-hidden="true" class="list-line-break"></li><li><a href="/browse/topic/cancer" alt="View article keyword Cancer" data-interactiontype="article_recirculation_click">Cancer</a></li><li role="presentation" aria-hidden="true" class="list-line-break"></li></ol></div></section></section><section id="tab-contributors" aria-labelledby="tab-contributors-label" role="tabpanel" tabindex="-1"><h3>Authors</h3><section class="core-authors"><h4>Authors</h4><div role="paragraph"><span property="author" typeof="Person">Breast Cancer Association Consortium<sup class="xref"><a href="#fn1" role="doc-noteref">*</a></sup></span></div></section><section class="core-authors-notes"><h4>Notes</h4><div role="doc-footnote">Address reprint requests to Dr. Easton at the University of Cambridge, Strangeways Research Laboratory, Worts Causeway, Cambridge CB1 8RN, United Kingdom, or at <a href="mailto:dfe20@medschl.cam.ac.uk">dfe20@medschl.cam.ac.uk</a>.</div><div role="doc-footnote" data-has="label"><div class="label">*</div><div id="fn1"><div role="paragraph">The authors’ full names, academic degrees, and affiliations are listed in the <a href="#appendix-1">Appendix</a>.</div><div role="paragraph">A complete list of collaborators and investigators is provided in the <a href="#ap1">Supplementary Appendix</a>, available at NEJM.org.</div></div></div><div role="doc-footnote"><div id="fn2" role="paragraph">Dr. Dorling, Dr. Carvalho, and Mr. Allen and Drs. Teo, Devilee, and Easton contributed equally to this article.</div></div></section></section></div><div id="core-collateral-metrics" role="tabpanel" data-core-tabs="core-collateral-metrics" tabindex="-1" aria-labelledby="pane-core-collateral-metrics"><header><h2 id="pane-core-collateral-metrics"><i class="icon-timeline" aria-hidden="true"></i>Metrics &amp; Citations</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><div role="tablist"><button aria-controls="tab-metrics-inner" role="tab" id="tab-metrics-inner-label" aria-selected="true" class="active" data-interactiontype="article_tab" data-tabname="metricsWindow">Metrics</button><button aria-controls="tab-citations" role="tab" id="tab-citations-label" tabindex="-1" aria-selected="false" data-interactiontype="article_tab" data-tabname="metricsWindow">Citations<span class="citations-count">716</span></button></div><section id="tab-metrics-inner" aria-labelledby="tab-metrics-inner-label" role="tabpanel" tabindex="0"><h3>Metrics</h3><section>









    
    
        <div data-widget-def="UX3HTMLWidget" data-widget-id="95ea9f58-ec0e-4db2-b2ab-280fc876af53" data-location="article_metrics_article">
        



        
            <h4 class="">
                Altmetrics
            </h4>
        
        <div data-badge-details="right" data-badge-type="large-donut" data-doi="10.1056/NEJMoa1913948" data-hide-no-mentions="true" data-link-target="_blank" class="altmetric-embed" data-uuid="f273159b-1146-9b72-258e-167524987e4c"><div style="overflow:hidden;">
    <div class="altmetric-normal-legend">
        <a target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=98052114" style="display:inline-block;">
                <img alt="Article has an altmetric score of 682" src="https://badges.altmetric.com/?size=320&amp;score=682&amp;types=mabcttwf" width="180" height="180" style="border:0; margin:0; max-width: none;">
        </a>
        <p class="altmetric-see-more-details" style="padding-top: 10px; text-align: center;"><a target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=98052114">See more details</a></p>
    </div>
    <div id="_altmetric_popover_el_f273159b-1146-9b72-258e-167524987e4c" class="altmetric-embed right" style="margin:0; padding:0; display:inline-block; float:left; position:relative;">
        <div class="altmetric_container">
            <div class="altmetric-embed altmetric-popover-inner right">
                <div style="padding:0; margin: 0;" class="altmetric-embed altmetric-popover-content">
                        <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #FF0000;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=98052114&amp;tab=news">
          Picked up by <b>68</b> news outlets
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #ffd140;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=98052114&amp;tab=blogs">
          Blogged by <b>4</b>
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=98052114&amp;tab=twitter">
          Posted by <b>256</b> X users
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #f27700;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=98052114&amp;tab=patents">
          Referenced in <b>1</b> patents
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #2445bd;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=98052114&amp;tab=facebook">
          On <b>5</b> Facebook pages
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #958899;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=98052114&amp;tab=wikipedia">
          Referenced in <b>1</b> Wikipedia pages
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #A1E3E4;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=98052114&amp;tab=guidelines">
          Referenced in <b>2</b> clinical guideline sources
      </a>
    </div>

    <div class="altmetric-embed readers" style="margin-top: 10px;">
          <div class="altmetric-embed tip_mendeley" style="padding-left: 10px; line-height:18px; border-left: 16px solid #A60000;">
              <b>985</b> readers on Mendeley
          </div>
    </div>

                </div>
            </div>
        </div>
    </div>
</div></div>
<script async="" type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" nonce="94d66a15f0be1927-LAX"></script>

        </div>
    

</section></section><section id="tab-citations" aria-labelledby="tab-citations-label" role="tabpanel" tabindex="-1"><h3>Citations</h3><section>



        
            <h4 class="">
                Export citation
            </h4>
        
        <div class="citation-download cd-sec">
<p class="citation-download_msg">Select the format you want to export the citation of this publication.</p>
<form action="/action/downloadCitation" name="frmCitmgr" method="post" target="_self" class="citation-download_form"><input type="hidden" name="doi" value="10.1056/NEJMoa1913948"> <input type="hidden" name="downloadFileName" value="csp_384_"> <input type="hidden" name="include" value="abs">
<div class="dropdown dropdown-selectable dropdown-selectable--form-control"><input type="hidden" name="format" value=""> <label class="form-label">Format*</label> <button id="slct_format" type="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false" class="btn dropdown-toggle d-flex align-items-center justify-content-between">Please Select </button>
<div aria-labelledby="slct_format" role="listbox" class="dropdown-menu"><a href="#" data-value="ris" class="dropdown-item">RIS (ProCite, Reference Manager)</a><a href="#" data-value="endnote" class="dropdown-item">EndNote</a><a href="#" data-value="bibtex" class="dropdown-item">BibTex</a><a href="#" data-value="medlars" class="dropdown-item">Medlars</a><a href="#" data-value="refworks" class="dropdown-item">RefWorks</a></div>
<div class="invalid-feedback">Please select an item in the list</div>
</div>
<div class="citation-download_checkbox"><label class="checkbox--primary"><input type="checkbox" name="direct" value="true"><span class="checkbox--primary-icons"><span class="checkbox--primary-unchecked"><span class="icon-component "><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#toggles-checboxUnchecked"></use></svg></span></span><span class="checkbox--primary-checked"><span class="icon-component "><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#toggles-checboxChecked"></use></svg></span></span></span><span class="checkbox--primary-label"><span class="checkbox--primary-label-text">Direct Import</span></span></label></div>
<div class="citation-download_btn"><button type="submit" name="submit" value="Download" class="ng-btn_default ng-btn_iconLeft" data-interactiontype="article_tools_citation_download" data-multimedia-type="Citation"><span class="icon-component "><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#citations"></use></svg></span><span class="ng-btn_text">Export citation</span></button></div>
</form></div>
</section><section>









    
    
        <div data-widget-def="UX3CitedByWidget" data-widget-id="efb4df9a-8e1a-47f9-bfb7-271959277a9f" data-location="citedby_article">
        



        
            <h4 class="">
                Cited by
            </h4>
        
        <section id="cited-by" class="cited-by"><div class="cited-by__wrapper"><div id="cited-by__content" class="cited-by__content"><ol data-source="/pb/widgets/citedBy?page=1&amp;widgetId=efb4df9a-8e1a-47f9-bfb7-271959277a9f&amp;pbContext=%3BrequestedJournal%3Ajournal%3Anejm%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AMMS+NextGen+Website+Group%3Barticle%3Aarticle%3Adoi%5C%3A10.1056%2FNEJMoa1913948%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bwebsite%3Awebsite%3Amms-site%3Bissue%3Aissue%3Adoi%5C%3A10.1056%2Fnejm_2021.384.issue-5%3Bjournal%3Ajournal%3Anejms" data-lazyload="false" data-total="716" class="cited-by__list list-unstyled"><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Toqir K Mukhtar, </li><li class="list-inline-item cited-by__entry__author">Leila Dorling, </li><li class="list-inline-item cited-by__entry__author">Naomi Wilcox, </li><li class="list-inline-item cited-by__entry__author">Joe Dennis, </li><li class="list-inline-item cited-by__entry__author">Xin Yang, </li><li class="list-inline-item cited-by__entry__author">Melissa Southey, </li><li class="list-inline-item cited-by__entry__author">Marc Tischkowitz, </li><li class="list-inline-item cited-by__entry__author">Douglas F Easton, </li></ul><span class="cited-by__entry__title">
              Associations between
              ATM
              c.7271T&gt;G and cancer risk: analysis of Breast Cancer Association Consortium and UK Biobank data
            , </span><span class="cited-by__entry__series-title">Journal of Medical Genetics, </span><span class="cited-by__entry__page-range">(jmg-2025-110769), </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.1136/jmg-2025-110769" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.1136/jmg-2025-110769</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.1136/jmg-2025-110769" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Emilia Ruggiero, </li><li class="list-inline-item cited-by__entry__author">Sukshma Sharma, </li><li class="list-inline-item cited-by__entry__author">Augusto Di Castelnuovo, </li><li class="list-inline-item cited-by__entry__author">Simona Costanzo, </li><li class="list-inline-item cited-by__entry__author">Teresa Panzera, </li><li class="list-inline-item cited-by__entry__author">Simona Esposito, </li><li class="list-inline-item cited-by__entry__author">Chiara Cerletti, </li><li class="list-inline-item cited-by__entry__author">Maria Benedetta Donati, </li><li class="list-inline-item cited-by__entry__author">Giovanni de Gaetano, </li><li class="list-inline-item cited-by__entry__author">Licia Iacoviello, </li><li class="list-inline-item cited-by__entry__author">Marialaura Bonaccio, </li></ul><span class="cited-by__entry__title">Olive oil consumption and risk of breast cancer: Prospective results from the Moli-sani Study, and a systematic review of observational studies and randomized clinical trials, </span><span class="cited-by__entry__series-title">European Journal of Cancer, </span><span class="cited-by__entry__volume"><strong>224</strong>, </span><span class="cited-by__entry__page-range">(115520), </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.1016/j.ejca.2025.115520" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.1016/j.ejca.2025.115520</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.1016/j.ejca.2025.115520" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Iulian Gabriel Goidescu, </li><li class="list-inline-item cited-by__entry__author">Ioana Cristina Rotar, </li><li class="list-inline-item cited-by__entry__author">Georgiana Nemeti, </li><li class="list-inline-item cited-by__entry__author">Adelina Staicu, </li><li class="list-inline-item cited-by__entry__author">Mihai Surcel, </li><li class="list-inline-item cited-by__entry__author">Gheorghe Cruciat, </li><li class="list-inline-item cited-by__entry__author">Daniel Mureșan, </li><li class="list-inline-item cited-by__entry__author">Cerasela Goidescu, </li><li class="list-inline-item cited-by__entry__author">Dan Eniu, </li></ul><span class="cited-by__entry__title">Moderate-Low Risk Breast Cancer Gene Expression in a Romanian Population, </span><span class="cited-by__entry__series-title">International Journal of Molecular Sciences, </span><span class="cited-by__entry__volume"><strong>26</strong>, </span><span class="cited-by__entry__issue">11, </span><span class="cited-by__entry__page-range">(5313), </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.3390/ijms26115313" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.3390/ijms26115313</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.3390/ijms26115313" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Anne K. Munch, </li><li class="list-inline-item cited-by__entry__author">Elisabeth S. Feldner, </li><li class="list-inline-item cited-by__entry__author">Caroline H. Bækgaard, </li><li class="list-inline-item cited-by__entry__author">Mie B. Larsen, </li><li class="list-inline-item cited-by__entry__author">Naja Slemming-Adamsen, </li><li class="list-inline-item cited-by__entry__author">Desirée S. Boonen, </li><li class="list-inline-item cited-by__entry__author">Nanna B. Møller, </li><li class="list-inline-item cited-by__entry__author">Inge S. Pedersen, </li><li class="list-inline-item cited-by__entry__author">Thomas V. O. Hansen, </li><li class="list-inline-item cited-by__entry__author">Thorkild Terkelsen, </li><li class="list-inline-item cited-by__entry__author">Mark Burton, </li><li class="list-inline-item cited-by__entry__author">Qin Hao, </li><li class="list-inline-item cited-by__entry__author">Susanne E. Boonen, </li><li class="list-inline-item cited-by__entry__author">Mads Thomassen, </li></ul><span class="cited-by__entry__title">Classification of Gene Variants in a Danish Population with Suspected Predisposition to Hereditary Breast and/or Ovarian Cancer, </span><span class="cited-by__entry__series-title">Cancers, </span><span class="cited-by__entry__volume"><strong>17</strong>, </span><span class="cited-by__entry__issue">11, </span><span class="cited-by__entry__page-range">(1819), </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.3390/cancers17111819" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.3390/cancers17111819</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.3390/cancers17111819" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Claudiu Ioan Filip, </li><li class="list-inline-item cited-by__entry__author">Andreea Cătană, </li><li class="list-inline-item cited-by__entry__author">Lorin-Manuel Pîrlog, </li><li class="list-inline-item cited-by__entry__author">Andrada-Adelaida Pătrășcanu, </li><li class="list-inline-item cited-by__entry__author">Mariela Sanda Militaru, </li><li class="list-inline-item cited-by__entry__author">Irina Iordănescu, </li><li class="list-inline-item cited-by__entry__author">George Călin Dindelegan, </li></ul><span class="cited-by__entry__title">Associations Between DNA Repair Gene Polymorphisms and Breast Cancer Histopathological Subtypes: A Preliminary Study, </span><span class="cited-by__entry__series-title">Journal of Clinical Medicine, </span><span class="cited-by__entry__volume"><strong>14</strong>, </span><span class="cited-by__entry__issue">11, </span><span class="cited-by__entry__page-range">(3764), </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.3390/jcm14113764" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.3390/jcm14113764</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.3390/jcm14113764" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Maria Zanti, </li><li class="list-inline-item cited-by__entry__author">Denise G. O’Mahony, </li><li class="list-inline-item cited-by__entry__author">Michael T. Parsons, </li><li class="list-inline-item cited-by__entry__author">Leila Dorling, </li><li class="list-inline-item cited-by__entry__author">Joe Dennis, </li><li class="list-inline-item cited-by__entry__author">Nicholas J. Boddicker, </li><li class="list-inline-item cited-by__entry__author">Wenan Chen, </li><li class="list-inline-item cited-by__entry__author">Chunling Hu, </li><li class="list-inline-item cited-by__entry__author">Marc Naven, </li><li class="list-inline-item cited-by__entry__author">Kristia Yiangou, </li><li class="list-inline-item cited-by__entry__author">Thomas U. Ahearn, </li><li class="list-inline-item cited-by__entry__author">Christine B. Ambrosone, </li><li class="list-inline-item cited-by__entry__author">Irene L. Andrulis, </li><li class="list-inline-item cited-by__entry__author">Antonis C. Antoniou, </li><li class="list-inline-item cited-by__entry__author">Paul L. Auer, </li><li class="list-inline-item cited-by__entry__author">Caroline Baynes, </li><li class="list-inline-item cited-by__entry__author">Clara Bodelon, </li><li class="list-inline-item cited-by__entry__author">Natalia V. Bogdanova, </li><li class="list-inline-item cited-by__entry__author">Stig E. Bojesen, </li><li class="list-inline-item cited-by__entry__author">Manjeet K. Bolla, </li><li class="list-inline-item cited-by__entry__author">Kristen D. Brantley, </li><li class="list-inline-item cited-by__entry__author">Nicola J. Camp, </li><li class="list-inline-item cited-by__entry__author">Archie Campbell, </li><li class="list-inline-item cited-by__entry__author">Jose E. Castelao, </li><li class="list-inline-item cited-by__entry__author">Melissa H. Cessna, </li><li class="list-inline-item cited-by__entry__author">Jenny Chang-Claude, </li><li class="list-inline-item cited-by__entry__author">Fei Chen, </li><li class="list-inline-item cited-by__entry__author">Georgia Chenevix-Trench, </li><li class="list-inline-item cited-by__entry__author">Vessela N. Kristensen, </li><li class="list-inline-item cited-by__entry__author">Don M. Conroy, </li><li class="list-inline-item cited-by__entry__author">Kamila Czene, </li><li class="list-inline-item cited-by__entry__author">Arcangela De Nicolo, </li><li class="list-inline-item cited-by__entry__author">Susan M. Domchek, </li><li class="list-inline-item cited-by__entry__author">Thilo Dörk, </li><li class="list-inline-item cited-by__entry__author">Alison M. Dunning, </li><li class="list-inline-item cited-by__entry__author">A. Heather Eliassen, </li><li class="list-inline-item cited-by__entry__author">D. Gareth Evans, </li><li class="list-inline-item cited-by__entry__author">Peter A. Fasching, </li><li class="list-inline-item cited-by__entry__author">Jonine D. Figueroa, </li><li class="list-inline-item cited-by__entry__author">Henrik Flyger, </li><li class="list-inline-item cited-by__entry__author">Manuela Gago-Dominguez, </li><li class="list-inline-item cited-by__entry__author">Montserrat García-Closas, </li><li class="list-inline-item cited-by__entry__author">Gord Glendon, </li><li class="list-inline-item cited-by__entry__author">Anna González-Neira, </li><li class="list-inline-item cited-by__entry__author">Felix Grassmann, </li><li class="list-inline-item cited-by__entry__author">Andreas Hadjisavvas, </li><li class="list-inline-item cited-by__entry__author">Christopher A. Haiman, </li><li class="list-inline-item cited-by__entry__author">Ute Hamann, </li><li class="list-inline-item cited-by__entry__author">Steven N. Hart, </li><li class="list-inline-item cited-by__entry__author">Mikael B. A. Hartman, </li><li class="list-inline-item cited-by__entry__author">Weang-Kee Ho, </li><li class="list-inline-item cited-by__entry__author">James M. Hodge, </li><li class="list-inline-item cited-by__entry__author">Reiner Hoppe, </li><li class="list-inline-item cited-by__entry__author">Sacha J. Howell, </li><li class="list-inline-item cited-by__entry__author">Georgia Chenevix-Trench, </li><li class="list-inline-item cited-by__entry__author">Anna Jakubowska, </li><li class="list-inline-item cited-by__entry__author">Elza K. Khusnutdinova, </li><li class="list-inline-item cited-by__entry__author">Yon-Dschun Ko, </li><li class="list-inline-item cited-by__entry__author">Peter Kraft, </li><li class="list-inline-item cited-by__entry__author">Vessela N. Kristensen, </li><li class="list-inline-item cited-by__entry__author">James V. Lacey, </li><li class="list-inline-item cited-by__entry__author">Jingmei Li, </li><li class="list-inline-item cited-by__entry__author">Geok Hoon Lim, </li><li class="list-inline-item cited-by__entry__author">Sara Lindström, </li><li class="list-inline-item cited-by__entry__author">Artitaya Lophatananon, </li><li class="list-inline-item cited-by__entry__author">Craig Luccarini, </li><li class="list-inline-item cited-by__entry__author">Arto Mannermaa, </li><li class="list-inline-item cited-by__entry__author">Maria Elena Martinez, </li><li class="list-inline-item cited-by__entry__author">Dimitrios Mavroudis, </li><li class="list-inline-item cited-by__entry__author">Roger L. Milne, </li><li class="list-inline-item cited-by__entry__author">Kenneth Muir, </li><li class="list-inline-item cited-by__entry__author">Katherine L. Nathanson, </li><li class="list-inline-item cited-by__entry__author">Rocio Nuñez-Torres, </li><li class="list-inline-item cited-by__entry__author">Nadia Obi, </li><li class="list-inline-item cited-by__entry__author">Janet E. Olson, </li><li class="list-inline-item cited-by__entry__author">Julie R. Palmer, </li><li class="list-inline-item cited-by__entry__author">Mihalis I. Panayiotidis, </li><li class="list-inline-item cited-by__entry__author">Alpa V. Patel, </li><li class="list-inline-item cited-by__entry__author">Paul D. P. Pharoah, </li><li class="list-inline-item cited-by__entry__author">Eric C. Polley, </li><li class="list-inline-item cited-by__entry__author">Muhammad U. Rashid, </li><li class="list-inline-item cited-by__entry__author">Kathryn J. Ruddy, </li><li class="list-inline-item cited-by__entry__author">Emmanouil Saloustros, </li><li class="list-inline-item cited-by__entry__author">Elinor J. Sawyer, </li><li class="list-inline-item cited-by__entry__author">Marjanka K. Schmidt, </li><li class="list-inline-item cited-by__entry__author">Melissa C. Southey, </li><li class="list-inline-item cited-by__entry__author">Veronique Kiak-Mien Tan, </li><li class="list-inline-item cited-by__entry__author">Soo Hwang Teo, </li><li class="list-inline-item cited-by__entry__author">Lauren R. Teras, </li><li class="list-inline-item cited-by__entry__author">Diana Torres, </li><li class="list-inline-item cited-by__entry__author">Amy Trentham-Dietz, </li><li class="list-inline-item cited-by__entry__author">Thérèse Truong, </li><li class="list-inline-item cited-by__entry__author">Celine M. Vachon, </li><li class="list-inline-item cited-by__entry__author">Qin Wang, </li><li class="list-inline-item cited-by__entry__author">Jeffrey N. Weitzel, </li><li class="list-inline-item cited-by__entry__author">Siddhartha Yadav, </li><li class="list-inline-item cited-by__entry__author">Song Yao, </li><li class="list-inline-item cited-by__entry__author">Gary R. Zirpoli, </li><li class="list-inline-item cited-by__entry__author">Melissa S. Cline, </li><li class="list-inline-item cited-by__entry__author">Peter Devilee, </li><li class="list-inline-item cited-by__entry__author">Sean V. Tavtigian, </li><li class="list-inline-item cited-by__entry__author">David E. Goldgar, </li><li class="list-inline-item cited-by__entry__author">Fergus J. Couch, </li><li class="list-inline-item cited-by__entry__author">Douglas F. Easton, </li><li class="list-inline-item cited-by__entry__author">Amanda B. Spurdle, </li><li class="list-inline-item cited-by__entry__author">Kyriaki Michailidou, </li></ul><span class="cited-by__entry__title">Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classification, </span><span class="cited-by__entry__series-title">Nature Communications, </span><span class="cited-by__entry__volume"><strong>16</strong>, </span><span class="cited-by__entry__issue">1, </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.1038/s41467-025-59979-6" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.1038/s41467-025-59979-6</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.1038/s41467-025-59979-6" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Aleksandar M. Kostov, </li><li class="list-inline-item cited-by__entry__author">Maj-Britt Jensen, </li><li class="list-inline-item cited-by__entry__author">Bent Ejlertsen, </li><li class="list-inline-item cited-by__entry__author">Mads Thomassen, </li><li class="list-inline-item cited-by__entry__author">Maria Rossing, </li><li class="list-inline-item cited-by__entry__author">Inge S. Pedersen, </li><li class="list-inline-item cited-by__entry__author">Annabeth H. Petersen, </li><li class="list-inline-item cited-by__entry__author">Lise Lotte Christensen, </li><li class="list-inline-item cited-by__entry__author">Karin A. W. Wadt, </li><li class="list-inline-item cited-by__entry__author">Luis C. Berrocal-Almanza, </li><li class="list-inline-item cited-by__entry__author">Miguel Miranda, </li><li class="list-inline-item cited-by__entry__author">Anne-Vibeke Lænkholm, </li></ul><span class="cited-by__entry__title">Timely germline BRCA testing after invasive breast cancer promotes contralateral risk-reducing mastectomy and improves survival: an observational retrospective study, </span><span class="cited-by__entry__series-title">Breast Cancer Research and Treatment, </span><span class="cited-by__entry__volume"><strong>212</strong>, </span><span class="cited-by__entry__issue">2, </span><span class="cited-by__entry__page-range">(309-323), </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.1007/s10549-025-07726-2" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.1007/s10549-025-07726-2</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.1007/s10549-025-07726-2" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Evan Weber, </li><li class="list-inline-item cited-by__entry__author">Carlos A. Carmona-Gonzalez, </li><li class="list-inline-item cited-by__entry__author">Melanie Boucher, </li><li class="list-inline-item cited-by__entry__author">Andrea Eisen, </li><li class="list-inline-item cited-by__entry__author">Kara Laing, </li><li class="list-inline-item cited-by__entry__author">Jennifer Melvin, </li><li class="list-inline-item cited-by__entry__author">Kasmintan A. Schrader, </li><li class="list-inline-item cited-by__entry__author">Sandeep Sehdev, </li><li class="list-inline-item cited-by__entry__author">Stephanie M. Wong, </li><li class="list-inline-item cited-by__entry__author">Karen A. Gelmon, </li></ul><span class="cited-by__entry__title">Canadian Recommendations for Germline Genetic Testing of Patients with Breast Cancer: A Call to Action, </span><span class="cited-by__entry__series-title">Current Oncology, </span><span class="cited-by__entry__volume"><strong>32</strong>, </span><span class="cited-by__entry__issue">6, </span><span class="cited-by__entry__page-range">(290), </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.3390/curroncol32060290" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.3390/curroncol32060290</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.3390/curroncol32060290" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Laura Lema, </li><li class="list-inline-item cited-by__entry__author">José Manuel Pérez-García, </li><li class="list-inline-item cited-by__entry__author">Salvador Blanch, </li><li class="list-inline-item cited-by__entry__author">Judith Balmaña, </li><li class="list-inline-item cited-by__entry__author">José Ángel García-Sáenz, </li><li class="list-inline-item cited-by__entry__author">Elena Filipovich Vegas, </li><li class="list-inline-item cited-by__entry__author">Begoña Jiménez, </li><li class="list-inline-item cited-by__entry__author">Juan de la Haba, </li><li class="list-inline-item cited-by__entry__author">Marta Campolier, </li><li class="list-inline-item cited-by__entry__author">Eileen Shimizu, </li><li class="list-inline-item cited-by__entry__author">Daniel Alcalá-López, </li><li class="list-inline-item cited-by__entry__author">Miguel Sampayo-Cordero, </li><li class="list-inline-item cited-by__entry__author">Javier Cortés, </li><li class="list-inline-item cited-by__entry__author">Antonio Llombart-Cussac, </li></ul><span class="cited-by__entry__title">Niraparib Plus Aromatase Inhibitors for Hormone Receptor-Positive/HER2-Negative Advanced Breast Cancer with a Germline BRCA Mutation, </span><span class="cited-by__entry__series-title">Cancers, </span><span class="cited-by__entry__volume"><strong>17</strong>, </span><span class="cited-by__entry__issue">11, </span><span class="cited-by__entry__page-range">(1744), </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.3390/cancers17111744" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.3390/cancers17111744</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.3390/cancers17111744" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Allison W. Kurian, </li><li class="list-inline-item cited-by__entry__author">Elisha Hughes, </li><li class="list-inline-item cited-by__entry__author">Ryan Bernhisel, </li><li class="list-inline-item cited-by__entry__author">Eudora Hu, </li><li class="list-inline-item cited-by__entry__author">Eric C. Polley, </li><li class="list-inline-item cited-by__entry__author">Siddhartha Yadav, </li><li class="list-inline-item cited-by__entry__author">Chunling Hu, </li><li class="list-inline-item cited-by__entry__author">Jennifer L. Caswell-Jin, </li><li class="list-inline-item cited-by__entry__author">Esther M. John, </li><li class="list-inline-item cited-by__entry__author">Aladdin H. Shadyab, </li><li class="list-inline-item cited-by__entry__author">Rowan Chlebowski, </li><li class="list-inline-item cited-by__entry__author">Rami Nassir, </li><li class="list-inline-item cited-by__entry__author">Peter Kraft, </li><li class="list-inline-item cited-by__entry__author">Marcia L. Stefanick, </li><li class="list-inline-item cited-by__entry__author">Fergus J. Couch, </li></ul><span class="cited-by__entry__title">
              Breast Cancer Risk Modification in Women with Pathogenic Variants in
              BRCA1
              ,
              BRCA2
              ,
              ATM
              ,
              CHEK2
              , and
              PALB2
               , </span><span class="cited-by__entry__series-title">Cancer Research Communications, </span><span class="cited-by__entry__volume"><strong>5</strong>, </span><span class="cited-by__entry__issue">5, </span><span class="cited-by__entry__page-range">(783-791), </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.1158/2767-9764.CRC-24-0592" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.1158/2767-9764.CRC-24-0592</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.1158/2767-9764.CRC-24-0592" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry--see-more"><a href="javascript:void(0)" data-source="/pb/widgets/citedBy?page=1&amp;widgetId=efb4df9a-8e1a-47f9-bfb7-271959277a9f&amp;pbContext=%3BrequestedJournal%3Ajournal%3Anejm%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AMMS+NextGen+Website+Group%3Barticle%3Aarticle%3Adoi%5C%3A10.1056%2FNEJMoa1913948%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bwebsite%3Awebsite%3Amms-site%3Bissue%3Aissue%3Adoi%5C%3A10.1056%2Fnejm_2021.384.issue-5%3Bjournal%3Ajournal%3Anejms" class="cited-by__see-more">See more</a></li></ol></div><div class="cited-by__spinner justify-content-center align-items-center d-none"><div role="status" class="spinner-border text-gray"><span class="sr-only">Loading...</span></div></div></div></section>

        </div>
    

</section></section></div><div id="core-collateral-fulltext-options" role="tabpanel" data-core-tabs="core-collateral-fulltext-options" tabindex="-1" aria-labelledby="pane-core-collateral-fulltext-options"><header><h2 id="pane-core-collateral-fulltext-options"><i class="icon-eye" aria-hidden="true"></i>View Options</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><div class="section--wrapper"><h3>View options</h3><section class="format--pdf"><h4> <abbr title="Portable Document Format">PDF</abbr></h4><a href="https://www.nejm.org/doi/pdf/10.1056/NEJMoa1913948" class="btn btn--pdf" aria-label="View PDF" data-behavior="trackDownloadEvent" data-doi="10.1056/NEJMoa1913948" data-interactiontype="article_tools_download_pdf" data-multimedia-type="Article PDF" data-multimedia-filename="nejmoa1913948.pdf"><i aria-hidden="true" class="icon-pdf"></i><span>View PDF</span></a></section></div><!-- Its needed to duplicate this for PB check Collateral.js as well--></div><div id="core-collateral-media" role="tabpanel" data-core-tabs="core-collateral-media" tabindex="-1" aria-labelledby="pane-core-collateral-media"><header><h2 id="pane-core-collateral-media"><i class="icon-photo" aria-hidden="true"></i>Media</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><div role="tablist"><button aria-controls="tab-figures" role="tab" id="tab-figures-label" aria-selected="true" class="active">Figures</button><button aria-controls="tab-other" role="tab" id="tab-other-label" tabindex="-1" aria-selected="false" class="inactive" aria-disabled="true">Other</button></div><section id="tab-figures" aria-labelledby="tab-figures-label" role="tabpanel" tabindex="0"><h3>Figures</h3><div class="text-right"><a class="btn btn--inverse  open-in-viewer" href="#figures"><span>Open all in viewer</span><i class="icon-open_in_new" aria-hidden="true"></i></a></div><div id="core-f1"><figure class="graphic"><a class="open-in-viewer" href="#f1" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa1913948_f1.jpg"><img src="/cms/10.1056/NEJMoa1913948/asset/d5f4eaa6-7576-49a3-889f-554c9e046254/assets/images/large/nejmoa1913948_f1.jpg" height="1376" width="2640" aria-labelledby="f1" loading="lazy"></a><figcaption><div class="caption">Frequency of Protein-Truncating Variants in 34 Genes in Population-Based Studies.</div><div class="notes"><div role="doc-footnote">Shown are percentages of women with breast cancer and controls who were carriers of protein-truncating variants in 34 genes. The genes are listed in order of increasing estimated odds ratios for breast cancer overall.</div></div></figcaption></figure><div class="external-links"><a class="pill__to-original" href="#f1"><i class="icon-return" aria-hidden="true"></i><span>Go to Figure</span></a><a class="open-in-viewer" href="#f1" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa1913948_f1.jpg"><span>Open in Viewer</span><i class="icon-expand" aria-hidden="true"></i></a></div></div><div id="core-f2"><figure class="graphic"><a class="open-in-viewer" href="#f2" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa1913948_f2.jpg"><img src="/cms/10.1056/NEJMoa1913948/asset/3fc0bdd2-fe62-4d6f-ad60-b59ea2386dfd/assets/images/large/nejmoa1913948_f2.jpg" height="2155" width="2640" aria-labelledby="f2" loading="lazy"></a><figcaption><div class="caption">Risk of Breast Cancer Overall and Tumor Subtypes Associated with Protein-Truncating Variants in 34 Genes in Population-Based Studies.</div><div class="notes"><div role="doc-footnote">Shown are odds ratios and 95% confidence intervals (CIs) for breast cancer overall (Panel A), estrogen receptor (ER)–positive breast cancer (Panel B), and ER-negative breast cancer (Panel C) associated with protein-truncating variants in 34 genes. The genes are listed in order of decreasing estimated odds ratios for breast cancer overall.</div></div></figcaption></figure><div class="external-links"><a class="pill__to-original" href="#f2"><i class="icon-return" aria-hidden="true"></i><span>Go to Figure</span></a><a class="open-in-viewer" href="#f2" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa1913948_f2.jpg"><span>Open in Viewer</span><i class="icon-expand" aria-hidden="true"></i></a></div></div><div id="core-f3"><figure class="graphic"><a class="open-in-viewer" href="#f3" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa1913948_f3.jpg"><img src="/cms/10.1056/NEJMoa1913948/asset/d4de3f12-da9d-4d12-a59c-9d6381e05ea6/assets/images/large/nejmoa1913948_f3.jpg" height="1620" width="2231" aria-labelledby="f3" loading="lazy"></a><figcaption><div class="caption">Estimated Absolute Risk of Breast Cancer Associated with Protein-Truncating Variants in 8 Genes.</div><div class="notes"><div role="doc-footnote">Shown are absolute risks of breast cancer through 80 years of age associated with protein-truncating variants in 8 genes that had significant evidence of an association with breast cancer overall, on the basis of estimated odds ratios from population-based studies. The absolute risk was not calculated for <i>TP53</i> because of the wide 95% confidence interval for the odds ratio and the known association with a substantial risk of childhood cancer. Baseline absolute risks were derived from population incidences in the United Kingdom in 2016.<sup><a href="#core-r6" role="doc-biblioref" data-xml-rid="r6" id="core-body-ref-r6-2" href-manipulated="true" aria-label="Reference 6" data-to-manipulate="false">6</a></sup> The 𝙸 bars indicate 95% confidence intervals.</div></div></figcaption></figure><div class="external-links"><a class="pill__to-original" href="#f3"><i class="icon-return" aria-hidden="true"></i><span>Go to Figure</span></a><a class="open-in-viewer" href="#f3" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa1913948_f3.jpg"><span>Open in Viewer</span><i class="icon-expand" aria-hidden="true"></i></a></div></div></section><section id="tab-other" aria-labelledby="tab-other-label" role="tabpanel" tabindex="-1"><h3>Other</h3></section></div><div id="core-collateral-tables" role="tabpanel" data-core-tabs="core-collateral-tables" tabindex="-1" aria-labelledby="pane-core-collateral-tables"><header><h2 id="pane-core-collateral-tables"><i class="icon-tables" aria-hidden="true"></i>Tables</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><!-- There is no content. --><div class="section--wrapper"><div class="text-right"><a class="btn btn--inverse  open-in-viewer" href="#tables"><span>Open all in viewer</span><i class="icon-open_in_new" aria-hidden="true"></i></a></div><div id="core-t1"><figure class="table"><a class="open-in-viewer" href="#t1" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa1913948_t1.jpg"><div class="graphic-wrap" data-presentation="suppressed-in-viewer"><img src="/cms/10.1056/NEJMoa1913948/asset/258fd6a8-9ef9-490a-ac10-fbd526187536/assets/images/large/nejmoa1913948_t1.jpg" height="2788" width="1999" loading="lazy"></div><div class="table-wrap catalyst-standard" data-presentation="suppressed-in-flow"><table data-shading="custom"><thead><tr class="head1" data-type="row head1"><th class="txlx-borders" data-xml-align="left">Gene</th><th class="txxx-borders" colspan="4"><span>Population-Based Studies<br>(48,826 patients and 50,703 controls)<a href="#core-t1fn2" role="doc-noteref">†</a></span></th><th class="txxx-borders">All Studies<br>(60,466 patients and 53,461 controls)<a href="#core-t1fn2" role="doc-noteref">†</a></th><th class="txxx-borders">Prior Probability<a href="#core-t1fn3" role="doc-noteref">‡</a></th><th class="txxr-borders">BFDP</th></tr><tr class="head2" data-type="row head2"><td class="xxlx-borders">&nbsp;</td><th class="xxxx-borders" colspan="2"><span>No. of Carriers of Protein-Truncating Variants</span></th><th class="xxxx-borders">Odds Ratio (95% CI)</th><th class="xxxx-borders">P Value</th><th class="xxxx-borders">P Value</th><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr class="head2" data-type="row head2"><td class="xxlx-borders">&nbsp;</td><th class="xxxx-borders">Women with Breast Cancer</th><th class="xxxx-borders">Controls</th><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr></thead><tbody><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left"><i>ABRAXAS1</i></td><td class="xxxx-borders shading">17</td><td class="xxxx-borders shading">19</td><td class="xxxx-borders shading">0.98 (0.50–1.94)</td><td class="xxxx-borders shading">0.96</td><td class="xxxx-borders shading">0.93</td><td class="xxxx-borders shading">0.1</td><td class="xxxr-borders shading">0.98</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left"><i>AKT1</i></td><td class="xxxx-borders">3</td><td class="xxxx-borders">6</td><td class="xxxx-borders">0.47 (0.12–1.93)</td><td class="xxxx-borders">0.29</td><td class="xxxx-borders">0.14</td><td class="xxxx-borders">0.1</td><td class="xxxr-borders">0.94</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left"><i>ATM</i></td><td class="xxxx-borders shading">294</td><td class="xxxx-borders shading">150</td><td class="xxxx-borders shading">2.10 (1.71–2.57)</td><td class="xxxx-borders shading">9.2×10<sup>−13</sup></td><td class="xxxx-borders shading">5.5×10<sup>−20</sup></td><td class="xxxx-borders shading">0.8</td><td class="xxxr-borders shading">1.3×10<sup>−18</sup></td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left"><i>BABAM2</i></td><td class="xxxx-borders">7</td><td class="xxxx-borders">9</td><td class="xxxx-borders">0.62 (0.23–1.71)</td><td class="xxxx-borders">0.36</td><td class="xxxx-borders">0.34</td><td class="xxxx-borders">0.1</td><td class="xxxr-borders">0.95</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left"><i>BARD1</i></td><td class="xxxx-borders shading">62</td><td class="xxxx-borders shading">32</td><td class="xxxx-borders shading">2.09 (1.35–3.23)</td><td class="xxxx-borders shading">0.00098</td><td class="xxxx-borders shading">0.00011</td><td class="xxxx-borders shading">0.2</td><td class="xxxr-borders shading">0.0076</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left"><i>BRCA1</i></td><td class="xxxx-borders">515</td><td class="xxxx-borders">58</td><td class="xxxx-borders">10.57 (8.02–13.93)</td><td class="xxxx-borders">1.1×10<sup>−62</sup></td><td class="xxxx-borders">3.7×10<sup>−65</sup></td><td class="xxxx-borders">0.99</td><td class="xxxr-borders">1.5×10<sup>−64</sup></td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left"><i>BRCA2</i></td><td class="xxxx-borders shading">754</td><td class="xxxx-borders shading">135</td><td class="xxxx-borders shading">5.85 (4.85–7.06)</td><td class="xxxx-borders shading">2.2×10<sup>−75</sup></td><td class="xxxx-borders shading">8.4×10<sup>−77</sup></td><td class="xxxx-borders shading">0.99</td><td class="xxxr-borders shading">3.1×10<sup>−76</sup></td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left"><i>BRIP1</i></td><td class="xxxx-borders">86</td><td class="xxxx-borders">75</td><td class="xxxx-borders">1.11 (0.80–1.53)</td><td class="xxxx-borders">0.54</td><td class="xxxx-borders">0.54</td><td class="xxxx-borders">0.2</td><td class="xxxr-borders">0.85</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left"><i>CDH1</i></td><td class="xxxx-borders shading">11</td><td class="xxxx-borders shading">12</td><td class="xxxx-borders shading">0.86 (0.37–1.98)</td><td class="xxxx-borders shading">0.72</td><td class="xxxx-borders shading">0.58</td><td class="xxxx-borders shading">0.2</td><td class="xxxr-borders shading">0.94</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left"><i>CHEK2</i></td><td class="xxxx-borders">704</td><td class="xxxx-borders">315</td><td class="xxxx-borders">2.54 (2.21–2.91)</td><td class="xxxx-borders">3.1×10<sup>−39</sup></td><td class="xxxx-borders">3.2×10<sup>−61</sup></td><td class="xxxx-borders">0.99</td><td class="xxxr-borders">1.3×10<sup>−60</sup></td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">c.1100delC variant</td><td class="xxxx-borders shading">548</td><td class="xxxx-borders shading">245</td><td class="xxxx-borders shading">2.66 (2.27–3.11)</td><td class="xxxx-borders shading">1.1×10<sup>−33</sup></td><td class="xxxx-borders shading">5.3×10<sup>−53</sup></td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Other variants</td><td class="xxxx-borders">156</td><td class="xxxx-borders">70</td><td class="xxxx-borders">2.13 (1.60–2.84)</td><td class="xxxx-borders">3.0×10<sup>−7</sup></td><td class="xxxx-borders">7.4×10<sup>−10</sup></td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left"><i>EPCAM</i></td><td class="xxxx-borders shading">14</td><td class="xxxx-borders shading">19</td><td class="xxxx-borders shading">0.73 (0.36–1.49)</td><td class="xxxx-borders shading">0.39</td><td class="xxxx-borders shading">0.13</td><td class="xxxx-borders shading">0.1</td><td class="xxxr-borders shading">0.95</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left"><i>FANCC</i></td><td class="xxxx-borders">71</td><td class="xxxx-borders">65</td><td class="xxxx-borders">1.26 (0.89–1.79)</td><td class="xxxx-borders">0.20</td><td class="xxxx-borders">0.20</td><td class="xxxx-borders">0.1</td><td class="xxxr-borders">0.87</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left"><i>FANCM</i></td><td class="xxxx-borders shading">302</td><td class="xxxx-borders shading">300</td><td class="xxxx-borders shading">1.06 (0.90–1.26)</td><td class="xxxx-borders shading">0.48</td><td class="xxxx-borders shading">0.28</td><td class="xxxx-borders shading">0.1</td><td class="xxxr-borders shading">0.96</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left"><i>GEN1</i></td><td class="xxxx-borders">31</td><td class="xxxx-borders">43</td><td class="xxxx-borders">0.66 (0.41–1.06)</td><td class="xxxx-borders">0.088</td><td class="xxxx-borders">0.18</td><td class="xxxx-borders">0.1</td><td class="xxxr-borders">0.95</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left"><i>MEN1</i></td><td class="xxxx-borders shading">2</td><td class="xxxx-borders shading">5</td><td class="xxxx-borders shading">0.37 (0.07–1.97)</td><td class="xxxx-borders shading">0.24</td><td class="xxxx-borders shading">0.64</td><td class="xxxx-borders shading">0.1</td><td class="xxxr-borders shading">0.95</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left"><i>MLH1</i></td><td class="xxxx-borders">5</td><td class="xxxx-borders">9</td><td class="xxxx-borders">0.58 (0.19–1.77)</td><td class="xxxx-borders">0.34</td><td class="xxxx-borders">0.55</td><td class="xxxx-borders">0.1</td><td class="xxxr-borders">0.95</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left"><i>MRE11</i></td><td class="xxxx-borders shading">48</td><td class="xxxx-borders shading">55</td><td class="xxxx-borders shading">0.88 (0.59–1.32)</td><td class="xxxx-borders shading">0.54</td><td class="xxxx-borders shading">0.34</td><td class="xxxx-borders shading">0.1</td><td class="xxxr-borders shading">0.98</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left"><i>MSH2</i></td><td class="xxxx-borders">13</td><td class="xxxx-borders">13</td><td class="xxxx-borders">1.06 (0.47–2.36)</td><td class="xxxx-borders">0.89</td><td class="xxxx-borders">0.80</td><td class="xxxx-borders">0.1</td><td class="xxxr-borders">0.92</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left"><i>MSH6</i></td><td class="xxxx-borders shading">39</td><td class="xxxx-borders shading">23</td><td class="xxxx-borders shading">1.96 (1.15–3.33)</td><td class="xxxx-borders shading">0.013</td><td class="xxxx-borders shading">0.021</td><td class="xxxx-borders shading">0.1</td><td class="xxxr-borders shading">0.55</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left"><i>MUTYH</i></td><td class="xxxx-borders">232</td><td class="xxxx-borders">231</td><td class="xxxx-borders">1.00 (0.83–1.21)</td><td class="xxxx-borders">0.99</td><td class="xxxx-borders">0.88</td><td class="xxxx-borders">0.1</td><td class="xxxr-borders">1.00</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left"><i>NBN</i></td><td class="xxxx-borders shading">90</td><td class="xxxx-borders shading">103</td><td class="xxxx-borders shading">0.90 (0.67–1.20)</td><td class="xxxx-borders shading">0.48</td><td class="xxxx-borders shading">0.65</td><td class="xxxx-borders shading">0.2</td><td class="xxxr-borders shading">0.95</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left"><i>NF1</i></td><td class="xxxx-borders">31</td><td class="xxxx-borders">17</td><td class="xxxx-borders">1.76 (0.96–3.21)</td><td class="xxxx-borders">0.068</td><td class="xxxx-borders">0.011</td><td class="xxxx-borders">0.2</td><td class="xxxr-borders">0.25</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left"><i>PALB2</i></td><td class="xxxx-borders shading">274</td><td class="xxxx-borders shading">55</td><td class="xxxx-borders shading">5.02 (3.73–6.76)</td><td class="xxxx-borders shading">1.6×10<sup>−26</sup></td><td class="xxxx-borders shading">1.1×10<sup>−32</sup></td><td class="xxxx-borders shading">0.99</td><td class="xxxr-borders shading">2.9×10<sup>−32</sup></td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left"><i>PIK3CA</i></td><td class="xxxx-borders">3</td><td class="xxxx-borders">12</td><td class="xxxx-borders">0.21 (0.06–0.75)</td><td class="xxxx-borders">0.016</td><td class="xxxx-borders">0.19</td><td class="xxxx-borders">0.1</td><td class="xxxr-borders">0.94</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left"><i>PMS2</i></td><td class="xxxx-borders shading">40</td><td class="xxxx-borders shading">36</td><td class="xxxx-borders shading">1.16 (0.73–1.85)</td><td class="xxxx-borders shading">0.53</td><td class="xxxx-borders shading">0.37</td><td class="xxxx-borders shading">0.1</td><td class="xxxr-borders shading">0.92</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left"><i>PTEN</i></td><td class="xxxx-borders">14</td><td class="xxxx-borders">6</td><td class="xxxx-borders">2.25 (0.85–6.00)</td><td class="xxxx-borders">0.10</td><td class="xxxx-borders">0.0040</td><td class="xxxx-borders">0.2</td><td class="xxxr-borders">0.14</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left"><i>RAD50</i></td><td class="xxxx-borders shading">120</td><td class="xxxx-borders shading">121</td><td class="xxxx-borders shading">1.08 (0.83–1.40)</td><td class="xxxx-borders shading">0.57</td><td class="xxxx-borders shading">0.45</td><td class="xxxx-borders shading">0.1</td><td class="xxxr-borders shading">0.95</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left"><i>RAD51C</i></td><td class="xxxx-borders">54</td><td class="xxxx-borders">26</td><td class="xxxx-borders">1.93 (1.20–3.11)</td><td class="xxxx-borders">0.0070</td><td class="xxxx-borders">0.00026</td><td class="xxxx-borders">0.3</td><td class="xxxr-borders">0.0090</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left"><i>RAD51D</i></td><td class="xxxx-borders shading">51</td><td class="xxxx-borders shading">25</td><td class="xxxx-borders shading">1.80 (1.11–2.93)</td><td class="xxxx-borders shading">0.018</td><td class="xxxx-borders shading">0.0018</td><td class="xxxx-borders shading">0.3</td><td class="xxxr-borders shading">0.044</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left"><i>RECQL</i></td><td class="xxxx-borders">103</td><td class="xxxx-borders">120</td><td class="xxxx-borders">0.84 (0.64–1.10)</td><td class="xxxx-borders">0.21</td><td class="xxxx-borders">0.89</td><td class="xxxx-borders">0.1</td><td class="xxxr-borders">0.95</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left"><i>RINT1</i></td><td class="xxxx-borders shading">32</td><td class="xxxx-borders shading">49</td><td class="xxxx-borders shading">0.72 (0.46–1.14)</td><td class="xxxx-borders shading">0.17</td><td class="xxxx-borders shading">0.31</td><td class="xxxx-borders shading">0.1</td><td class="xxxr-borders shading">0.96</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left"><i>STK11</i></td><td class="xxxx-borders">6</td><td class="xxxx-borders">5</td><td class="xxxx-borders">1.60 (0.48–5.28)</td><td class="xxxx-borders">0.44</td><td class="xxxx-borders">0.50</td><td class="xxxx-borders">0.2</td><td class="xxxr-borders">0.70</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left"><i>TP53</i></td><td class="xxxx-borders shading">7</td><td class="xxxx-borders shading">2</td><td class="xxxx-borders shading">3.06 (0.63–14.91)</td><td class="xxxx-borders shading">0.17</td><td class="xxxx-borders shading">0.015</td><td class="xxxx-borders shading">0.8</td><td class="xxxr-borders shading">0.033</td></tr><tr data-xml-align="center" data-type="row"><td class="xblx-borders hanging02" data-xml-align="left"><i>XRCC2</i></td><td class="xbxx-borders">15</td><td class="xbxx-borders">18</td><td class="xbxx-borders">0.96 (0.47–1.93)</td><td class="xbxx-borders">0.90</td><td class="xbxx-borders">0.81</td><td class="xbxx-borders">0.1</td><td class="xbxr-borders">0.98</td></tr></tbody></table></div></a><figcaption><a class="open-in-viewer" href="#t1" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa1913948_t1.jpg"></a><div class="notes"><a class="open-in-viewer" href="#t1" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa1913948_t1.jpg"><div role="doc-footnote" data-has="label"><div class="label">*</div><div id="core-t1fn1" role="paragraph" data-to-manipulate="true">BFDP denotes Bayesian false-discovery probability, and CI confidence interval.</div></div><div role="doc-footnote" data-has="label"><div class="label">†</div><div id="core-t1fn2" role="paragraph" data-to-manipulate="true">The sample sizes reflect totals after quality control. Analyses for genes other than <i>BRCA1</i> and <i>BRCA2</i> excluded carriers of protein-truncating variants in <i>BRCA1</i> and <i>BRCA2</i>; therefore, sample sizes were slightly lower in those analyses (47,522 patients and 50,475 controls in population-based studies, and 58,728 patients and 52,976 controls in all studies).</div></div></a><div role="doc-footnote" data-has="label"><a class="open-in-viewer" href="#t1" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa1913948_t1.jpg"><div class="label">‡</div></a><div id="core-t1fn3" role="paragraph" data-to-manipulate="true"><a class="open-in-viewer" href="#t1" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa1913948_t1.jpg">Details regarding the prior probabilities are provided in the Supplementary Methods section in the </a><a href="#ap1">Supplementary Appendix</a>.</div></div></div></figcaption><figcaption><div class="caption">Risk of Breast Cancer Overall Associated with Protein-Truncating Variants in 34 Genes in Population-Based Studies and All Studies.<a href="#core-t1fn1" role="doc-noteref">*</a></div></figcaption></figure><div class="external-links"><a class="pill__to-original" href="#t1"><i class="icon-return" aria-hidden="true"></i><span>Go to Table</span></a><a class="open-in-viewer" href="#t1" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa1913948_t1.jpg"><span>Open in Viewer</span><i class="icon-expand" aria-hidden="true"></i></a></div></div><div id="core-t2"><figure class="table"><a class="open-in-viewer" href="#t2" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa1913948_t2.jpg"><div class="graphic-wrap" data-presentation="suppressed-in-viewer"><img src="/cms/10.1056/NEJMoa1913948/asset/a9b74e0e-f682-4c89-9b28-9bb002c84e18/assets/images/large/nejmoa1913948_t2.jpg" height="2602" width="1711" loading="lazy"></div><div class="table-wrap catalyst-standard" data-presentation="suppressed-in-flow"><table data-shading="custom"><thead><tr class="head1" data-type="row head1"><th class="txlx-borders" data-xml-align="left">Gene</th><th class="txxx-borders" colspan="4"><span>Population-Based Studies<br>(48,826 patients and 50,703 controls)<a href="#core-t2fn1" role="doc-noteref">*</a></span></th><th class="txxr-borders">All Studies<br>(60,466 patients and 53,461 controls)<a href="#core-t2fn1" role="doc-noteref">*</a></th></tr><tr class="head2" data-type="row head2"><td class="xxlx-borders">&nbsp;</td><th class="xxxx-borders" colspan="2"><span>No. of Carriers of Rare Missense Variants</span></th><th class="xxxx-borders">Odds Ratio (95% CI)</th><th class="xxxx-borders">P Value</th><th class="xxxr-borders">P Value</th></tr><tr class="head2" data-type="row head2"><td class="xxlx-borders">&nbsp;</td><th class="xxxx-borders">Women with Breast Cancer</th><th class="xxxx-borders">Controls</th><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr></thead><tbody><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01 shading" data-xml-align="left"><i>ABRAXAS1</i></td><td class="xxxx-borders shading">233</td><td class="xxxx-borders shading">242</td><td class="xxxx-borders shading" data-xml-valign="middle">1.04 (0.86–1.25)</td><td class="xxxx-borders shading">0.70</td><td class="xxxr-borders shading">0.40</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01" data-xml-align="left"><i>AKT1</i></td><td class="xxxx-borders">142</td><td class="xxxx-borders">156</td><td class="xxxx-borders" data-xml-valign="middle">0.96 (0.76–1.21)</td><td class="xxxx-borders">0.72</td><td class="xxxr-borders">0.63</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01 shading" data-xml-align="left"><i>ATM</i></td><td class="xxxx-borders shading">2411</td><td class="xxxx-borders shading">2471</td><td class="xxxx-borders shading" data-xml-valign="middle">1.06 (1.00–1.13)</td><td class="xxxx-borders shading">0.051</td><td class="xxxr-borders shading">0.0010</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01" data-xml-align="left"><i>BABAM2</i></td><td class="xxxx-borders">167</td><td class="xxxx-borders">170</td><td class="xxxx-borders" data-xml-valign="middle">1.01 (0.81–1.26)</td><td class="xxxx-borders">0.91</td><td class="xxxr-borders">0.63</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01 shading" data-xml-align="left"><i>BARD1</i></td><td class="xxxx-borders shading">591</td><td class="xxxx-borders shading">616</td><td class="xxxx-borders shading" data-xml-valign="middle">1.00 (0.89–1.12)</td><td class="xxxx-borders shading">0.94</td><td class="xxxr-borders shading">0.41</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01" data-xml-align="left"><i>BRCA1</i></td><td class="xxxx-borders">1393</td><td class="xxxx-borders">1300</td><td class="xxxx-borders" data-xml-valign="middle">1.11 (1.02–1.20)</td><td class="xxxx-borders">0.010</td><td class="xxxr-borders">0.027</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01 shading" data-xml-align="left"><i>BRCA2</i></td><td class="xxxx-borders shading">2831</td><td class="xxxx-borders shading">3038</td><td class="xxxx-borders shading" data-xml-valign="middle">0.98 (0.93–1.04)</td><td class="xxxx-borders shading">0.50</td><td class="xxxr-borders shading">0.58</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01" data-xml-align="left"><i>BRIP1</i></td><td class="xxxx-borders">868</td><td class="xxxx-borders">961</td><td class="xxxx-borders" data-xml-valign="middle">0.95 (0.86–1.04)</td><td class="xxxx-borders">0.25</td><td class="xxxr-borders">0.54</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01 shading" data-xml-align="left"><i>CDH1</i></td><td class="xxxx-borders shading">682</td><td class="xxxx-borders shading">668</td><td class="xxxx-borders shading" data-xml-valign="middle">1.10 (0.98–1.23)</td><td class="xxxx-borders shading">0.096</td><td class="xxxr-borders shading">0.042</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01" data-xml-align="left"><i>CHEK2</i></td><td class="xxxx-borders">895</td><td class="xxxx-borders">697</td><td class="xxxx-borders" data-xml-valign="middle">1.42 (1.28–1.58)</td><td class="xxxx-borders">2.5×10<sup>−11</sup></td><td class="xxxr-borders">2.9×10<sup>−18</sup></td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01 shading" data-xml-align="left"><i>EPCAM</i></td><td class="xxxx-borders shading">290</td><td class="xxxx-borders shading">328</td><td class="xxxx-borders shading" data-xml-valign="middle">0.97 (0.82–1.14)</td><td class="xxxx-borders shading">0.69</td><td class="xxxr-borders shading">0.43</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01" data-xml-align="left"><i>FANCC</i></td><td class="xxxx-borders">597</td><td class="xxxx-borders">620</td><td class="xxxx-borders" data-xml-valign="middle">0.95 (0.85–1.07)</td><td class="xxxx-borders">0.42</td><td class="xxxr-borders">0.80</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01 shading" data-xml-align="left"><i>FANCM</i></td><td class="xxxx-borders shading">1434</td><td class="xxxx-borders shading">1566</td><td class="xxxx-borders shading" data-xml-valign="middle">0.95 (0.88–1.02)</td><td class="xxxx-borders shading">0.17</td><td class="xxxr-borders shading">0.85</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01" data-xml-align="left"><i>GEN1</i></td><td class="xxxx-borders">701</td><td class="xxxx-borders">707</td><td class="xxxx-borders" data-xml-valign="middle">1.05 (0.94–1.17)</td><td class="xxxx-borders">0.38</td><td class="xxxr-borders">0.25</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01 shading" data-xml-align="left"><i>MEN1</i></td><td class="xxxx-borders shading">109</td><td class="xxxx-borders shading">130</td><td class="xxxx-borders shading" data-xml-valign="middle">0.86 (0.66–1.12)</td><td class="xxxx-borders shading">0.25</td><td class="xxxr-borders shading">0.81</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01" data-xml-align="left"><i>MLH1</i></td><td class="xxxx-borders">677</td><td class="xxxx-borders">711</td><td class="xxxx-borders" data-xml-valign="middle">1.02 (0.91–1.13)</td><td class="xxxx-borders">0.78</td><td class="xxxr-borders">0.68</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01 shading" data-xml-align="left"><i>MRE11</i></td><td class="xxxx-borders shading">552</td><td class="xxxx-borders shading">611</td><td class="xxxx-borders shading" data-xml-valign="middle">0.94 (0.84–1.06)</td><td class="xxxx-borders shading">0.33</td><td class="xxxr-borders shading">0.93</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01" data-xml-align="left"><i>MSH2</i></td><td class="xxxx-borders">908</td><td class="xxxx-borders">1024</td><td class="xxxx-borders" data-xml-valign="middle">0.92 (0.84–1.01)</td><td class="xxxx-borders">0.093</td><td class="xxxr-borders">0.12</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01 shading" data-xml-align="left"><i>MSH6</i></td><td class="xxxx-borders shading">1088</td><td class="xxxx-borders shading">1155</td><td class="xxxx-borders shading" data-xml-valign="middle">1.00 (0.92–1.09)</td><td class="xxxx-borders shading">0.98</td><td class="xxxr-borders shading">0.74</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01" data-xml-align="left"><i>MUTYH</i></td><td class="xxxx-borders">659</td><td class="xxxx-borders">702</td><td class="xxxx-borders" data-xml-valign="middle">1.00 (0.90–1.12)</td><td class="xxxx-borders">1.00</td><td class="xxxr-borders">0.58</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01 shading" data-xml-align="left"><i>NBN</i></td><td class="xxxx-borders shading">665</td><td class="xxxx-borders shading">725</td><td class="xxxx-borders shading" data-xml-valign="middle">0.95 (0.85–1.06)</td><td class="xxxx-borders shading">0.37</td><td class="xxxr-borders shading">0.71</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01" data-xml-align="left"><i>NF1</i></td><td class="xxxx-borders">816</td><td class="xxxx-borders">899</td><td class="xxxx-borders" data-xml-valign="middle">0.94 (0.85–1.03)</td><td class="xxxx-borders">0.19</td><td class="xxxr-borders">0.53</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01 shading" data-xml-align="left"><i>PALB2</i></td><td class="xxxx-borders shading">805</td><td class="xxxx-borders shading">892</td><td class="xxxx-borders shading" data-xml-valign="middle">0.96 (0.87–1.06)</td><td class="xxxx-borders shading">0.39</td><td class="xxxr-borders shading">1.00</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01" data-xml-align="left"><i>PIK3CA</i></td><td class="xxxx-borders">170</td><td class="xxxx-borders">205</td><td class="xxxx-borders" data-xml-valign="middle">0.83 (0.67–1.02)</td><td class="xxxx-borders">0.080</td><td class="xxxr-borders">0.33</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01 shading" data-xml-align="left"><i>PMS2</i></td><td class="xxxx-borders shading">934</td><td class="xxxx-borders shading">963</td><td class="xxxx-borders shading" data-xml-valign="middle">0.95 (0.87–1.05)</td><td class="xxxx-borders shading">0.31</td><td class="xxxr-borders shading">0.62</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01" data-xml-align="left"><i>PTEN</i></td><td class="xxxx-borders">68</td><td class="xxxx-borders">70</td><td class="xxxx-borders" data-xml-valign="middle">1.08 (0.76–1.53)</td><td class="xxxx-borders">0.65</td><td class="xxxr-borders">0.48</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01 shading" data-xml-align="left"><i>RAD50</i></td><td class="xxxx-borders shading">1046</td><td class="xxxx-borders shading">1089</td><td class="xxxx-borders shading" data-xml-valign="middle">0.99 (0.91–1.08)</td><td class="xxxx-borders shading">0.83</td><td class="xxxr-borders shading">0.44</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01" data-xml-align="left"><i>RAD51C</i></td><td class="xxxx-borders">196</td><td class="xxxx-borders">206</td><td class="xxxx-borders" data-xml-valign="middle">0.93 (0.76–1.14)</td><td class="xxxx-borders">0.49</td><td class="xxxr-borders">0.60</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01 shading" data-xml-align="left"><i>RAD51D</i></td><td class="xxxx-borders shading">224</td><td class="xxxx-borders shading">212</td><td class="xxxx-borders shading" data-xml-valign="middle">1.05 (0.86–1.27)</td><td class="xxxx-borders shading">0.64</td><td class="xxxr-borders shading">0.57</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01" data-xml-align="left"><i>RECQL</i></td><td class="xxxx-borders">656</td><td class="xxxx-borders">627</td><td class="xxxx-borders" data-xml-valign="middle">1.12 (1.00–1.26)</td><td class="xxxx-borders">0.047</td><td class="xxxr-borders">0.036</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01 shading" data-xml-align="left"><i>RINT1</i></td><td class="xxxx-borders shading">732</td><td class="xxxx-borders shading">762</td><td class="xxxx-borders shading" data-xml-valign="middle">1.01 (0.91–1.12)</td><td class="xxxx-borders shading">0.89</td><td class="xxxr-borders shading">0.18</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01" data-xml-align="left"><i>STK11</i></td><td class="xxxx-borders">114</td><td class="xxxx-borders">139</td><td class="xxxx-borders" data-xml-valign="middle">0.83 (0.64–1.07)</td><td class="xxxx-borders">0.15</td><td class="xxxr-borders">0.16</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01 shading" data-xml-align="left"><i>TP53</i></td><td class="xxxx-borders shading">257</td><td class="xxxx-borders shading">244</td><td class="xxxx-borders shading" data-xml-valign="middle">1.10 (0.91–1.31)</td><td class="xxxx-borders shading">0.32</td><td class="xxxr-borders shading">0.00080</td></tr><tr data-xml-align="center" data-type="row"><td class="xblx-borders hanging01" data-xml-align="left"><i>XRCC2</i></td><td class="xbxx-borders">207</td><td class="xbxx-borders">213</td><td class="xbxx-borders" data-xml-valign="middle">1.03 (0.84–1.25)</td><td class="xbxx-borders">0.80</td><td class="xbxr-borders">0.53</td></tr></tbody></table></div><figcaption><div class="notes"><div role="doc-footnote" data-has="label"><div class="label">*</div><div id="core-t2fn1" role="paragraph" data-to-manipulate="true">The sample sizes reflect totals after quality control. The analysis for each gene excluded carriers of protein-truncating variants in that gene.</div></div></div></figcaption></a><figcaption><div class="caption">Risk of Breast Cancer Overall Associated with Rare Missense Variants in 34 Genes in Population-Based Studies and All Studies.</div></figcaption></figure><div class="external-links"><a class="pill__to-original" href="#t2"><i class="icon-return" aria-hidden="true"></i><span>Go to Table</span></a><a class="open-in-viewer" href="#t2" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa1913948_t2.jpg"><span>Open in Viewer</span><i class="icon-expand" aria-hidden="true"></i></a></div></div></div></div><div id="core-collateral-share" role="tabpanel" data-core-tabs="core-collateral-share" tabindex="-1" aria-labelledby="pane-core-collateral-share"><header><h2 id="pane-core-collateral-share"><i class="icon-share" aria-hidden="true"></i>Share</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><h3>Share</h3><div class="section--wrapper"><section><h4>CONTENT LINK</h4><div id="share-self"><p data-id="article-share-self-link" class="share-self__source">https://www.nejm.org/doi/full/10.1056/NEJMoa1913948</p><button data-id="article-share-access" aria-label="CONTENT LINK" class="share-self__action btn btn--inverse"><i aria-hidden="true" class="icon-copy-o"></i><span>Copy Link</span></button><div aria-live="polite" class="share-self__status"><p class="share-self__success"><i aria-hidden="true" class="icon-check_circle"></i><span>Copied!</span></p><p class="share-self__failed"><i aria-hidden="true" class="icon-x_btnclose"></i><span>Copying failed.</span></p></div></div></section><section data-location="share_tools_article"><h4>Share</h4><div class="share-buttons a2a a2a_kit" style="line-height: 16px;"><a href="/#facebook" aria-label="Share on Facebook" data-id="article-share-facebook" rel="nofollow noopener" role="link" target="_blank" title="Share on Facebook" class="btn btn--facebook a2a_button_facebook" data-interactiontype="social"><i aria-hidden="true" class="icon-facebook"></i><span>Facebook</span></a><a href="/#twitter" aria-label="Share on X (formerly Twitter)" data-id="article-share-twitter" rel="nofollow noopener" role="link" target="_blank" title="Share on X (formerly Twitter)" class="btn btn--twitter a2a_button_twitter" data-interactiontype="social"><i aria-hidden="true" class="icon-twitter"></i><span>X (formerly Twitter)</span></a><a href="/#linkedin" aria-label="Share on LinkedIn" data-id="article-share-linkedin" rel="nofollow noopener" role="link" target="_blank" title="Share on LinkedIn" class="btn btn--linkedin a2a_button_linkedin" data-interactiontype="social"><i aria-hidden="true" class="icon-linkedin"></i><span>LinkedIn</span></a><a href="/#email" aria-label="Share on email" data-id="article-share-email" rel="nofollow noopener" role="link" target="_blank" title="Share on email" class="btn btn--email a2a_button_email" data-interactiontype="content_email_click"><i aria-hidden="true" class="icon-mail"></i><span>email</span></a><a href="/#bluesky" aria-label="Share on Bluesky" data-id="article-share-bluesky" rel="nofollow noopener" role="link" target="_blank" title="Share on Bluesky" class="btn btn--bluesky a2a_button_bluesky" data-interactiontype="social"><i aria-hidden="true" class="icon-bluesky"></i><span>Bluesky</span></a></div></section></div></div><div data-location="references_article" id="core-collateral-references" role="tabpanel" aria-labelledby="pane-core-collateral-references" data-core-tabs="core-collateral-references" tabindex="-1"><header><h2 id="pane-core-collateral-references"><i aria-hidden="true" class="icon-references"></i>References</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><h3>References</h3><div role="list" class="section--wrapper"><div role="listitem" data-has="label"><div class="label">1.</div><div id="core-r1" class="citations"><div class="citation"><div class="citation-content">Easton DF, Pharoah PDP, Antoniou AC, et al. Gene-panel sequencing and the prediction of breast-cancer risk. <em>N Engl J Med</em> 2015;372:2243-2257.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r1"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_4_2_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa1913948&amp;key=10.1056%2FNEJMsr1501341&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26014596/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000355955100014" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Gene-panel+sequencing+and+the+prediction+of+breast-cancer+risk.&amp;publication_year=2015&amp;journal=N+Engl+J+Med&amp;pages=2243-2257&amp;doi=10.1056%2FNEJMsr1501341&amp;pmid=26014596" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">2.</div><div id="core-r2" class="citations"><div class="citation"><div class="citation-content">University of Cambridge and Cancer Research UK. Breast Cancer Association Consortium. 2020 (<a href="http://bcac.ccge.medschl.cam.ac.uk">http://bcac.ccge.medschl.cam.ac.uk</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r2"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=University+of+Cambridge+and+Cancer+Research+UK.+Breast+Cancer+Association+Consortium.+2020+%28http%3A%2F%2Fbcac.ccge.medschl.cam.ac.uk%29." target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">3.</div><div id="core-r3" class="citations"><div class="citation"><div class="citation-content">Antoniou AC, Easton DF. Polygenic inheritance of breast cancer: implications for design of association studies. <em>Genet Epidemiol</em> 2003;25:190-202.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r3"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1002/gepi.10261" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/14557987/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000186053600002" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Polygenic+inheritance+of+breast+cancer%3A+implications+for+design+of+association+studies.&amp;publication_year=2003&amp;journal=Genet+Epidemiol&amp;pages=190-202&amp;doi=10.1002%2Fgepi.10261&amp;pmid=14557987" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">4.</div><div id="core-r4" class="citations"><div class="citation"><div class="citation-content">Wakefield J. A Bayesian measure of the probability of false discovery in genetic epidemiology studies. <em>Am J Hum Genet</em> 2007;81:208-227.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r4"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1086/519024" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/17668372/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000248540400002" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=A+Bayesian+measure+of+the+probability+of+false+discovery+in+genetic+epidemiology+studies.&amp;publication_year=2007&amp;journal=Am+J+Hum+Genet&amp;pages=208-227&amp;doi=10.1086%2F519024&amp;pmid=17668372" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">5.</div><div id="core-r5" class="citations"><div class="citation"><div class="citation-content">Schmidt MK, Hogervorst F, van Hien R, et al. Age- and tumor subtype-specific breast cancer risk estimates for CHEK2*1100delC carriers. <em>J Clin Oncol</em> 2016;34:2750-2760.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r5-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1200/JCO.2016.66.5844" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27269948/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000382467000012" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Age-+and+tumor+subtype-specific+breast+cancer+risk+estimates+for+CHEK2%2A1100delC+carriers.&amp;publication_year=2016&amp;journal=J+Clin+Oncol&amp;pages=2750-2760&amp;doi=10.1200%2FJCO.2016.66.5844&amp;pmid=27269948" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r5-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r6-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] the United Kingdom in 2016 as a baseline. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r8" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] consistent with earlier observations, </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">6.</div><div id="core-r6" class="citations"><div class="citation"><div class="citation-content">Cancer Research UK. Breast cancer incidence (invasive) statistics. 2020 (<a href="https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/breast-cancer/incidence-invasive">https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/breast-cancer/incidence-invasive</a>).</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r6-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=Cancer+Research+UK.+Breast+cancer+incidence+%28invasive%29+statistics.+2020+%28https%3A%2F%2Fwww.cancerresearchuk.org%2Fhealth-professional%2Fcancer-statistics%2Fstatistics-by-cancer-type%2Fbreast-cancer%2Fincidence-invasive%29." target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r6-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r6-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] the United Kingdom in 2016 as a baseline. </span></a></li><li role="none"><a class="to-citation open-in-viewer" href="#f3" role="menuitem" data-target="#fv-body-ref-r6-2"><i aria-hidden="true" class="icon-return"></i><span>b [...] incidences in the United Kingdom in 2016. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">7.</div><div id="core-r7" class="citations"><div class="citation"><div class="citation-content">National Institute for Health and Care Excellence. Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer. November 20, 2019 (<a href="https://www.nice.org.uk/guidance/cg164">https://www.nice.org.uk/guidance/cg164</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r7"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=National+Institute+for+Health+and+Care+Excellence.+Familial+breast+cancer%3A+classification%2C+care+and+managing+breast+cancer+and+related+risks+in+people+with+a+family+history+of+breast+cancer.+November+20%2C+2019+%28https%3A%2F%2Fwww.nice.org.uk%2Fguidance%2Fcg164%29." target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">8.</div><div id="core-r8" class="citations"><div class="citation"><div class="citation-content">Renault A-L, Mebirouk N, Fuhrmann L, et al. Morphology and genomic hallmarks of breast tumours developed by ATM deleterious variant carriers. <em>Breast Cancer Res</em> 2018;20:28-28.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r8"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1186/s13058-018-0951-9" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29665859/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000430444600001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Morphology+and+genomic+hallmarks+of+breast+tumours+developed+by+ATM+deleterious+variant+carriers.&amp;publication_year=2018&amp;journal=Breast+Cancer+Res&amp;pages=28-28&amp;doi=10.1186%2Fs13058-018-0951-9&amp;pmid=29665859" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">9.</div><div id="core-r9" class="citations"><div class="citation"><div class="citation-content">Spurdle AB, Greville-Heygate S, Antoniou AC, et al. Towards controlled terminology for reporting germline cancer susceptibility variants: an ENIGMA report. <em>J Med Genet</em> 2019;56:347-357.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r9-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1136/jmedgenet-2018-105872" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30962250/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000471883900001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Towards+controlled+terminology+for+reporting+germline+cancer+susceptibility+variants%3A+an+ENIGMA+report.&amp;publication_year=2019&amp;journal=J+Med+Genet&amp;pages=347-357&amp;doi=10.1136%2Fjmedgenet-2018-105872&amp;pmid=30962250" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r9-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r9-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] for “pathogenic, moderate risk alleles” </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r9-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] for “pathogenic, moderate risk alleles” </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">10.</div><div id="core-r10" class="citations"><div class="citation"><div class="citation-content">Lee K, Seifert BA, Shimelis H, et al. Clinical validity assessment of genes frequently tested on hereditary breast and ovarian cancer susceptibility sequencing panels. <em>Genet Med</em> 2019;21:1497-1506.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r10-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41436-018-0361-5" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30504931/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000473518700007" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Clinical+validity+assessment+of+genes+frequently+tested+on+hereditary+breast+and+ovarian+cancer+susceptibility+sequencing+panels.&amp;publication_year=2019&amp;journal=Genet+Med&amp;pages=1497-1506&amp;doi=10.1038%2Fs41436-018-0361-5&amp;pmid=30504931" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r10-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r10-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] the results of an analysis by Lee et al., </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r10-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] with breast cancer risk in that analysis, </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">11.</div><div id="core-r11" class="citations"><div class="citation"><div class="citation-content">Song H, Dicks E, Ramus SJ, et al. Contribution of germline mutations in the RAD51B, RAD51C, and RAD51D genes to ovarian cancer in the population. <em>J Clin Oncol</em> 2015;33:2901-2907.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r11"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1200/JCO.2015.61.2408" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26261251/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000366017800013" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Contribution+of+germline+mutations+in+the+RAD51B%2C+RAD51C%2C+and+RAD51D+genes+to+ovarian+cancer+in+the+population.&amp;publication_year=2015&amp;journal=J+Clin+Oncol&amp;pages=2901-2907&amp;doi=10.1200%2FJCO.2015.61.2408&amp;pmid=26261251" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">12.</div><div id="core-r12" class="citations"><div class="citation"><div class="citation-content">Tavtigian SV, Oefner PJ, Babikyan D, et al. Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer. <em>Am J Hum Genet</em> 2009;85:427-446.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r12"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.ajhg.2009.08.018" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19781682/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000270836000001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Rare%2C+evolutionarily+unlikely+missense+substitutions+in+ATM+confer+increased+risk+of+breast+cancer.&amp;publication_year=2009&amp;journal=Am+J+Hum+Genet&amp;pages=427-446&amp;doi=10.1016%2Fj.ajhg.2009.08.018&amp;pmid=19781682" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">13.</div><div id="core-r13" class="citations"><div class="citation"><div class="citation-content">Antoniou A, Pharoah PDP, Narod S, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. <em>Am J Hum Genet</em> 2003;72:1117-1130.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r15"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1086/375033" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/12677558/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000182474400005" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Average+risks+of+breast+and+ovarian+cancer+associated+with+BRCA1+or+BRCA2+mutations+detected+in+case+series+unselected+for+family+history%3A+a+combined+analysis+of+22+studies.&amp;publication_year=2003&amp;journal=Am+J+Hum+Genet&amp;pages=1117-1130&amp;doi=10.1086%2F375033&amp;pmid=12677558" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">14.</div><div id="core-r14" class="citations"><div class="citation"><div class="citation-content">Kuchenbaecker KB, Hopper JL, Barnes DR, et al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. <em>JAMA</em> 2017;317:2402-2416.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r15"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1001/jama.2017.7112" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28632866/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000403654600014" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Risks+of+breast%2C+ovarian%2C+and+contralateral+breast+cancer+for+BRCA1+and+BRCA2+mutation+carriers.&amp;publication_year=2017&amp;journal=JAMA&amp;pages=2402-2416&amp;doi=10.1001%2Fjama.2017.7112&amp;pmid=28632866" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">15.</div><div id="core-r15" class="citations"><div class="citation"><div class="citation-content">Hwang SJ, Lozano G, Amos CI, Strong LC. Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk. <em>Am J Hum Genet</em> 2003;72:975-983.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r15"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1086/374567" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/12610779/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000181972600017" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Germline+p53+mutations+in+a+cohort+with+childhood+sarcoma%3A+sex+differences+in+cancer+risk.&amp;publication_year=2003&amp;journal=Am+J+Hum+Genet&amp;pages=975-983&amp;doi=10.1086%2F374567&amp;pmid=12610779" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">16.</div><div id="core-r16" class="citations"><div class="citation"><div class="citation-content">Fortuno C, James PA, Spurdle AB. Current review of TP53 pathogenic germline variants in breast cancer patients outside Li-Fraumeni syndrome. <em>Hum Mutat</em> 2018;39:1764-1773.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r16"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1002/humu.23656" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30240537/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000451194400003" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Current+review+of+TP53+pathogenic+germline+variants+in+breast+cancer+patients+outside+Li-Fraumeni+syndrome.&amp;publication_year=2018&amp;journal=Hum+Mutat&amp;pages=1764-1773&amp;doi=10.1002%2Fhumu.23656&amp;pmid=30240537" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">17.</div><div id="core-r17" class="citations"><div class="citation"><div class="citation-content">Watson CJ, Papula AL, Poon GYP, et al. The evolutionary dynamics and fitness landscape of clonal hematopoiesis. <em>Science</em> 2020;367:1449-1454.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r20"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aay9333" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32217721/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000523251600030" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=The+evolutionary+dynamics+and+fitness+landscape+of+clonal+hematopoiesis.&amp;publication_year=2020&amp;journal=Science&amp;pages=1449-1454&amp;doi=10.1126%2Fscience.aay9333&amp;pmid=32217721" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">18.</div><div id="core-r18" class="citations"><div class="citation"><div class="citation-content">Boettcher S, Miller PG, Sharma R, et al. A dominant-negative effect drives selection of <i>TP53</i> missense mutations in myeloid malignancies. <em>Science</em> 2019;365:599-604.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r20"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aax3649" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31395785/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000483195200042" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=A+dominant-negative+effect+drives+selection+of+TP53+missense+mutations+in+myeloid+malignancies.&amp;publication_year=2019&amp;journal=Science&amp;pages=599-604&amp;doi=10.1126%2Fscience.aax3649&amp;pmid=31395785" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">19.</div><div id="core-r19" class="citations"><div class="citation"><div class="citation-content">Coffee B, Cox HC, Kidd J, et al. Detection of somatic variants in peripheral blood lymphocytes using a next generation sequencing multigene pan cancer panel. <em>Cancer Genet</em> 2017;211:5-8.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r20"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.cancergen.2017.01.002" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28279308/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000398331600002" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Detection+of+somatic+variants+in+peripheral+blood+lymphocytes+using+a+next+generation+sequencing+multigene+pan+cancer+panel.&amp;publication_year=2017&amp;journal=Cancer+Genet&amp;pages=5-8&amp;doi=10.1016%2Fj.cancergen.2017.01.002&amp;pmid=28279308" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">20.</div><div id="core-r20" class="citations"><div class="citation"><div class="citation-content">Coffee B, Cox HC, Bernhisel R, et al. A substantial proportion of apparently heterozygous TP53 pathogenic variants detected with a next-generation sequencing hereditary pan-cancer panel are acquired somatically. <em>Hum Mutat</em> 2020;41:203-211.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r20"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1002/humu.23910" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31490007/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000487441800001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=A+substantial+proportion+of+apparently+heterozygous+TP53+pathogenic+variants+detected+with+a+next-generation+sequencing+hereditary+pan-cancer+panel+are+acquired+somatically.&amp;publication_year=2020&amp;journal=Hum+Mutat&amp;pages=203-211&amp;doi=10.1002%2Fhumu.23910&amp;pmid=31490007" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">21.</div><div id="core-r21" class="citations"><div class="citation"><div class="citation-content">Lee A, Mavaddat N, Wilcox AN, et al. BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors. <em>Genet Med</em> 2019;21:1708-1718.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r21"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41436-018-0406-9" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30643217/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000478784800009" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=BOADICEA%3A+a+comprehensive+breast+cancer+risk+prediction+model+incorporating+genetic+and+nongenetic+risk+factors.&amp;publication_year=2019&amp;journal=Genet+Med&amp;pages=1708-1718&amp;doi=10.1038%2Fs41436-018-0406-9&amp;pmid=30643217" target="_blank">Google Scholar</a></div></div></div></div></div></div></div></div><aside data-core-aside="right-rail">



        
        <div id="DTM_Position_MedRectangle" class="ad">
 <!--emptycomment-->
</div>




        
        <div class="ng-page_layout-sidebarSpacing"></div>










    
    
        <div data-widget-def="relatedArticlesWidget" data-widget-id="8206d5cd-cb8c-4ff9-8c46-3d22e0dee215" data-location="recirc_curatedRelated_article">
        



        
        <div class="ng-related-articles"><h3 class="ng-subsection-title"><span class="ng-subsection-title_text">Related articles</span></h3><ul class="ng-related-articles_list"><li class="ng-related-articles_item"><div class="issue-item issue-item_sm"><div class="issue-item_meta"><ul class="issue-item_meta-list clearfix"><li class="issue-item_meta-item"><a href="/browse/nejm-article-type/original-article" class="issue-item_type">Original Article</a></li><li class="issue-item_meta-item"><span class="issue-item_date">Jan 20, 2021</span></li></ul></div><div class="issue-item_row"><div class="issue-item_left"><div class="issue-item_content clearfix"><h4 class="issue-item_title"><a href="/doi/full/10.1056/NEJMoa2005936" data-interactiontype="article_recirculation_click" class="issue-item_title-link animation-underline">A Population-Based Study of Genes Previously Implicated in Breast Cancer</a></h4><div class="issue-item_authors-and-text"><span class="issue-item_authors">C. Hu and Others</span></div></div></div></div></div></li><li class="ng-related-articles_item"><div class="issue-item issue-item_sm"><div class="issue-item_meta"><ul class="issue-item_meta-list clearfix"><li class="issue-item_meta-item"><a href="/browse/nejm-article-type/editorial" class="issue-item_type">Editorial</a></li><li class="issue-item_meta-item"><span class="issue-item_date">Jan 20, 2021</span></li></ul></div><div class="issue-item_row"><div class="issue-item_left"><div class="issue-item_content clearfix"><h4 class="issue-item_title"><a href="/doi/full/10.1056/NEJMe2035083" data-interactiontype="article_recirculation_click" class="issue-item_title-link animation-underline">Which Genes for Hereditary Breast Cancer?</a></h4><div class="issue-item_authors-and-text"><span class="issue-item_authors">S.A. Narod</span></div></div></div></div></div></li></ul></div>

        </div>
    





        
        <div class="ng-page_layout-sidebarSpacing"></div>




        
        <div id="nejm_jobs" class="nejm_jobs"> <!-- top red rectangle --><div id="nejm-widget" class="nejm-widget" style="display: block;"><div class="nejm-widget_logo">	<a target="nejm-win" href="https://www.nejmcareercenter.org/?query=fjw">		<img alt="CareerCenter" src="https://apps1.nejmcareercenter.org/images/nejmCCID-JobsWidget.gif" width="140" height="36">	</a></div><div class="nejm-widget_cont"> <!-- content --><div class="nejm-widget_title">PHYSICIAN JOBS</div><div class="nejm-widget_date">June 10, 2025</div><div class="nejm-widget_item"><div><span> Tucson, Arizona</span></div><div><span>Anesthesiology</span></div><div><a target="nejm-job-win" onmouseover="jlho(this);" onmouseout="jlou(this);" href="https://www.nejmcareercenter.org/job/888914/anesthesiologist-community-practice-opportunity-banner-university-medical-center-tucson-az-/?query=fjwp&amp;rid=120">Anesthesiologist Community Practice Opportunity | Banner University Medical Center Tucson, AZ!</a></div></div><div class="nejm-widget_item"><div><span> Manhasset, New York</span></div><div><span>Pulmonary Disease</span></div><div><a target="nejm-job-win" onmouseover="jlho(this);" onmouseout="jlou(this);" href="https://www.nejmcareercenter.org/job/858772/interventional-pulmonary-physician-north-shore-university-hosp-and-long-island-jewish-medical-center/?query=fjwp&amp;rid=3059">Interventional Pulmonary Physician North Shore University Hosp and Long Island Jewish Medical Center</a></div></div><div class="nejm-widget_item"><div><span> Portland, Maine</span></div><div><span>Hematology / Oncology</span></div><div><a target="nejm-job-win" onmouseover="jlho(this);" onmouseout="jlou(this);" href="https://www.nejmcareercenter.org/job/890570/inpatient-consultative-hematologist-oncologist/?query=fjwp&amp;rid=1000">Inpatient Consultative Hematologist-Oncologist</a></div></div><div class="nejm-widget_item"><div><span> Beaverton, Oregon</span></div><div><span>Psychiatry</span></div><div><a target="nejm-job-win" onmouseover="jlho(this);" onmouseout="jlou(this);" href="https://www.nejmcareercenter.org/job/890419/child-and-adolescent-psychiatrist-outpatient/?query=fjwf&amp;rid=377088">Child and Adolescent Psychiatrist - Outpatient</a></div></div><div class="nejm-widget_item"><div><span> Sterling, Colorado</span></div><div><span>Surgery, Orthopedic</span></div><div><a target="nejm-job-win" onmouseover="jlho(this);" onmouseout="jlou(this);" href="https://www.nejmcareercenter.org/job/887185/ft-orthopedic-surgeon-sterling-regional-medical-center-srmc-sterling-co/?query=fjwp&amp;rid=120">FT Orthopedic Surgeon - Sterling Regional Medical Center (SRMC) - Sterling, CO</a></div></div><div class="nejm-widget_item"><div><span> Spokane Valley, Washington State</span></div><div><span>Family Medicine</span></div><div><a target="nejm-job-win" onmouseover="jlho(this);" onmouseout="jlou(this);" href="https://www.nejmcareercenter.org/job/875777/primary-care-physician/?query=fjwf&amp;rid=329661">Primary Care Physician</a></div></div></div> <!-- content --> <!-- footer --></div> <!-- nejm-widget --></div><script src="https://apps1.nejmcareercenter.org/?width=300&amp;sp=all"></script>




        
        <div class="ng-page_layout-sidebarSpacing"></div>










    
    
        <div data-widget-def="literatumAd" data-widget-id="001e4aa7-b6fe-4b21-9d5b-5bde81227c67" id="ad-article-right-rail-300x250-1">
        



        
        



    
        <div class="pb-house-message adplaceholder exists">
            <a href="/action/clickThrough?id=128129&amp;url=https%3A%2F%2Fstore.nejm.org%2Fsignup%2Fnejm%2Fregister%2Falerts%3Fpromo%3DONFQSR51%26query%3Dcm_rr%26utm_source%3Dnejm%26utm_medium%3Dcm%26utm_campaign%3Dalerts23&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJMoa1913948&amp;pubId=41291327&amp;placeholderId=101337&amp;productId=1035"><img src="/sda/128129/rightRail--SpecialtyUpdates23-001.jpg" width="300" height="250"></a>
            
        </div>
    

    

    



        </div>
    





        
        <div class="ng-page_layout-sidebarSpacing"></div>




        
        <script src="https://widgets.nejm.org/onepub-widgets/loader/webcomponents-loader.js" async="" nonce="94d66a15f0be1927-LAX">
<script src="https://widgets.nejm.org/onepub-widgets/loader/polyfill-support.js"  nonce="94d66a15f0be1927-LAX"></script>
<script src="https://widgets.nejm.org/onepub-widgets/more-like-this.js" type="module" nonce="94d66a15f0be1927-LAX"></script>

<more-like-this class="onepub-widget" dataid="onepub-more-like-this" collections="catalyst-article, clinician-article, evidence-article, nejm-ai-article, nejm-article" headertitle="More Like This" maxitems="5"><!----><div class="more-like-this onepub-more-like-this_"><!--?lit$478419353$--><onepub-fonts><wc-fetch></wc-fetch><!--?lit$478419353$--><div class="mlt-wrapper"><div class="mlt-header-container"><div class="mlt-header-content-left"><div class="mlt-header-title-container"><span class="mlt-header-title">More Like This</span></div><!--?lit$478419353$--></div></div><div class="mlt-body"><!--?lit$478419353$--><!----><div class="mlt-article-container"><div class="mlt-article-container-header"><a data-location="recirc_Semantic" class="mlt-article-type nejm" href="https://www.nejm.org/browse/nejm-article-type/perspective" target="_self"><!--?lit$478419353$-->Perspective</a> <span class="mlt-article-site-label"><!--?lit$478419353$-->NEJM</span> <span class="mlt-article-pubdate"><!--?lit$478419353$-->Apr 18, 2024</span></div><div class="mlt-article-title"><a data-location="recirc_Semantic" href="https://www.nejm.org/doi/full/10.1056/NEJMp2311466?query=recirc_Semantic" target="_self">Fundamentals of Medical Ethics: Expanding Applications of Clinical Genetic Testing — Ethical Challenges</a></div><div class="mlt-article-authors"><!--?lit$478419353$-->S.M. Fullerton and K.B. Brothers</div></div><!----><!----><div class="mlt-article-container"><div class="mlt-article-container-header"><a data-location="recirc_Semantic" class="mlt-article-type nejm" href="https://www.nejm.org/browse/nejm-article-type/original-article" target="_self"><!--?lit$478419353$-->Original Article</a> <span class="mlt-article-site-label"><!--?lit$478419353$-->NEJM</span> <span class="mlt-article-pubdate"><!--?lit$478419353$-->May 31, 2025</span></div><div class="mlt-article-title"><a data-location="recirc_Semantic" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2505725?query=recirc_Semantic" target="_self">Vepdegestrant, a PROTAC Estrogen Receptor Degrader, in Advanced Breast Cancer</a></div><div class="mlt-article-authors"><!--?lit$478419353$-->M. Campone and Others</div></div><!----><!----><div class="mlt-article-container"><div class="mlt-article-container-header"><a data-location="recirc_Semantic" class="mlt-article-type nejm" href="https://www.nejm.org/browse/nejm-article-type/original-article" target="_self"><!--?lit$478419353$-->Original Article</a> <span class="mlt-article-site-label"><!--?lit$478419353$-->NEJM</span> <span class="mlt-article-pubdate"><!--?lit$478419353$-->Jun 01, 2025</span></div><div class="mlt-article-title"><a data-location="recirc_Semantic" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2502929?query=recirc_Semantic" target="_self">First-Line Camizestrant for Emerging <em>ESR1</em>-Mutated Advanced Breast Cancer</a></div><div class="mlt-article-authors"><!--?lit$478419353$-->F.-C. Bidard and Others</div></div><!----><!----><div class="mlt-article-container"><div class="mlt-article-container-header"><a data-location="recirc_Semantic" class="mlt-article-type nejm" href="https://www.nejm.org/browse/nejm-article-type/original-article" target="_self"><!--?lit$478419353$-->Original Article</a> <span class="mlt-article-site-label"><!--?lit$478419353$-->NEJM</span> <span class="mlt-article-pubdate"><!--?lit$478419353$-->Mar 27, 2025</span></div><div class="mlt-article-title"><a data-location="recirc_Semantic" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2410858?query=recirc_Semantic" target="_self">Imlunestrant with or without Abemaciclib in Advanced Breast Cancer</a></div><div class="mlt-article-authors"><!--?lit$478419353$-->K.L. Jhaveri and Others</div></div><!----><!----><div class="mlt-article-container"><div class="mlt-article-container-header"><a data-location="recirc_Semantic" class="mlt-article-type nejm" href="https://www.nejm.org/browse/nejm-article-type/original-article" target="_self"><!--?lit$478419353$-->Original Article</a> <span class="mlt-article-site-label"><!--?lit$478419353$-->NEJM</span> <span class="mlt-article-pubdate"><!--?lit$478419353$-->Jan 16, 2025</span></div><div class="mlt-article-title"><a data-location="recirc_Semantic" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2406070?query=recirc_Semantic" target="_self">Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer</a></div><div class="mlt-article-authors"><!--?lit$478419353$-->C.E. Geyer, Jr., and Others</div></div><!----></div><div class="mlt-footer"></div></div></onepub-fonts><style>:host{display:block}@keyframes fadeIn{0%{opacity:0}100%{opacity:1}}.more-like-this{max-width:25rem}.more-like-this *{font-variant-numeric:lining-nums}.mlt-wrapper{animation:fadeIn 1s}.mlt-header-container{border-bottom:#4d4d4d solid .0625rem;border-top:#4d4d4d solid .125rem}.mlt-header-title{color:#1a1a1a;display:block;font-family:var(--sans-serif);font-size:1rem;font-weight:700;letter-spacing:.02rem;line-height:1.5rem;padding-bottom:.94rem;padding-top:.94rem;text-transform:uppercase}.mlt-header-description{color:#333;display:block;font-family:ff-scala-sans-pro;font-size:.75rem;letter-spacing:.05rem;margin-top:-.5rem;padding-bottom:1rem;text-transform:uppercase}.mlt-article-container{border-bottom:#e5e5e5 solid .0625rem;margin-top:1.38rem}.mlt-article-container-header{font-family:var(--sans-serif);font-size:.6875rem;letter-spacing:.04em;line-height:1.125rem;margin:0 0 1rem;text-transform:uppercase}.mlt-article-type{font-weight:700;line-height:1.25rem;letter-spacing:.04rem;text-decoration:none}.mlt-article-type:hover{text-decoration:underline}.nejm{color:#f30}.nejm-ai{color:#006197}.nejm-catalyst{color:#5708a6}.nejm-evidence{color:#69a323}.mlt-article-site-label::after,.mlt-article-type::after{border-right:1px solid #e5e5e5;content:'';display:inline;padding:.1875rem .375rem .125rem 0;margin:0 .375rem 0 0}.mlt-article-pubdate{color:#666;font-style:normal;font-weight:700;line-height:1.25rem;letter-spacing:.04em}.mlt-article-authors{color:#666;font-family:var(--sans-serif);font-size:1rem;font-style:normal;font-weight:400;letter-spacing:normal;line-height:1.5rem;margin-bottom:1.38rem}.mlt-article-site-label{color:#666;font-style:normal;font-weight:700;letter-spacing:.04em}.mlt-article-title{margin-bottom:.5rem}.mlt-article-title>a{background-image:linear-gradient(#f30,#f30);background-position:0 90%;background-repeat:no-repeat;background-size:0 0;color:#1a1a1a;font-family:var(--quadraat-web);font-size:1.25rem;font-style:normal;font-weight:700;letter-spacing:normal;line-height:1.8rem;margin:1.5rem 0 .35rem 0;text-decoration:none;transition:background .25s ease-in-out}.mlt-article-title>a:hover{background-position:0 98%;background-size:100% .125rem;text-decoration:none}.skeleton-card{box-shadow:0 0 4px 1px rgba(0,0,0,.1);margin:1rem 0;padding:1rem}</style></div></more-like-this>




        
        <div><div class="pb-dropzone" data-pb-dropzone="col-0" title="col-0"></div></div>










    
    
        <div data-widget-def="UX3HTMLWidget" data-widget-id="ad06db99-f228-4c92-9ad7-c4ae0fdbdbf1" id="bc-web-rec">
        



        
        <!-- BlueConic TEST empty HTML widget with DIV wrapper with id=bc-web-rec -->

        </div>
    

</aside></article><div data-extent="article-wrapper"><div class="core-container"></div><div class="after-credits"><div class="core-container"><a href="/doi/pdf/10.1056/NEJMoa1913948?download=true" id="downloadPdfUrl" data-doi="10.1056/NEJMoa1913948" data-behavior="trackDownloadEvent" data-interactiontype="article_tools_download_pdf" data-multimedia-type="Article PDF" data-multimedia-filename="nejmoa1913948.pdf"><span>Download PDF</span></a></div></div></div><script id="axel-publication-metadata" type="application/json">{"doi":"10.1056/NEJMoa1913948"}
</script><script type="text/javascript" data-ot-ignore="data-ot-ignore" defer="defer" src="https://static.addtoany.com/menu/page.js" class="optanon-category-C0004 ot-vscat-C0004"></script><div class="articles-nav"></div><template id="figure_nav_template"><nav><a href="#" title="Open in viewer" class="open-in-viewer"><i aria-hidden="true" class="icon-expand"></i></a></nav></template><template id="fv_panel_template" data-sharesocial="Share"><div class="fv__panel js--hidden"><div class="fv__panel__text"><div class="fv__panel__contentTitle"></div><div class="fv__panel__contentText"></div></div></div></template>
<template id="fv_directory_template" data-overlay="View figure"><div class="fv__directory"><div class="fv__header"><nav class="tab__nav"></nav><a href="#" title="Close figure viewer" class="fv__close"><i aria-hidden="true" class="icon-close"></i></a></div><div class="fv__content tab__content"></div></div></template><template id="fv_directory_tabItem_template" data-figures="Figures" data-others="Others" data-tables="Tables"><button role="tab" data-toggle="tab" class="tab__nav__item"></button></template>
<template id="fv_lightbox_template" data-sr-back="Go to figure location within the article" data-sr-closealt="Close" data-sr-download="Toggle download panel" data-sr-download-pptx="Download PPT" data-sr-info="Toggle information panel" data-sr-panel="Close panel" data-sr-share="Toggle share panel" data-sr-zoom="Zoom" data-text-close="Back to article" data-text-nav-figures="All figures" data-text-nav-others="All others" data-text-nav-tables="All tables" data-text-viewall="View all material" data-title-back="Back to article" data-title-closealt="Close" data-title-download="Download" data-title-download-pptx="Download PPT" data-title-info="Info" data-title-share="Share" data-title-zoom="Zoom"></template>
<template id="fv_toolbar_template"><div class="fv__toolbar__info"><strong class="fv__toolbar__contentTitle uppercase"></strong><p class="fv__toolbar__contentText"></p></div></template><template id="toCitationLink" data-citation="Citation" data-footnote="Footnote"><div class="to-citation__wrapper"><a class="to-citation"><i aria-hidden="true" class="icon-return"></i><span>Go to</span></a></div></template><template id="toCitationButton" data-citation="Citation" data-footnote="Footnote"><div class="to-citation__wrapper"><button class="to-citation"><i aria-hidden="true" class="icon-return"></i><span>Go to</span></button></div></template><template id="toCitationAccordion" data-collapse-citation="Hide Citations" data-expand-citation="Show Citations" data-collapse-footnote="Hide Footnotes" data-expand-footnote="Show Footnotes"><div class="to-citation__wrapper"><button aria-controls="aria-controls" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="data-expand-title" data-collapsed-title="data-collapsed-title" class="accordion__toggle__title"></span></button><div role="menu" aria-label="links" class="to-citation__accordion no-separator"><ul></ul></div></div></template><template id="toCitationAccordionItem"><li><a class="to-citation"><i aria-hidden="true" class="icon-return"></i><span></span></a></li></template><template id="citations_truncate_template"><div class="citations-truncation"><button data-label-expand="Show all references" data-label-collapse="Show fewer" data-label-remaining="references remaining" class="btn btn--secondary"><span>Show all references</span></button></div></template><template id="collateral_texts_template" data-references="References" data-figure="Go to Figure" data-media="Go to Media" data-more="More" data-original="Go to original" data-table="Go to Table" data-inviewer="Open in Viewer" data-allinviewer="Open all in viewer"><svg data-tags="copyright" viewBox="0 0 24 24"><path d="M12 20.016q3.281 0 5.648-2.368T20.016 12t-2.368-5.648T12 3.984 6.352 6.352 3.984 12t2.368 5.648T12 20.016zm0-18q4.125 0 7.055 2.93T21.985 12t-2.93 7.055T12 21.985t-7.055-2.93T2.015 12t2.93-7.055T12 2.015zm-.14 7.125q-1.876 0-1.876 2.718v.282q0 2.718 1.875 2.718.704 0 1.172-.398t.469-1.008h1.781q0 1.172-1.031 2.063-.984.843-2.39.843-1.876 0-2.86-1.125t-.984-3.093v-.282q0-1.921.937-3 1.125-1.265 2.906-1.265 1.547 0 2.438.89.984.985.984 2.297H13.5q0-.328-.14-.61-.235-.468-.329-.562-.469-.468-1.172-.468z"></path></svg><span>Request permissions</span><i aria-hidden="true" class="icon-open_in_new"></i></template><template id="collapsible_authors_template"><button aria-expanded="false" data-expandable="all" data-label-expand="Expand All" data-label-collapse="Collapse All" class="collateral-contributors-control"><span>Expand All</span></button></template>
<template id="collapsible_tables_collapse_template"><div class="collapsible-figure-btn__wrapper expanded"><button aria-expanded="true" class="btn collapsible-figure-btn btn--inverse"><i aria-hidden="true" class="icon-arrow-up"></i><span class="text-uppercase">Collapse</span></button></div></template>
<template id="collapsible_tables_expand_template"><div class="collapsible-figure-btn__wrapper collapsed"><button aria-expanded="false" class="btn collapsible-figure-btn btn--inverse"><i aria-hidden="true" class="icon-arrow-down"></i><span class="text-uppercase">Expand Table</span></button></div></template><template id="authorsAffiliationsLink"><a href="#tab-contributors" class="to-authors-affiliations">Authors Info &amp; Affiliations</a></template>

        <div role="navigation" aria-label="Sticky Navigation" class="st-header"><div class="st-header__content"><div class="st-header__item st-header__menu"></div><div class="st-header__current st-header__item"><div class="st-header__label">Now Reading:</div><div class="st-header__title">Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women</div></div><div class="st-header__share st-header__item"><div class="share-dropblock dropdown"><a id="sticky-header-dropBlock" href="#" role="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false" class="dropdown-toggle"><span title="" data-toggle="tooltip" data-trigger="hover" data-original-title="Share options"><span class="sr-only">Share</span><i aria-hidden="true" class="icon-share"></i></span></a><div aria-labelledby="sticky-header-dropBlock" data-location="share_tools_article" class="dropdown-menu"><ul class="rlist--inline a2a a2a_kit" style="line-height: 16px;"><li><a href="/#facebook" aria-label="Share on Facebook" data-id="article-share-facebook" rel="nofollow noopener" role="link" target="_blank" title="Share on Facebook" class="btn btn--facebook a2a_button_facebook" data-interactiontype="social"><i aria-hidden="true" class="icon-facebook"></i></a></li><li><a href="/#twitter" aria-label="Share on X (formerly Twitter)" data-id="article-share-twitter" rel="nofollow noopener" role="link" target="_blank" title="Share on X (formerly Twitter)" class="btn btn--twitter a2a_button_twitter" data-interactiontype="social"><i aria-hidden="true" class="icon-twitter"></i></a></li><li><a href="/#linkedin" aria-label="Share on LinkedIn" data-id="article-share-linkedin" rel="nofollow noopener" role="link" target="_blank" title="Share on LinkedIn" class="btn btn--linkedin a2a_button_linkedin" data-interactiontype="social"><i aria-hidden="true" class="icon-linkedin"></i></a></li><li><a href="/#email" aria-label="Share on email" data-id="article-share-email" rel="nofollow noopener" role="link" target="_blank" title="Share on email" class="btn btn--email a2a_button_email" data-interactiontype="content_email_click"><i aria-hidden="true" class="icon-mail"></i></a></li><li><a href="/#bluesky" aria-label="Share on Bluesky" data-id="article-share-bluesky" rel="nofollow noopener" role="link" target="_blank" title="Share on Bluesky" class="btn btn--bluesky a2a_button_bluesky" data-interactiontype="social"><i aria-hidden="true" class="icon-bluesky"></i></a></li></ul></div></div></div><div class="st-header__nav st-header__item"><div class="content-navigation"><a href="/doi/full/10.1056/NEJMoa2021801" aria-label="Previous article" aria-disabled="false" class="content-navigation__prev"><div aria-hidden="true" class="content-navigation__hint"><div class="content-navigation__hint__content"><h6>PREVIOUS ARTICLE</h6><div>A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19</div></div></div><i aria-hidden="true" class="icon-arrow-left"></i><span>Previous</span></a><a href="/doi/full/10.1056/NEJMoa2005936" aria-label="Next article" aria-disabled="false" class="content-navigation__next"><div aria-hidden="true" class="content-navigation__hint"><div class="content-navigation__hint__content"><h6>NEXT ARTICLE</h6><div>A Population-Based Study of Genes Previously Implicated in Breast Cancer</div></div></div><span>Next</span><i aria-hidden="true" class="icon-arrow-right"></i></a></div></div></div><div class="st-header__track"><div id="progress-tracker" class="st-header__tracker" style="width: 0px;"></div></div></div><div class="fv figureViewer js--has-focus-mode"><div class="fv__directory" data-core-tabs="default" style="display: flex;"><div class="fv__header"><nav class="tab__nav" role="tablist"><button role="tab" data-toggle="tab" class="tab__nav__item active" aria-controls="#tab-pane-figures" aria-selected="true">Figures</button><button role="tab" data-toggle="tab" class="tab__nav__item" aria-controls="#tab-pane-tables" tabindex="-1" aria-selected="false">Tables</button></nav><a href="#" title="Close figure viewer" class="fv__close"><i aria-hidden="true" class="icon-close"></i></a></div><div class="fv__content tab__content"><div class="tab__pane fv__list fv__list--figures" id="tab-pane-figures" aria-label="All figures" tabindex="0" role="tabpanel"><div class="fv__item"><a class="fv__open-item fv__item__view fv__fit" href="#fv-f1" data-type="figures" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa1913948_f1.jpg"><img src="/cms/10.1056/NEJMoa1913948/asset/d5f4eaa6-7576-49a3-889f-554c9e046254/assets/images/large/nejmoa1913948_f1.jpg" height="1376" width="2640" aria-labelledby="f1" loading="lazy"><span class="fv__fit--overlay"><span>View figure</span></span></a><div class="fv__item__title">Figure 1</div><div class="fv__item__description"><figcaption><div class="caption">Frequency of Protein-Truncating Variants in 34 Genes in Population-Based Studies.</div><div class="notes"><div role="doc-footnote">Shown are percentages of women with breast cancer and controls who were carriers of protein-truncating variants in 34 genes. The genes are listed in order of increasing estimated odds ratios for breast cancer overall.</div></div></figcaption></div></div><div class="fv__item"><a class="fv__open-item fv__item__view fv__fit" href="#fv-f2" data-type="figures" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa1913948_f2.jpg"><img src="/cms/10.1056/NEJMoa1913948/asset/3fc0bdd2-fe62-4d6f-ad60-b59ea2386dfd/assets/images/large/nejmoa1913948_f2.jpg" height="2155" width="2640" aria-labelledby="f2" loading="lazy"><span class="fv__fit--overlay"><span>View figure</span></span></a><div class="fv__item__title">Figure 2</div><div class="fv__item__description"><figcaption><div class="caption">Risk of Breast Cancer Overall and Tumor Subtypes Associated with Protein-Truncating Variants in 34 Genes in Population-Based Studies.</div><div class="notes"><div role="doc-footnote">Shown are odds ratios and 95% confidence intervals (CIs) for breast cancer overall (Panel A), estrogen receptor (ER)–positive breast cancer (Panel B), and ER-negative breast cancer (Panel C) associated with protein-truncating variants in 34 genes. The genes are listed in order of decreasing estimated odds ratios for breast cancer overall.</div></div></figcaption></div></div><div class="fv__item"><a class="fv__open-item fv__item__view fv__fit" href="#fv-f3" data-type="figures" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa1913948_f3.jpg"><img src="/cms/10.1056/NEJMoa1913948/asset/d4de3f12-da9d-4d12-a59c-9d6381e05ea6/assets/images/large/nejmoa1913948_f3.jpg" height="1620" width="2231" aria-labelledby="f3" loading="lazy"><span class="fv__fit--overlay"><span>View figure</span></span></a><div class="fv__item__title">Figure 3</div><div class="fv__item__description"><figcaption><div class="caption">Estimated Absolute Risk of Breast Cancer Associated with Protein-Truncating Variants in 8 Genes.</div><div class="notes"><div role="doc-footnote">Shown are absolute risks of breast cancer through 80 years of age associated with protein-truncating variants in 8 genes that had significant evidence of an association with breast cancer overall, on the basis of estimated odds ratios from population-based studies. The absolute risk was not calculated for <i>TP53</i> because of the wide 95% confidence interval for the odds ratio and the known association with a substantial risk of childhood cancer. Baseline absolute risks were derived from population incidences in the United Kingdom in 2016.<sup><a href="#core-r6" role="doc-biblioref" data-xml-rid="r6" id="fv-body-ref-r6-2" href-manipulated="true" aria-label="Reference 6" data-to-manipulate="false">6</a></sup> The 𝙸 bars indicate 95% confidence intervals.</div></div></figcaption></div></div></div><div class="tab__pane fv__list fv__list--tables" id="tab-pane-tables" aria-label="All tables" tabindex="-1" role="tabpanel"><div class="fv__item"><a class="fv__open-item fv__item__view" href="#fv-t1" data-type="tables" data-interactiontype="multimedia_click" data-multimedia-type="Table"><i class="icon-tables"></i></a><div class="fv__item__title">Table 1</div><div class="fv__item__description"><figcaption><div class="caption">Risk of Breast Cancer Overall Associated with Protein-Truncating Variants in 34 Genes in Population-Based Studies and All Studies.<a href="#fv-t1fn1" role="doc-noteref">*</a></div></figcaption></div></div><div class="fv__item"><a class="fv__open-item fv__item__view" href="#fv-t2" data-type="tables" data-interactiontype="multimedia_click" data-multimedia-type="Table"><i class="icon-tables"></i></a><div class="fv__item__title">Table 2</div><div class="fv__item__description"><figcaption><div class="caption">Risk of Breast Cancer Overall Associated with Rare Missense Variants in 34 Genes in Population-Based Studies and All Studies.</div></figcaption></div></div></div></div></div></div><div class="references-pop-up fade" aria-hidden="true"><div class="references-pop-up__heading text-dark d-flex align-items-center"><div class="references-pop-up__title flex-grow-1">Reference <span class="references-pop-up__heading-number">1</span></div><a class="references-pop-up__close text-dark" href="#" title="close pop-up" tabindex="-1" aria-hidden="true"><i class="icon-close" aria-hidden="true"></i></a></div><div class="references-pop-up__items citations to-citation__accordion external-links"></div></div></main>
    

</div>

                    
                        



        
        <div class="ng-page_layout ng-page_layout-fullWidth"><div class="container-fluid"><div class="row"><div class="col-12">



        
        




        
        <div class="ng-page_layout-contentSpacing"></div>










    
    
        <div data-widget-def="oneSearchMultiSearch" data-widget-id="778b3ad8-1a8d-43d8-8196-63b03df4a138" data-location="recirc_inIssue_bottom_article">
        



        
        <div class="os-ms os-ms-more-from-issue"><h3 class="ng-subsection-title"><a href="/toc/nejm/384/5" class="ng-subsection-title_link animation-icon-shift"><span class="ng-subsection-title_text">More from Vol. 384 No. 5</span><span class="ng-subsection-title_icon"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-longArrowRight"></use></svg></span></span></a></h3><ul class="os-ms-more-from-issue_list"><li class="os-ms-more-from-issue_item"><div class="issue-item issue-item_sm"><div class="issue-item_meta"><ul class="issue-item_meta-list clearfix"><li class="issue-item_meta-item"><a href="/browse/nejm-article-type/original-article" class="issue-item_type">Original Article</a></li><li class="issue-item_meta-item"><span class="issue-item_date">Feb 04, 2021</span></li><li data-toggle="tooltip" data-original-title="Video" class="issue-item_meta-item"><span role="img" aria-label="Video" tabindex="0" class="issue-item_video"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#tooltip-video"></use></svg></span></span></li><li class="issue-item_meta-item"><span class="issue-item_free">FREE</span></li></ul></div><div class="issue-item_row"><div class="issue-item_left"><div class="issue-item_content clearfix"><h4 class="issue-item_title"><a href="/doi/full/10.1056/NEJMoa2035389" data-interactiontype="article_recirculation_click" class="issue-item_title-link animation-underline">Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine</a></h4><div class="issue-item_authors-and-text"><span class="issue-item_authors">L.R. Baden and Others</span></div></div></div></div></div></li><li class="os-ms-more-from-issue_item"><div class="issue-item issue-item_sm"><div class="issue-item_meta"><ul class="issue-item_meta-list clearfix"><li class="issue-item_meta-item"><a href="/browse/nejm-article-type/original-article" class="issue-item_type">Original Article</a></li><li class="issue-item_meta-item"><span class="issue-item_date">Feb 04, 2021</span></li><li class="issue-item_meta-item"><span class="issue-item_free">FREE</span></li></ul></div><div class="issue-item_row"><div class="issue-item_left"><div class="issue-item_content clearfix"><h4 class="issue-item_title"><a href="/doi/full/10.1056/NEJMoa2021801" data-interactiontype="article_recirculation_click" class="issue-item_title-link animation-underline">A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19</a></h4><div class="issue-item_authors-and-text"><span class="issue-item_authors">O. Mitjà and Others</span></div></div></div></div></div></li><li class="os-ms-more-from-issue_item"><div class="issue-item issue-item_sm"><div class="issue-item_meta"><ul class="issue-item_meta-list clearfix"><li class="issue-item_meta-item"><a href="/browse/nejm-article-type/review-article" class="issue-item_type">Review Article</a></li><li class="issue-item_meta-item"><span class="issue-item_date">Feb 04, 2021</span></li></ul></div><div class="issue-item_row"><div class="issue-item_left"><div class="issue-item_content clearfix"><h4 class="issue-item_title"><a href="/doi/full/10.1056/NEJMra1607714" data-interactiontype="article_recirculation_click" class="issue-item_title-link animation-underline">Management of Antithrombotic Therapy after Acute Coronary Syndromes</a></h4><div class="issue-item_authors-and-text"><span class="issue-item_authors">F. Rodriguez and R.A. Harrington</span></div></div></div></div></div></li></ul></div>

        </div>
    

</div></div></div></div>

                    
                        



        
        <div class="ng-page_layout-bottomAd"><div class="container-fluid"><div class="row"><div class="col-12">









    
    
        <div data-widget-def="literatumAd" data-widget-id="7e022d0d-4a48-44a7-af66-033cf5c13eb8" id="ad-article-bottom-FULLx320-1">
        



        
        



    
        <div class="pb-house-message adplaceholder exists">
            <!-- START: Circulation Footer 3 -->
<aside class="g-cta-subscribe">
	<style>
.bads_footer-banner24-ONJQNRF1{background:url(/pb-assets/contextual_messaging/footer-yel-background-2x-1513629627453.jpg) center center no-repeat;padding:20px;display:block;margin:0;min-height:inherit;background-size:cover;text-decoration:none!important;color:#1a1a1a;text-align:left}.bads_footer-banner24-ONJQNRF1 .g-cta-subscribe__title{font-size:42px;line-height:44px;letter-spacing:.2px;margin:0 0 20px;font-family:ff-quadraat-web-pro,sans-serif;font-weight:600}.bads_footer-banner24-ONJQNRF1-inner{max-width:1300px;margin:0 auto}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__actions .a-btn{width:130px;padding-left:12px}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__login{position:static;color:#000;font-size:18px;line-height:27px;border:0}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__actions{margin:20px 0 20px 0;list-style-type:none;padding:0}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__login a{color:#0a68ad}.bads_clearfix:after{visibility:hidden;display:block;font-size:0;content:" ";clear:both;height:0}.bads_clearfix{display:block}.bads_footer-banner24-ONJQNRF1-inner .bads_subs-btn{float:left;width:50%;padding:30px 0}.bads_footer-banner24-ONJQNRF1-inner .bads_device-img{float:left;padding-left:30px;width:50%}.bads_footer-banner24-ONJQNRF1 .bads_device-img>img{display:block;max-width:100%;height:auto}.bads_footer-banner24-ONJQNRF1 .bads_h5{font-size:18px;text-transform:uppercase;line-height:24px;font-weight:600;margin:-15px 0 0;letter-spacing:.2px}@media only screen and (max-width:480px){.bads_footer-banner24-ONJQNRF1-inner .bads_device-img,.bads_footer-banner24-ONJQNRF1-inner .bads_subs-btn{width:100%;float:none}.bads_footer-banner24-ONJQNRF1-inner .bads_device-img{padding-left:0}.bads_footer-banner24-ONJQNRF1 .g-cta-subscribe__title{font-size:20px;line-height:27px;margin-bottom:10px}.bads_footer-banner24-ONJQNRF1-inner .bads_subs-btn{padding-top:0;padding-bottom:0}.bads_footer-banner24-ONJQNRF1{height:auto}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__actions{margin:0 0 12px;list-style-type:none}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__login{line-height:25px;font-size:15px;margin-bottom:10px}.bads_footer-banner24-ONJQNRF1 .bads_device-img{width:280px!important;margin:0 auto}.bads_footer-banner24-ONJQNRF1 .bads_h5{margin:0 0 3px;font-size:14px}}@media only screen and (min-width:480px) and (max-width:1024px){.bads_footer-banner24-ONJQNRF1 .g-cta-subscribe__title{font-size:20px;line-height:30px;margin-bottom:15px}.bads_footer-banner24-ONJQNRF1-inner .bads_subs-btn{padding:0}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__login{font-size:14px}.bads_footer-banner24-ONJQNRF1 .bads_h5{font-size:13px;margin-top:0}}@media only screen and (min-width:1025px) and (max-width:1200px){.bads_footer-banner24-ONJQNRF1-inner .bads_subs-btn{padding:10px 0}.bads_footer-banner24-ONJQNRF1 .bads_h5{margin:0 0 5px}}@media only screen and (min-width:1401px){.bads_footer-banner24-ONJQNRF1 .bads_device-img>img{float:right}}
	</style>
	<div class="bads_footer-banner24-ONJQNRF1">
	  <div class="bads_footer-banner24-ONJQNRF1-inner bads_clearfix">
		 <div class="bads_subs-btn">
			<p class="g-cta-subscribe__title">Tap into groundbreaking research and clinically relevant insights</p>
			<ul class="g-cta-subscribe__actions">
				<li class="g-cta-subscribe__actions-primary">
				  <a href="/action/clickThrough?id=127716&amp;url=%2Faction%2FstoreProxy%3Faction%3Dsubscribe%26url%3Dhttps%253A%252F%252Fwww.nejm.org%252Fdoi%252Ffull%252F10.1056%252FNEJMoa1913948%26promo%3DONFQNRF1&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJMoa1913948&amp;pubId=41291327&amp;placeholderId=101336&amp;productId=1035" class="ng-btn_primary ng-btn_iconRight"><span class="ng-btn_text">Subscribe </span><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#arrows-longArrowRight"></use></svg></span></a>
				</li>
			</ul>
			<p class="g-cta-subscribe__login">Already a subscriber? <a href="/action/clickThrough?id=127716&amp;url=%2Faction%2FstoreProxy%3Faction%3Dactivate%26url%3Dhttps%253A%252F%252Fwww.nejm.org%252Fdoi%252Ffull%252F10.1056%252FNEJMoa1913948%26promo%3DONFQANR4&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJMoa1913948&amp;pubId=41291327&amp;placeholderId=101336&amp;productId=1035">Activate</a> your online access.</p>
		 </div>

		<div class="bads_device-img">
		   <img src="/sda/127716/footer-devices-2x.png" alt="Devices">
		</div>
	   </div>
	</div>
</aside>
<!--/END: Circulation Footer 3 -->
            
        </div>
    

    

    



        </div>
    

</div></div></div></div>

                    
                        



        
        <footer class="ng-footer footer__top" style="position: relative;"><div data-location="footer" class="ng-footer_columns"><div class="container-fluid"><div class="row"><div class="col-lg-4 col-md-6 col-sm-12 ng-footer_column"><div class="row"><div class="col-6 ng-footer_column-nested">



        
        <h4 class="ng-footer_column-title">ARTICLE CATEGORIES</h4>
<ul class="ng-footer_column-list">
    <li class="ng-footer_column-list-item">
        <a href="/browse/nejm-article-category/research" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Research</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/browse/nejm-article-category/review" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Reviews</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/browse/nejm-article-category/clinical-cases" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Clinical Cases</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/browse/nejm-article-category/perspective" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Perspective</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/browse/nejm-article-category/commentary" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Commentary</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/browse/nejm-article-category/other" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Other</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/medical-article-index" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Browse all Articles</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/toc/nejm/current" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Current Issue</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/loi/nejm" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Issue Index</span></a></li>
</ul>
</div><div class="col-6 ng-footer_column-nested">



        
        <h4 class="ng-footer_column-title">RESOURCES</h4>
<ul class="ng-footer_column-list">
    <li class="ng-footer_column-list-item"><a href="/author-center/home" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Authors &amp; Reviewers</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/author-center/home" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Submit a Manuscript</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/products-and-services" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Subscribers</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://tools.ovid.com/ovidtools/nejm.html" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Institutional Administrators</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/media" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Media</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/how-to-advertise" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Advertisers</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/information-for-subscription-agents" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Agents</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/permissions" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Permissions &amp; Licensing</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/reprints" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Reprints</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.nejmcareercenter.org" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">NEJM CareerCenter</span></a>
    </li>
</ul>
</div></div></div><div class="col-lg-4 col-md-6 col-sm-12 ng-footer_column"><div class="row"><div class="col-6 ng-footer_column-nested">



        
        <h4 class="ng-footer_column-title" aria-label="About us">ABOUT US</h4>
<ul class="ng-footer_column-list">
    <li class="ng-footer_column-list-item"><a href="/about-nejm/about-nejm" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">About NEJM</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.nejmgroup.org/" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">NEJM Group</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/products-and-services" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Products &amp; Services</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/editors-and-publishers" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Editors &amp; Publishers</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/advertising-policies" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Advertising Policies</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/contact-nejm" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text" aria-label="Contact us">Contact Us</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/frequently-asked-questions?#Accessibility" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Accessibility</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/frequently-asked-questions" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">FAQs</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/help" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Help</span></a></li>
    <li class="ng-footer_column-list-item"><a href="mailto:sitefeedback@nejm.org" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Site Feedback</span></a></li>
</ul>
</div><div class="col-6 ng-footer_column-nested">



        
        <h4 class="ng-footer_column-title">SUBSCRIPTIONS</h4>
<ul class="ng-footer_column-list">
    <li class="ng-footer_column-list-item"><a href="/action/storeProxy?action=subscribe&amp;promo=ONF4NRS3" class="ng-footer_column-link animation-underline ro-mode_disabled"><span class="ng-footer_column-link-text">Subscribe</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/action/storeProxy?action=renew&amp;product=nejm&amp;promo=ONFLNRR3&amp;prc=ONFARN52" class="ng-footer_column-link animation-underline ro-mode_disabled"><span class="ng-footer_column-link-text">Renew</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/action/storeProxy?action=activate&amp;promo=ONFLNAA1" class="ng-footer_column-link animation-underline ro-mode_disabled"><span class="ng-footer_column-link-text">Activate Subscription</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/action/storeProxy?action=register&amp;promo=ONFLNRC4" class="ng-footer_column-link animation-underline ro-mode_disabled"><span class="ng-footer_column-link-text">Create Account</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://myaccount.nejm.org" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Manage Account</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/action/storeProxy?action=paybill&amp;product=nejm&amp;promo=BNFLPBA1" class="ng-footer_column-link animation-underline ro-mode_disabled"><span class="ng-footer_column-link-text">Pay Bill</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.wolterskluwer.com/en/solutions/ovid/nejm-complete-collection" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Institutional Sales</span></a></li>    
    <li class="ng-footer_column-list-item"><a href="https://myaccount.nejm.org/special-content" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Special Content</span></a></li>
</ul>
</div></div></div><div class="col-lg-4 col-md-12 ng-footer_column"><div class="row"><div class="col-6 ng-footer_column-nested">



        
        <h4 class="ng-footer_column-title">STAY CONNECTED</h4>
<ul class="ng-footer_column-list">
    <li class="ng-footer_column-list-item"><a href="https://myaccount.nejm.org/emails?section=NEJM" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Email Alerts</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/action/storeProxy?action=register&amp;promo=ONFLNRC3" class="ng-footer_column-link animation-underline ro-mode_disabled"><span class="ng-footer_column-link-text">Create Account</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/products-and-services" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Apps</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.nejmcareercenter.org" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">NEJM CareerCenter</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/rss-feed/" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Podcasts</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/rss-feed/" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">RSS Feed</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/institutional-access" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Remote Access</span></a></li>
</ul>
</div><div class="col-6 ng-footer_column-nested">



        
        <h4 class="ng-footer_column-title" aria-label="Follow us">FOLLOW US</h4>
<ul class="ng-footer_column-list">
<li class="ng-footer_column-list-item"><a href="https://www.facebook.com/TheNewEnglandJournalofMedicine" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-facebook"></use></svg></span></span><span class="ng-footer_column-link-text">Facebook</span></a></li>
<li class="ng-footer_column-list-item"><a href="https://twitter.com/nejm" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-twitter"></use></svg></span></span><span class="ng-footer_column-link-text">X (formerly Twitter)</span></a></li>
<li class="ng-footer_column-list-item"><a href="https://www.instagram.com/nejm/" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-instagram"></use></svg></span></span><span class="ng-footer_column-link-text">Instagram</span></a></li>
<li class="ng-footer_column-list-item"><a href="https://www.youtube.com/user/NEJMvideo" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-youtube"></use></svg></span></span><span class="ng-footer_column-link-text">Youtube</span></a></li>
<li class="ng-footer_column-list-item"><a href="https://www.linkedin.com/company/nejm-group" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-linkedin"></use></svg></span></span><span class="ng-footer_column-link-text">LinkedIn</span></a></li>
<li class="ng-footer_column-list-item"><a href="https://bsky.app/profile/nejm.org" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-bluesky"></use></svg></span></span><span class="ng-footer_column-link-text">Bluesky</span></a></li>
<li class="ng-footer_column-list-item"><a href="https://www.tiktok.com/@nejm.org" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-tiktok"></use></svg></span></span><span class="ng-footer_column-link-text">TikTok</span></a></li>
</ul>
</div></div></div></div></div></div><div data-location="footer" class="ng-footer_journals"><div class="container-fluid"><div class="row"><div class="col-12">



        
        <h4 class="ng-footer_journals-label">JOURNALS</h4>
<ul class="ng-footer_journals-list">
<li class="ng-footer_journals-item"><a href="https://www.nejm.org/" target="_blank" rel="noopener" class="ng-footer_journals-link">The New England Journal of Medicine</a></li>
<li class="ng-footer_journals-item"><a href="https://catalyst.nejm.org/" target="_blank" rel="noopener" class="ng-footer_journals-link">NEJM Catalyst Innovations in Care Delivery</a></li>
<li class="ng-footer_journals-item"><a href="https://evidence.nejm.org/" target="_blank" rel="noopener" class="ng-footer_journals-link">NEJM Evidence</a></li>
<li class="ng-footer_journals-item"><a href="https://ai.nejm.org/" target="_blank" rel="noopener" class="ng-footer_journals-link">NEJM AI</a></li>
</ul>
</div></div></div></div><div data-location="legal" class="ng-footer_bottom"><div class="container-fluid"><div class="row"><div class="col-lg-7 col-md-6 ng-footer_bottom-left">



        
        <p>Copyright © 2025 <a href="https://www.massmed.org/" target="_blank" rel="noopener" class="ng-footer_bottom-link"><b>Massachusetts Medical Society</b></a>. All rights reserved, including those for text and data mining, AI training, and similar technologies. Electronic ISSN 1533-4406. Print ISSN 0028-4793.The content of this site is intended for health care professionals.</p>
</div><div class="col-lg-5 col-md-6 ng-footer_bottom-right">



        
        <style>
  #teconsent a {
    color: #666;
    text-decoration: none;
  }
  #teconsent a:hover {
    color: #666;
    text-decoration: underline;
  }
</style>
<ul class="ng-footer_bottom-list">
<li class="ng-footer_bottom-list-item"><a href="https://www.nejmgroup.org/legal/copyright-information.htm" target="_blank" rel="noopener" class="ng-footer_bottom-link">Copyright</a></li>
<li class="ng-footer_bottom-list-item"><a href="https://www.nejmgroup.org/legal/terms-of-use.htm" target="_blank" rel="noopener" class="ng-footer_bottom-link">Terms</a></li>
<li class="ng-footer_bottom-list-item"><a href="https://www.nejmgroup.org/legal/privacy-policy.htm" target="_blank" rel="noopener" class="ng-footer_bottom-link">Privacy Policy</a></li>
<li class="ng-footer_bottom-list-item"><span id="teconsent" consent="undefined" aria-label="Open Cookie Preferences Modal" role="complementary"><a role="link" id="icon-id011858809981340246" tabindex="0" lang="en" aria-haspopup="dialog" aria-label="Cookie Preferences, opens a dedicated popup modal window" class="truste_cursor_pointer">Cookie Preferences</a></span></li>
</ul>
<a href="https://www.nejmgroup.org/" title="NEJM Group" target="_blank" rel="noopener" class="ng-footer_logo-link"><img src="/specs/products/mms-nextgen/mms/releasedAssets/images/other-images/logo_group.svg" alt="NEJM Group logo" class="ng-footer_logo" loading="lazy" width="103" height="40"></a>
</div></div></div></div><div data-show-after="400" class="back-to-top back-to-top--align-right  "><button data-snap="footer__top" class="back-to-top__action position-relative p-0 m-0 border-0 d-flex flex-column align-items-center justify-content-center"><svg viewBox="0 0 36 36" class="position-relative"><path d="M18 2.0845 a 15.9155 15.9155 0 0 1 0 31.831 a 15.9155 15.9155 0 0 1 0 -31.831" class="back-to-top__action__ring-bg"></path><path d="M18 2.0845 a 15.9155 15.9155 0 0 1 0 31.831 a 15.9155 15.9155 0 0 1 0 -31.831" stroke-dasharray="0, 100" class="back-to-top__action__ring"></path></svg><span class="back-to-top__action-icon position-absolute d-flex"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-up"></use></svg></span></span><span class="sr-only">Back to top</span></button></div></footer>

                    
                        



        
        <!-- TrustArc: Banner -->
<div id="consent_blackbar"><style>  #consent_blackbar{    position:relative;    width:100%;    z-index: 999999;  }    #trustarc-banner-overlay {  background-color: rgb(0, 0, 0);   opacity: 0.3;   position: fixed;   z-index: 1000000;   width: 100%;  height: 100%;   top: 0px;   left: 0px;   overflow: hidden;}.truste-title {  /*font-family: "Source Sans Pro", sans-serif;  font-size: 23px;  font-style: normal;  font-stretch: normal;*/  color: #222;  margin-bottom: 20px;  text-align: center;/*  font-weight:bold;*/}.truste-footer {  margin: 0 auto;      }.truste-left {  margin: 0px 0px 15px 15px;/*font-family: "Source Sans Pro", sans-serif;  font-size: 14px;    */}.truste-banner { margin: 0 auto; }.truste-messageColumn {/*font-family: "Source Sans Pro", sans-serif;  font-size: 14px;*/  color: #666666;  margin: 0px;}#truste-consent-button, #truste-consent-required {    background-color: #FF1E00;    color: #F2F1F1;    padding: 5px 10px;    border: 1px solid #FF1E00;    border-radius: 0px;    cursor: pointer;    text-transform:uppercase;/*    font-family: "Source Sans Pro",sans-serif;    font-size: 15px;*/  }      #truste-show-consent {    background-color: #FF1E00;    color: #F2F1F1;    border: 1px solid #FF1E00;    padding: 5px 10px;    border-radius: 0px;    cursor: pointer;    text-transform:uppercase;/*    font-family: "Source Sans Pro",sans-serif;    font-size: 15px;*/  }div.truste-consent-track-class {  position: fixed;  z-index:9999999;   background: #666;   border: 1px solid #333;    /*padding: 10px 60px;*/    bottom:0px;    right:0px;    left:0px;    margin: 10px;}.truste-left {  margin: 0;}div.text-content {  display: flex;  flex-direction: column;  align-self: baseline;}#truste-consent-text {    /*font-family: "Source Sans Pro", sans-serif;    font-size: 16px;*/    color: #fff;    margin: 15px 0px;}.truste-footer {  padding-top: 15px;}#truste-consent-content {  margin: 0 auto;    padding: 0 10px;    max-width: 1366px;}.truste-consent-footer {  display: none;}.flex-container {  display: block;  align-items: center;  justify-content: space-between;}#truste-consent-buttons {  float: right;  margin: 10px 5px 10px 0px;}#truste-show-consent { background: #F30 !important;}#truste-consent-button, #truste-consent-required { background: #F30 !important; } /* MEDIA QUERIES */  @media screen and (max-width: 500px) {  #truste-consent-track {    padding: 5px 20px;  }  }@media screen and (max-width: 375px) {  .truste-buttonsColumn {    float: none;    margin: 0;  }  #truste-consent-button, #truste-consent-required, #truste-show-consent {    width: 100%;    margin-bottom: 5px;  }          #truste-consent-buttons {  float: none;  margin: 10px 0px 10px 0px;	}}</style><div id="truste-consent-track" style="display: block; opacity: 1;">  <div id="trustarc-banner-overlay"></div>  <div class="truste-consent-track-class">    <div id="truste-consent-content" class="truste-banner">        <div class="flex-container">          <div class="text-content">            <div id="truste-consent-text" class="truste-messageColumn">This site uses cookies and related technologies, as described in our privacy policy, for purposes that may include site operation, analytics, enhanced user experience, or advertising. You may choose to consent to our use of these technologies, or manage your own preferences.                       </div>          </div>          <div id="truste-consent-buttons" class="truste-buttonsColumn">            <button id="truste-show-consent" aria-haspopup="dialog">Manage Settings</button>      <button id="truste-consent-button">Accept</button>      <!-- <button id="truste-consent-required">Decline All</button> -->          </div>        </div>                <div style="clear:both;"></div>    </div>  </div></div><!--emptycomment--></div>
<!-- /TrustArc: Banner -->

                    
                        



        
        <link rel="stylesheet" href="https://cssjs.nejm.org/mmsWidgets.css"><script nonce="94d66a15f0be1927-LAX" type="text/javascript" src="https://cssjs.nejm.org/mmsWidgets.js"></script><script nonce="94d66a15f0be1927-LAX" type="text/javascript">var litSSO = {
    "ucid": null,
    "accessToken": null,
    "authState": null
};

var loginUri = '/action/doSsoLogin';
var logoutUri = '/action/doLogout';

displayAuthenticatedMessage();

mmsWidgets.init({
    clientId: 'qsra7g4d6jwdsgn3zbe6udp6r6278mr9',
    origin: 'NEJM',
    xdReceiver: 'http://www.nejm.org/pb-assets/sso/xd.html',
    isFullPageSignIn: isSignInPage(),
    debug: true,

    onReady: function (e) {
        console.log('<<<<<<<<<< client: received onReady event.');
        $("A.litSsoLogin").click(function (e) {
            if (!$(e.currentTarget).hasClass("noMd") || $(e.currentTarget).parents(".header_sm-login").length === 0) {
                mmsWidgets.signIn(e);
                return false;
            }
        });
        $("A.litSsoLogout").click(function (e) {
            mmsWidgets.signOut(e);
            return false;
        });
        $("A.litSsoCreate").click(function (e) {
            mmsWidgets.showRegModal(e);
            return false;
        });
        $("A.litSsoSubscribe").click(function (e) {
            if (!$(e.currentTarget).hasClass("noMd") || $(e.currentTarget).parents(".header_sm-login").length === 0)
                location.assign(e.currentTarget.href);
            return false;
        });
        if (window.doSSOLogin) {
            window.setTimeout(function () {
                mmsWidgets.signIn();
            }, 500);
        }
        ;
    },
    onLoginSuccess: function (e) {
        console.log('<<<<<<<<<< client: received onLoginSuccess event.' + JSON.stringify(e));

        const redirectUrl = getRedirectUri(window.location.search, location.href.replace(window.location.origin, ""));
        document.cookie = "skipSso=; expires=; path=/";
        if (!litSSO.ucid || e.ucid != litSSO.ucid || !litSSO.accessToken || e.accessToken != litSSO.accessToken) {
            location.assign(loginUri + "?ucid=" + e.profile.ucid
                + "&accessToken=" + e.accessToken
                + "&authState=" + e.authState
                + "&email=" + encodeURIComponent(e.profile.email)
                + "&givenNames=" + e.profile.givenName
                + "&surname=" + e.profile.familyName
                + "&redirectUri=" + redirectUrl
                + "&uccLastUpdatedDate=" + encodeURIComponent(e.profile.uccLastUpdatedDate)
                + "&rememberMe=" + e.rememberMe);
        }
    },
    onAuthStateReady: function (e) {
        console.log('<<<<<<<<<< client: received onAuthStateReady event.' + JSON.stringify(e))

        var isMmsSsoAuthenticated = (e.authState && e.authState !== "anonymous" && e.authState !== "lead" && e.ucid && e.accessToken) ? true : false;
        var isLitSsoAuthenticated = (litSSO.ucid && litSSO.accessToken && litSSO.authState) ? true : false;
        console.log('           isMmsSsoAuthenticated=' + isMmsSsoAuthenticated + ', isLitSsoAuthenticated=' + isLitSsoAuthenticated);

        if (isMmsSsoAuthenticated) {
            if (!isLitSsoAuthenticated || litSSO.ucid != e.ucid) {
                if (window.skipSso)
                    document.cookie = "skipSso=" + encodeURIComponent(e.ucid) + "; expires=; path=/";

                if (!window.skipSso && document.cookie.indexOf("skipSso=" + encodeURIComponent(e.ucid)) == -1) {
                    location.assign(loginUri + "?ucid=" + e.profile.ucid
                        + "&accessToken=" + e.accessToken
                        + "&authState=" + e.authState
                        + "&email=" + encodeURIComponent(e.profile.email)
                        + "&givenNames=" + e.profile.givenName
                        + "&surname=" + e.profile.familyName
                        + "&redirectUri=" + location.href.replace(window.location.origin, "")
                        + "&uccLastUpdatedDate=" + encodeURIComponent(e.profile.uccLastUpdatedDate)
                        + "&rememberMe=" + e.rememberMe);
                } else
                    console.log('**** client: Skip SSO ****');
            } else if (e.accessToken !== litSSO.accessToken)
                updateLitSession(e.ucid, e.accessToken);
        } else if (isLitSsoAuthenticated)
            location.assign(logoutUri + "?redirectUri=" + encodeURIComponent(location.href.replace(window.location.origin, "")));

        if (document.getElementById("ssoerr-ucid"))
            document.getElementById("ssoerr-ucid").innerHTML = e.ucid;

    },
    onRegistrationSuccess: function (e) {
        console.log('<<<<<<<<<< client: received onRegistrationSuccess event.' + JSON.stringify(e))
        document.cookie = "skipSso=; expires=; path=/";
        var uccLastUpdatedDate = '1812-01-01 00:00:00.1 +0000';
        location.assign(loginUri + "?ucid=" + e.profile.ucid
            + "&accessToken=" + e.accessToken
            + "&authState=" + e.authState
            + "&email=" + encodeURIComponent(e.profile.email)
            + "&givenNames=" + e.profile.givenName
            + "&surname=" + e.profile.familyName
            + "&redirectUri=" + location.href.replace(window.location.origin, "")
            + "&uccLastUpdatedDate=" + encodeURIComponent(uccLastUpdatedDate)
            + "&rememberMe=" + e.rememberMe);
    },
    onLogoutSuccess: function (e) {
        console.log('<<<<<<<<<< client: received onLogoutSuccess event.' + JSON.stringify(e))

        document.cookie = "skipSso=; expires=; path=/";
        location.assign(logoutUri);
    },
});

function updateLitSession(ucid, accessToken) {
    $.ajax({
        method: "GET",
        url: "/action/doSsoSessionUpdate",
        data: {ucid: ucid, accessToken: accessToken},
        success: function (callData, textStatus) {
            console.log("Session accessToken updated")
            litSSO.accessToken = accessToken
        },
        error: function (jqXHR, textStatus, errorThrown) {
            alert("Your website session has expired and will now be reset.")
            console.log("Session update failed: " + jqXHR.responseText)
            location.assign(logoutUri + "?redirectUri=" + encodeURIComponent(location.href.replace(window.location.origin, "")));
        }
    });
}

function getRedirectUri(location, fallback) {
    const urlParams = new URLSearchParams(location);
    const uriUrlParam = urlParams.get('uri');
    if (uriUrlParam)
        return encodeURIComponent(uriUrlParam);
    else
        return encodeURIComponent(fallback);
}

function isSignInPage() {
    return document.querySelector('meta[name="pbContext"]').content.indexOf("customPage:string:/sign-in") > -1;
}

function displayAuthenticatedMessage() {
    if (isSignInPage()) {
        var div = document.getElementById('authMsg');
        if ("" === "PersonUser") {
            div.innerHTML += "You are already signed in to " + window.location.origin.replace("https://", "").replace("www.", "") + ". If you would like to sign in with a different email address, please use the form below.";
        } else {
            div.innerHTML = '';
        }
    }
}</script>

                    
                
            </div>
        </div><iframe name="trustarc_notice" id="trustarcNoticeFrame" title="Trustarc Cross-Domain Consent Frame" src="https://consent.trustarc.com/get?name=crossdomain.html&amp;domain=nejm.com" style="display: none;"></iframe><script src="https://consent.trustarc.com/asset/notice.js/v/v1.7-1576" async="async" crossorigin="" importance="high" nonce="94d66a15f0be1927-LAX"></script>
        


        
        

            <script src="/products/mms-nextgen/mms/releasedAssets/js/build.lazyload.bundle-c8c4e7d20884f81951fb.js" nonce="94d66a15f0be1927-LAX"></script>

        <script src="/products/mms-nextgen/mms/releasedAssets/js/main.bundle-3819a02ec7bc2aca01ec.js" nonce="94d66a15f0be1927-LAX"></script>
        


<div id="adModal" tabindex="-1" aria-labelledby="exampleModalCenterTitle" class="ng-modal modal" style="display: none;" aria-hidden="true">
    <div role="document" class="ng-modal_dialog modal-dialog modal-dialog-centered ad-promoLayer">
        <div class="ng-modal_content modal-content p-0">
            <div class="ng-modal_body modal-body m-0">
                <div class="ng-modal_header modal-header">
                    <button type="button" data-dismiss="modal" aria-label="Close" class="ng-modal_close close"><span aria-hidden="true"><span class="icon-component "><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#close"></use></svg></span></span>
                    </button>
                </div>

            </div>
        </div>
    </div>
</div>
<script type="text/javascript" src="/wro/1125813~product.js" nonce="94d66a15f0be1927-LAX"></script>








<input id="showLayers" type="hidden" value="true">

    <!-- placeholder id=null, description=ad-layer-config -->
    <!-- placeholder id=null, description=ad-lauchLayer-1 -->
    <!-- placeholder id=null, description=ad-layer-promo-1 -->

    <input id="firstAd" type="hidden" value="">
    <input id="secondAd" type="hidden" value="">

    
    
    

    
    
    <input id="IsInstitution" type="hidden" value="false">
    <input id="IsSubscriber" type="hidden" value="true">
    <input id="CustomerId" type="hidden" value="">


<script type="text/javascript" nonce="94d66a15f0be1927-LAX">
  jQuery.extend(jQuery.mmsLayers.config, {
    rules: [{
      "name": "Launch Layer Ad",
      "frequency": 30,
      "showOnPage": 5,
      "enabled": false,
      "cookieName": "MarketingLaunchLayer",
      "styleClass": "launchLayer"
    },
    {
      "name": "Promo Layer Ad",
      "frequency": 14,
      "enabled": true,
      "cookieName": "PromoLayer",
      "styleClass": "promoLayer"
    },
    {
      "name": "Interstitial Ad",
      "frequency": 7,
      "enabled": false,
      "cookieName": "InterstitialAd"
    },
    {
      "name": "Iperceptions - Ion Layer Ad",
      "showOnPage": 1,
      "enabled": false,
      "test": false,
      "cookieName":"Iperceptions"
    }]
 });
</script>

















    <script type="text/javascript" nonce="94d66a15f0be1927-LAX">
        $(document).ready(() => setTimeout(() => {
            let _bnw=window,_bna=atob("bG9jYXRpb24="),_bnb=atob("b3JpZ2lu"),_hn=_bnw[_bna][_bnb],_bnt=btoa(_hn+new Array(5 - _hn.length % 4).join(" "));
            $.get("/resource/lodash?t="+_bnt);
        },4000));
    </script>












    

    
    

    
    
    
    
        
            
                <script type="text/javascript" src="/wro/1125813~article-metrics.js" nonce="94d66a15f0be1927-LAX"></script>
            
            
            
        
    




<script type="text/javascript" src="/wro/1125813~full-text-analytics.js" nonce="94d66a15f0be1927-LAX"></script>


    


            <div style="display:none;" id="signInEmbedded" class="ucc-fullpage-signin ucc-widgets-nejm-next">
  <div class="capture_header">
    <h1>Sign In</h1>
  </div>    
  <div class="capture_signin">
    {* #signInForm *}
    <div class="ucc-form-inner-wrapper">
      {* signInEmailAddress *}
      {* currentPassword *}
      <div style="padding-top:10px;">
          <div class="capture_form_item capture_form_rememberme">
          <label class="ucc-form-checkbox">                
            <input checked="checked" id="ucc-remember-me-cb-embedded" name="ucc-remember-me-cb-embedded" type="checkbox" value="true">
            <span>Remember Me</span>
          </label>                           
          </div>
          <div class="capture_form_item capture_form_forgotpwd">
            <a role="button" class="ucc-anchor-button" data-capturescreen="forgotPassword">Forgot your password?</a>
          </div>
      </div>
      <div class="capture_form_item">      
        <button id="ucc-sign-in-submit-embedded" class="capture_primary capture-full-width-btn" type="submit">Sign In</button>
      </div>
      <div class="capture_form_item capture_form_footer">
        <div class="ucc-no-acct-msg">Don't have an account?</div>
        <div class="ucc-no-acct-msg-2">
          <a role="button" class="ucc-anchor-button" onclick="mmsWidgets.closeSignIn(event); mmsWidgets.showRegAuto(event);">Create Account</a>
          <span></span><a href="https://store.nejm.org/nejm?promo=ONF4NRS1">Subscribe</a>
        </div>
      </div>
      <div class="capture_form_item capture_form_submit">
        
      </div>      
    </div>
    {* /signInForm *}
  </div>
</div><div style="display:none;" id="forgotPassword" class="ucc-widgets-nejm-next">
  <div class="capture_header">
    <h1>Forgot Password</h1>
  </div>   
  <div class="ucc-form-inner-wrapper">
  <p style="color:black">Enter the email address associated with your account then click Continue. We will email you a link to a page where you can easily create a new password.</p>
  </div> 
  <div class="capture_forgotpassword">
    {* #forgotPasswordForm *}      
      <div class="ucc-form-inner-wrapper">
        {* forgotPasswordEmailAddress *}
        {* captcha *}
        <div class="capture_form_item" style="padding-top: 20px;">        
          <input id="ucc-widget-forgotpwd-submit" value="Continue" type="submit" class="capture_btn capture_primary capture-full-width-btn">
        </div>
      </div>
    {* /forgotPasswordForm *}
  </div>
  </div><div style="display:none;" id="forgotPasswordSuccess" class="ucc-widgets-nejm-next">
  <div class="capture_header">
    <h1>Create New Password</h1>
  </div>    
  <div class="capture_forgotpassword">
      <div class="ucc-form-inner-wrapper">
        <p style="padding-top: 30px; padding-bottom: 30px;">We've sent an email with instructions to create a new password. Your existing password has not been changed.</p>        
        <div class="capture_form_item">      
          <button class="capture_btn capture_primary capture-full-width-btn" onclick="janrain.capture.ui.modal.close()">CLOSE</button>
        </div>
      </div>
  </div>
  </div><div style="display:none;" id="resetPassword" class="ucc-widgets-nejm-next">
      <div class="row">      
        <div class="col-md-8 col-md-offset-2 reset-pwd-info"><p>To reset your password, enter a new password twice and click the 'Reset Password' button.</p></div>
      </div>
      <div class="col-md-4 col-md-offset-4">
        {* #changePasswordFormNoAuth *}
          {* newPassword *}
          {* newPasswordConfirm *}     
          <div class="capture_form_item">
            <input value="RESET PASSWORD" type="submit" class="capture_btn capture_primary capture-full-width-btn">
          </div>
          {* /changePasswordFormNoAuth *}
      </div>
    </div><div style="display:none;" id="resetPasswordSuccess">
        <div class="reset-pwd-info">
          <div class="reset-pwd-success-welcome"></div>
          <p class="reset-pwd-success-msg">Your password has been reset. You will need to <a href="/signin" onclick="mmsWidgets.signIn(event)">sign in</a> again using your new password to access site content and features.</p>
          <p class="reset-pwd-success-nav"></p>
        </div>      
    </div><div style="display:none;" id="resetPasswordRequestCode" class="ucc-widgets-nejm-next">
        {* #resetPasswordForm *}
        <div class="capture_form_error">The link that you followed to reset your password has expired.</div>
          <div class="col-md-8 col-md-offset-2">
            <p class="reset-pwd-info">Enter the email address associated with your account then click Continue. We will email you a link to a page where you can easily create a new password.</p>
          </div>
          <div class="col-md-4 col-md-offset-4">
            {* signInEmailAddress *}
            <div class="capture_form_item">
              <input value="continue" type="submit" class="capture_btn capture_primary capture-full-width-btn">
            </div>
          </div>
        {* /resetPasswordForm *}
    </div><div style="display:none;" id="resetPasswordRequestCodeSuccess">
      <div class="reset-pwd-info">
        <p>If the address matches an existing account, you will receive an email with instructions to reset your password.</p>
        <p class="reset-pwd-success-nav"></p>
      </div>
  </div><script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'94d66a15e9d11927',t:'MTc0OTUzMjc3My4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script><iframe height="1" width="1" style="position: absolute; top: 0px; left: 0px; border: none; visibility: hidden;"></iframe><script defer="" src="https://static.cloudflareinsights.com/beacon.min.js/vcd15cbe7772f49c399c6a5babf22c1241717689176015" integrity="sha512-ZpsOmlRQV6y907TI0dKBHq9Md29nnaEIPlkf84rnaERnq6zvWvPUqr2ft8M1aS28oN72PdrCzSjY4U6VaAw1EQ==" data-cf-beacon="{&quot;rayId&quot;:&quot;94d66a15e9d11927&quot;,&quot;serverTiming&quot;:{&quot;name&quot;:{&quot;cfExtPri&quot;:true,&quot;cfEdge&quot;:true,&quot;cfOrigin&quot;:true,&quot;cfL4&quot;:true,&quot;cfSpeedBrain&quot;:true,&quot;cfCacheStatus&quot;:true}},&quot;version&quot;:&quot;2025.5.0&quot;,&quot;token&quot;:&quot;f55e150c7a5f4a4ab9ef82f4a1c9c43c&quot;}" crossorigin="anonymous"></script>

        
        
    

<div id="addtoany" style="position: static;"><div class="a2a_overlay" id="a2a_overlay"></div><div id="a2a_modal" class="a2a_modal a2a_hide" role="dialog" tabindex="-1" aria-label=""><div class="a2a_modal_body a2a_menu a2a_hide" id="a2a_copy_link"><label for="a2a_copy_link_text" id="a2a_copy_link_icon" class="a2a_svg a2a_s_link a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><title>Copy link</title><path fill="#FFF" d="M7.591 21.177c0-.36.126-.665.377-.917l2.804-2.804a1.235 1.235 0 0 1 .913-.378c.377 0 .7.144.97.43-.026.028-.11.11-.255.25-.144.14-.24.236-.29.29a2.82 2.82 0 0 0-.2.256 1.056 1.056 0 0 0-.177.344 1.43 1.43 0 0 0-.046.37c0 .36.126.666.377.918a1.25 1.25 0 0 0 .918.377c.126.001.251-.015.373-.047.125-.037.242-.096.345-.175.09-.06.176-.127.256-.2.1-.094.196-.19.29-.29.14-.142.223-.23.25-.254.297.28.445.607.445.984 0 .36-.126.664-.377.916l-2.778 2.79a1.242 1.242 0 0 1-.917.364c-.36 0-.665-.118-.917-.35l-1.982-1.97a1.223 1.223 0 0 1-.378-.9l-.001-.004Zm9.477-9.504c0-.36.126-.665.377-.917l2.777-2.79a1.235 1.235 0 0 1 .913-.378c.35 0 .656.12.917.364l1.984 1.968c.254.252.38.553.38.903 0 .36-.126.665-.38.917l-2.802 2.804a1.238 1.238 0 0 1-.916.364c-.377 0-.7-.14-.97-.418.026-.027.11-.11.255-.25a7.5 7.5 0 0 0 .29-.29c.072-.08.139-.166.2-.255.08-.103.14-.22.176-.344.032-.12.048-.245.047-.37 0-.36-.126-.662-.377-.914a1.247 1.247 0 0 0-.917-.377c-.136 0-.26.015-.37.046-.114.03-.23.09-.346.175a3.868 3.868 0 0 0-.256.2c-.054.05-.15.148-.29.29-.14.146-.222.23-.25.258-.294-.278-.442-.606-.442-.983v-.003ZM5.003 21.177c0 1.078.382 1.99 1.146 2.736l1.982 1.968c.745.75 1.658 1.12 2.736 1.12 1.087 0 2.004-.38 2.75-1.143l2.777-2.79c.75-.747 1.12-1.66 1.12-2.737 0-1.106-.392-2.046-1.183-2.818l1.186-1.185c.774.79 1.708 1.186 2.805 1.186 1.078 0 1.995-.376 2.75-1.13l2.803-2.81c.751-.754 1.128-1.671 1.128-2.748 0-1.08-.382-1.993-1.146-2.738L23.875 6.12C23.13 5.372 22.218 5 21.139 5c-1.087 0-2.004.382-2.75 1.146l-2.777 2.79c-.75.747-1.12 1.66-1.12 2.737 0 1.105.392 2.045 1.183 2.817l-1.186 1.186c-.774-.79-1.708-1.186-2.805-1.186-1.078 0-1.995.377-2.75 1.132L6.13 18.426c-.754.755-1.13 1.672-1.13 2.75l.003.001Z"></path></svg></label><input id="a2a_copy_link_text" type="text" title="Copy link" readonly=""><div id="a2a_copy_link_copied">✓</div></div><div class="a2a_modal_body a2a_menu a2a_thanks a2a_hide" id="a2a_thanks"><div class="a2a_localize" data-a2a-localize="inner,ThanksForSharing">Thanks for sharing!</div></div></div><div class="a2a_menu a2a_full a2a_localize" id="a2apage_full" role="dialog" tabindex="-1" aria-label="Share" data-a2a-localize="title,Share"><div class="a2a_full_header"><div id="a2apage_find_container" class="a2a_menu_find_container"><label for="a2apage_find" id="a2apage_find_icon" class="a2a_svg a2a_s_find"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" aria-hidden="true"><title>Find any service</title><path fill="#CCC" d="M19.7 18.2l-4.5-4.5c.7-1.1 1.2-2.3 1.2-3.6 0-3.5-2.8-6.3-6.3-6.3s-6.3 2.8-6.3 6.3 2.8 6.3 6.3 6.3c1.4 0 2.6-.4 3.6-1.2l4.5 4.5c.6.6 1.3.7 1.7.2.5-.4.4-1.1-.2-1.7zm-9.6-3.6c-2.5 0-4.5-2.1-4.5-4.5 0-2.5 2.1-4.5 4.5-4.5 2.5 0 4.5 2.1 4.5 4.5s-2 4.5-4.5 4.5z"></path></svg></label><input id="a2apage_find" class="a2a_menu_find a2a_localize" type="text" autocomplete="off" title="Find any service" data-a2a-localize="title,FindAnyServiceToAddTo"></div></div><div class="a2a_full_services" id="a2apage_full_services" role="presentation"></div><div class="a2a_full_footer"><a href="https://www.addtoany.com" title="Share Buttons" rel="noopener" target="_blank"><span class="a2a_svg a2a_s__default a2a_s_a2a a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><g fill="#FFF"><path d="M14 7h4v18h-4z"></path><path d="M7 14h18v4H7z"></path></g></svg></span>AddToAny</a></div></div><div id="a2apage_dropdown" class="a2a_menu a2a_mini a2a_localize a2a_hide" tabindex="-1" aria-label="Share" data-a2a-localize="label,Share"><div class="a2a_mini_services" id="a2apage_mini_services"></div><div id="a2apage_cols_container" class="a2a_cols_container"><div class="a2a_col1" id="a2apage_col1"></div><div id="a2apage_2_col1" class="a2a_hide"></div><div class="a2a_clear"></div></div><div class="a2apage_wide a2a_wide"><a href="#addtoany" id="a2apage_show_more_less" class="a2a_more a2a_localize" title="Show all" data-a2a-localize="title,ShowAll"><span class="a2a_svg a2a_s__default a2a_s_a2a a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><g fill="#FFF"><path d="M14 7h4v18h-4z"></path><path d="M7 14h18v4H7z"></path></g></svg></span><span class="a2a_localize" data-a2a-localize="inner,More">More…</span></a></div></div><div style="height: 1px; width: 1px; position: absolute; z-index: 100000; top: 0px; visibility: hidden;"><iframe id="a2a_sm_ifr" title="AddToAny Utility Frame" aria-hidden="true" src="https://static.addtoany.com/menu/sm.25.html#type=core&amp;event=load" style="height: 1px; width: 1px; border: 0px; left: 0px; top: 0px; position: absolute; z-index: 100000; display: none;"></iframe></div></div><div id="janrainEngageEmbed" style="display: none;"><div class="janrainContent" style="width: 380px !important; height: 156px !important; padding-left: 5px !important; padding-right: 5px !important; box-sizing: content-box !important; background-color: rgb(255, 255, 255) !important; border: 1px solid rgb(192, 192, 192) !important; border-radius: 10px !important; overflow: hidden !important; position: relative !important;"><div id="janrainView"><div class="janrainHeader" style="background-color: rgb(255, 255, 255) !important; font-size: 14px !important; color: rgb(102, 102, 102) !important; position: relative !important; height: 20px !important; left: -5px !important; padding: 5px 5px 0px !important; white-space: nowrap !important; width: 380px !important; z-index: 100 !important; border-radius: 10px 10px 0px 0px !important; text-align: left !important;"><div style="padding-left: 1px !important; font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important;">Sign in using your account with</div></div><div id="janrainProviderPages" style="padding-top: 5px; left: 5px; position: absolute;"><div class="janrainPage" pageindex="0"><ul class="providers" id="janrainProviders_0" style="float: left !important; list-style-type: none !important; margin: 0px !important; padding: 0px !important;"><li id="janrain-aol" role="button" style="list-style: none !important; height: 30px !important; width: 185px !important; margin-top: 0px !important; margin-right: 5px !important; margin-bottom: 5px !important; position: relative !important; border: 1px solid rgb(204, 204, 204) !important; border-radius: 5px !important; cursor: pointer !important; white-space: nowrap !important; overflow: hidden !important; background-image: -webkit-linear-gradient(bottom, rgb(238, 238, 238), rgb(255, 255, 255)) !important;"><a tabindex="1" href="javascript:void(0);" style="font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; font-size: 12px !important; line-height: 14px !important; margin-left: auto !important; margin-right: auto !important; text-decoration: none !important; display: block !important; padding-left: 5px !important; padding-right: 5px !important; text-align: left !important; width: auto !important;"><span class="janrain-provider-icon-24 janrain-provider-icon-aol" style="margin-top: 3px !important; background-color: transparent !important;"></span><span class="janrain-provider-text-color-aol" style="font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; cursor: pointer !important; margin-left: 7px !important; text-align: left !important; margin-top: 9px !important; vertical-align: top !important; display: inline-block !important;">AOL</span></a></li><li id="janrain-openid" role="button" style="list-style: none !important; height: 30px !important; width: 185px !important; margin-top: 0px !important; margin-right: 5px !important; margin-bottom: 5px !important; position: relative !important; border: 1px solid rgb(204, 204, 204) !important; border-radius: 5px !important; cursor: pointer !important; white-space: nowrap !important; overflow: hidden !important; background-image: -webkit-linear-gradient(bottom, rgb(238, 238, 238), rgb(255, 255, 255)) !important;"><a tabindex="3" href="javascript:void(0);" style="font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; font-size: 12px !important; line-height: 14px !important; margin-left: auto !important; margin-right: auto !important; text-decoration: none !important; display: block !important; padding-left: 5px !important; padding-right: 5px !important; text-align: left !important; width: auto !important;"><span class="janrain-provider-icon-24 janrain-provider-icon-openid" style="margin-top: 3px !important; background-color: transparent !important;"></span><span class="janrain-provider-text-color-openid" style="font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; cursor: pointer !important; margin-left: 7px !important; text-align: left !important; margin-top: 9px !important; vertical-align: top !important; display: inline-block !important;">OpenID</span></a></li></ul><ul class="providers" id="janrainProviders_1" style="float: left !important; list-style-type: none !important; margin: 0px !important; padding: 0px !important;"><li id="janrain-yahoo" role="button" style="list-style: none !important; height: 30px !important; width: 185px !important; margin-top: 0px !important; margin-right: 5px !important; margin-bottom: 5px !important; position: relative !important; border: 1px solid rgb(204, 204, 204) !important; border-radius: 5px !important; cursor: pointer !important; white-space: nowrap !important; overflow: hidden !important; background-image: -webkit-linear-gradient(bottom, rgb(238, 238, 238), rgb(255, 255, 255)) !important;"><a tabindex="2" href="javascript:void(0);" style="font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; font-size: 12px !important; line-height: 14px !important; margin-left: auto !important; margin-right: auto !important; text-decoration: none !important; display: block !important; padding-left: 5px !important; padding-right: 5px !important; text-align: left !important; width: auto !important;"><span class="janrain-provider-icon-24 janrain-provider-icon-yahoo" style="margin-top: 3px !important; background-color: transparent !important;"></span><span class="janrain-provider-text-color-yahoo" style="font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; cursor: pointer !important; margin-left: 7px !important; text-align: left !important; margin-top: 9px !important; vertical-align: top !important; display: inline-block !important;">Yahoo!</span></a></li></ul></div></div><div style="background-color: rgb(255, 255, 255) !important; width: 380px !important; height: 10px !important; position: absolute !important; left: 0px !important; padding-left: 5px !important; padding-right: 5px !important; padding-bottom: 5px !important; bottom: 0px !important; font-size: 10px !important; text-align: left !important; color: rgb(102, 102, 102) !important; font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; border-radius: 0px 0px 10px 10px !important;"><div style="padding-left: 1px !important;"><a href="http://janrain.com/products/engage/social-login?utm_source=mms.rpxnow.com&amp;utm_medium=Partner&amp;utm_campaign=attribution" target="_blank">Social Login by Janrain</a></div></div></div></div></div><cvx-gnfrhwgmhcog></cvx-gnfrhwgmhcog><script type="text/javascript" src="https://api.altmetric.com/v1/internal-556fdf0f/doi/10.1056/nejmoa1913948?callback=_altmetric.embed_callback&amp;domain=www.nejm.org&amp;cache_until=2-10"></script><div role="status" aria-live="assertive" aria-relevant="additions" class="ui-helper-hidden-accessible"></div><iframe name="captureIFrame_gu451ac1ynhy6e7c2oelk83swqfs2vvf6tlf5lxu" data-transactionid="gu451ac1ynhy6e7c2oelk83swqfs2vvf6tlf5lxu" id="captureIFrame_gu451ac1ynhy6e7c2oelk83swqfs2vvf6tlf5lxu" src="about:blank" class="" data-captureiframeloadeventbound="yes" style="display: none;"></iframe><div id="janrainModalOverlay" style="inset: 0px; position: fixed; background-color: rgb(0, 0, 0); opacity: 0.4; display: none; z-index: 1000;"></div><div id="janrainModal" style="width: 380px; height: 131px; position: absolute; z-index: 1000; display: none;"><a href="#" class="janrain_modal_closebutton" style="position: absolute; cursor: pointer; z-index: 1000;">X</a><div style="display: block;" id="signIn" class="ucc-widgets-nejm-next janrain-capture-ui capture-ui-content capture_screen_container" data-capturescreenname="signIn" data-captureventadded="true">
    <div class="capture_header">
      <h1>Sign In</h1>
    </div>    
    <div class="capture_signin">
      <form id="capture_signIn_signInForm" name="signInForm" data-capturefield="signInForm" action="https://mms.us.janraincapture.com/widget/traditional_signin.jsonp" class="capture_form capture_signInForm" method="POST" novalidate="novalidate" data-transactionid="gu451ac1ynhy6e7c2oelk83swqfs2vvf6tlf5lxu" target="captureIFrame_gu451ac1ynhy6e7c2oelk83swqfs2vvf6tlf5lxu" accept-charset="UTF-8" next="{&quot;noop&quot;:&quot;&quot;}"><div id="capture_signIn_signInForm_defaultSavedProfileMessage"></div><div id="capture_signIn_signInForm_errorMessages"></div><input id="capture_signIn_utf8" data-capturefield="undefined" value="✓" type="hidden" class="capture_utf8" name="utf8"><input id="capture_signIn_screen_gu451ac1ynhy6e7c2oelk83swqfs2vvf6tlf5lxu" data-capturefield="undefined" value="signIn" type="hidden" class="capture_screen_gu451ac1ynhy6e7c2oelk83swqfs2vvf6tlf5lxu" name="capture_screen"><input id="capture_signIn_js_version_gu451ac1ynhy6e7c2oelk83swqfs2vvf6tlf5lxu" data-capturefield="undefined" value="d445bf4" type="hidden" class="capture_js_version_gu451ac1ynhy6e7c2oelk83swqfs2vvf6tlf5lxu" name="js_version"><input id="capture_signIn_transactionId_gu451ac1ynhy6e7c2oelk83swqfs2vvf6tlf5lxu" data-capturefield="undefined" value="gu451ac1ynhy6e7c2oelk83swqfs2vvf6tlf5lxu" type="hidden" class="capture_transactionId_gu451ac1ynhy6e7c2oelk83swqfs2vvf6tlf5lxu" name="capture_transactionId"><input id="capture_signIn_form_gu451ac1ynhy6e7c2oelk83swqfs2vvf6tlf5lxu" data-capturefield="undefined" value="signInForm" type="hidden" class="capture_form_gu451ac1ynhy6e7c2oelk83swqfs2vvf6tlf5lxu" name="form"><input id="capture_signIn_flow_gu451ac1ynhy6e7c2oelk83swqfs2vvf6tlf5lxu" data-capturefield="undefined" value="standard" type="hidden" class="capture_flow_gu451ac1ynhy6e7c2oelk83swqfs2vvf6tlf5lxu" name="flow"><input id="capture_signIn_client_id_gu451ac1ynhy6e7c2oelk83swqfs2vvf6tlf5lxu" data-capturefield="undefined" value="qsra7g4d6jwdsgn3zbe6udp6r6278mr9" type="hidden" class="capture_client_id_gu451ac1ynhy6e7c2oelk83swqfs2vvf6tlf5lxu" name="client_id"><input id="capture_signIn_redirect_uri_gu451ac1ynhy6e7c2oelk83swqfs2vvf6tlf5lxu" data-capturefield="undefined" value="https://www.nejm.org" type="hidden" class="capture_redirect_uri_gu451ac1ynhy6e7c2oelk83swqfs2vvf6tlf5lxu" name="redirect_uri"><input id="capture_signIn_response_type_gu451ac1ynhy6e7c2oelk83swqfs2vvf6tlf5lxu" data-capturefield="undefined" value="code" type="hidden" class="capture_response_type_gu451ac1ynhy6e7c2oelk83swqfs2vvf6tlf5lxu" name="response_type"><input id="capture_signIn_flow_version_gu451ac1ynhy6e7c2oelk83swqfs2vvf6tlf5lxu" data-capturefield="undefined" value="20240514181256512029" type="hidden" class="capture_flow_version_gu451ac1ynhy6e7c2oelk83swqfs2vvf6tlf5lxu" name="flow_version"><input id="capture_signIn_settings_version_gu451ac1ynhy6e7c2oelk83swqfs2vvf6tlf5lxu" data-capturefield="undefined" value="" type="hidden" class="capture_settings_version_gu451ac1ynhy6e7c2oelk83swqfs2vvf6tlf5lxu" name="settings_version"><input id="capture_signIn_locale_gu451ac1ynhy6e7c2oelk83swqfs2vvf6tlf5lxu" data-capturefield="undefined" value="en-US" type="hidden" class="capture_locale_gu451ac1ynhy6e7c2oelk83swqfs2vvf6tlf5lxu" name="locale"><input id="capture_signIn_recaptcha_version_gu451ac1ynhy6e7c2oelk83swqfs2vvf6tlf5lxu" data-capturefield="undefined" value="2" type="hidden" class="capture_recaptcha_version_gu451ac1ynhy6e7c2oelk83swqfs2vvf6tlf5lxu" name="recaptchaVersion">
      <div class="ucc-form-inner-wrapper">
        <div id="capture_signIn_form_item_signInEmailAddress" class="capture_form_item capture_email capture_form_item_signInEmailAddress" data-capturefield="undefined"><label for="capture_signIn_signInEmailAddress">Email Address</label><input id="capture_signIn_signInEmailAddress" data-capturefield="signInEmailAddress" value="" type="email" class="capture_signInEmailAddress capture_required capture_text_input" placeholder="Email Address" name="signInEmailAddress"><div class="capture_tip" style="display:none;"></div><div class="capture_tip_validating" data-elementname="signInEmailAddress">Validating</div><div class="capture_tip_error" data-elementname="signInEmailAddress"></div></div>
        <div id="capture_signIn_form_item_currentPassword" class="capture_form_item capture_password capture_form_item_currentPassword" data-capturefield="undefined"><label for="capture_signIn_currentPassword">Password</label><input id="capture_signIn_currentPassword" data-capturefield="currentPassword" value="" type="password" class="capture_currentPassword capture_required capture_text_input" placeholder="Password" name="currentPassword"><div class="capture_tip" style="display:none;"></div><div class="capture_tip_validating" data-elementname="currentPassword">Validating</div><div class="capture_tip_error" data-elementname="currentPassword"></div></div>
        <div style="padding-top:10px;">
            <div class="capture_form_item capture_form_rememberme">
                <label class="ucc-form-checkbox">                
                    <input checked="checked" id="ucc-remember-me-cb" name="ucc-remember-me-cb" type="checkbox" value="true">
                    <span>Remember Me</span>
                </label>          
            </div>
            <div class="capture_form_item capture_form_forgotpwd">
              <a role="button" class="ucc-anchor-button" data-capturescreen="forgotPassword">Forgot your password?</a>
            </div>
        </div>
        <div class="capture_form_item">
          <button id="ucc-sign-in-submit" class="capture_primary capture-full-width-btn" type="submit">Sign In</button>
        </div>
       
        <div class="capture_form_item">
          <div class="ucc-no-acct-msg">Don't have an account?</div>
          <div class="ucc-no-acct-msg-2" id="signInModalCreateAccountLink">
          <a role="button" class="ucc-anchor-button" onclick="mmsWidgets.closeSignIn(event); mmsWidgets.showRegAuto(event);">Create Account</a>
            <span></span><a href="https://store.nejm.org/nejm?promo=ONF4NRS1">Subscribe</a>
          </div>

          <div class="ucc-no-acct-msg-2" id="signInModalCloseLink" style="display:none">
          <a role="button" class="ucc-anchor-button" onclick="mmsWidgets.closeSignIn(event);">Create Account</a>
            <span></span><a href="https://store.nejm.org/nejm?promo=ONF4NRS1">Subscribe</a>
          </div>

        </div>
     
        <div class="capture_form_item capture_form_submit">
          
        </div>      
      </div>
      </form>
    </div>
  </div></div></body></html>